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Abstract 
Cardiac fibroblasts are the most numerous cells within the heart. Their traditional roles 
are the maintenance of the extracellular matrix to support the structure and 
contraction of the heart, and their activation and production of increased extracellular 
matrix in disease. Over the past 15 years, evidence has grown that shows fibroblasts 
are capable of modulating myocyte function. This is achieved through paracrine 
mediators, the release of biologically active soluble substances into the local 
environment, and through direct cell contact, involving gap junctions and mechanical 
connections. Fibroblasts can also modulate myocyte function indirectly through 
modification of the extracellular matrix which can transfer various signals to myocytes. 
However, research into the interaction between fibroblasts and myocytes has been 
largely limited to using neonatal cells and fibroblasts that have been maintained in 
culture. 
 
This thesis sets out to examine the paracrine effects of fibroblasts on myocyte 
structure and excitation contraction coupling. Adult myocytes and, where possible, 
fibroblasts before their activation in culture were used. The thesis also aimed to 
determine whether these effects are different using fibroblasts after pressure overload 
of the myocardium and potential mediators involved in the effects. 
 
Initial studies looked at the effect of normal rat cardiac fibroblasts isolated from 
healthy rat hearts, and showed that these fibroblasts reduced myocyte viability, 
induced myocyte hypertrophy and increased the amplitude of the Ca2+ transient. We 
then compared the effect of fibroblasts from pressure overloaded hearts with control 
fibroblasts. The pressure overloaded fibroblasts caused a similar reduction in myocyte 
viability and also induced myocyte hypertrophy. However, the functional effects were 
different and the Ca2+ transient amplitude was reduced in myocytes co-cultured with 
pressure overload fibroblasts.  
 
TGF-β was elevated in the both pressure overload and control fibroblasts co-cultures 
and was therefore investigated as the potential mediator of the effects. It was found 
 7 
that fibroblast derived TGF-β directly causes myocyte hypertrophy, whereas the other 
effects are due to more complex signalling with the involvement of secondary 
mediators released from the fibroblasts in response to TGF-β signalling. 
 
Finally, we investigated the paracrine effects of cultured canine fibroblasts on the 
electrical activity of adult myocardium using canine myocardial slices. These are thin 
viable slices of the left ventricle and allowed us to investigate the field potential and 
the conduction velocity of intact adult myocardium. It was found that fibroblasts-
derived paracrine mediators altered the conduction velocity of these slices.  
 
This work supports the growing body of evidence that fibroblasts are capable of 
modulating myocyte structure and function and, specifically, myocyte excitation 
contraction coupling. We have shown that these effects are evident in adult cells and 
are altered using fibroblasts from normal and diseased heart. Furthermore, we have 
shown that TGF-β appears to be central to these effects. 
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The heart is fundamental to life. The supply of blood, with the nutrients it carries and 
the waste it removes, is essential for every tissue within the body. To achieve this, a 
mammalian heart beats an average of 730,000,000 times over a lifetime (Levine, 
1997). 
 
Heart failure, which is defined as the inability of the heart to meet the metabolic 
demands of tissue (Jessup and Brozena, 2003), is universally prevalent. It is the leading 
cause of mortality in Europe and North America, accounting for nearly 50% of deaths, 
and is increasingly encountered in developing countries where it is already ranked the 
third most common cause of death (Murray and Lopez, 1997, Mendez and Cowie, 
2001). Although care for heart failure is improving, 6 month mortality was 14% in 
2004-5 (Mehta et al., 2009) , and heart failure also has a particularly significant impact 
on quality of life (Hobbs et al., 2002). In addition it presents a substantial burden on 
health care. Heart failure is one of the top ten diagnoses for hospital bed use and in 
2009 was estimated to cost the NHS £9 billion and the UK economy as a whole 
£19billion.1 
 
Heart failure is a complex syndrome that can result from a number of prior conditions, 
for example genetic disease, such as hypertrophic cardiomyopathy, or after ischemic 
injury from a myocardial infarction. Heart failure can involve failure of the left, right or 
both ventricles, and results in symptoms including breathlessness (due to pulmonary 
oedema), lethargy and reduced exercise capacity. The progression of heart failure is 
assessed using the New York Heart Association class system2. Class I describes patients 
with no functional restriction but with increasing symptoms patients enter higher 
classes, with class IV (the highest class) describing patients who cannot perform 
physical activity without breathlessness or discomfort and show symptoms at rest. 
 
Care for patients with heart failure has improved considerably. Early treatment 
included positive inotropes such as digitalis, to increase cardiac contractility, and 
                                                 
1
  British Heart Foundation Coronary Heart Disease Statistics 2012 
   http://www.bhf.org.uk/publications/view-publication.aspx?ps=1002097 
2
 The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of 
Diseases of the Heart and Blood Vessels. Boston: Little Brown, 1964. 
 20 
diuretics and rest, to reduce the load placed on the ventricles (Eichhorn and Bristow, 
1996). This provided symptomatic relief but in clinical trial was shown to have no 
benefit on mortality (Cohn et al., 1986, Packer et al., 1991). With the improving 
understanding of heart failure progression and novel therapies, treatment moved from 
positive inotropes and rest to negative inotropes, exercise and angiotensin converting 
enzyme inhibitors. This improvement in treatment is reflected by improved mortality 
figures with 6-month mortality falling from 26% in 1995-7 to 14% in 2004-5 (Mehta et 
al., 2009) . 
 
However, the treatment for heart failure is still largely only able to slow the 
progression of the disease. Therefore further understanding of the processes involved 
in heart failure initiation and progression are important in providing potential new 
targets for intervention and further improve patient outcomes.  
 
Despite the clear importance of the heart in health and the burden of heart disease, 
there are still many unknown elements to cardiac physiology and the processes 
involved in the pathogenesis of cardiac pathology, and an improved knowledge may 
improve future therapy. The focus of this thesis is to advance the understanding of the 
most common of all cells within the heart, cardiac fibroblasts, and their influence on 
myocyte excitation contraction coupling. 
 
1.1. Makeup of the heart 
The heart’s ultimate function is to pump blood around the body, which is achieved by 
the contraction of myocytes within the myocardium. However, to achieve successful 
cardiac muscle contraction there are many specialist structures and cells that are 
important in controlling and optimising heart function.  
 
1.1.1. Conduction system 
The cardiac conduction system is a network of specialised myocytes that initiates and 
controls the electrical impulses that stimulate each heartbeat. Cells within the sino 
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atrial node have specialised currents that allow controlled and consistent initiation of 
the electrical impulse, that is then directed around the heart via the atrioventricular 
node, bundle of His and Purkinje fibres to produced directed and efficient contraction 
of the myocardium (Moorman et al., 1998). 
 
1.1.2. Valves 
The valves control the unidirectional flow of blood essential for the efficient 
functioning of the heart (Nolan and Muller, 1965). The importance of the valves is 
clearly demonstrated by the extensive problems that arise when the valves become 
diseased and normal blood flow is interrupted (Shipton and Wahba, 2001) and surgical 
intervention to correct valve function accounted for 42% of all adult cardiac surgery in 
the UK in 2010.3 
 
1.1.3. Coronary vasculature 
The high energy demands of the heart mean that the coronary vasculature receives 
approximately 5% of total cardiac output at rest (Ramanathan and Skinner, 2005). The 
control of this system is essential for effective cardiac physiology, and disease of the 
vasculature is the main cause of cardiovascular pathology (Hansson, 2005). 
 
1.1.4. Working myocardium 
The working myocardium produces the force to expel blood from the heart and pump 
it around the body, which is achieved by the contraction of myocytes. However, the 
myocardium also contains non-myocyte cells. 
 
Fibroblasts are the most numerous cell type within the rat myocardium, accounting for 
62% of all cells and, although in adult mice they represent only 27% of the total 
number of cells, they are still the largest population of non-myocyte cells (Banerjee et 
al., 2007). The study of fibroblasts has historically been limited, due to a perception 
                                                 
3
 National Adult Cardiac Surgery Audit 2010-2011. National Institute for Cardiovascular Outcomes 
Research. 
http://www.ucl.ac.uk/nicor/audits/Adultcardiacsurgery/publications/pdfs/NACSA_annual_report_FINAL 
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that the cells were passive bystanders in myocardial function. However, more recently 
interest in these cells has grown and the role of fibroblasts in the structural, 
biochemical and mechanical functioning of the myocardium is beginning to be 
unravelled (Camelliti et al., 2005, Porter and Turner, 2009). 
 
1.2. What are fibroblasts 
Fibroblasts are cells of mesenchymal origin that are distributed diffusely throughout 
the heart as well as being found throughout the body. They are traditionally defined by 
their expression of extracellular matrix (ECM) molecules. The National Library of 
Medicine Unified Medical Language System defines them as ‘connective tissue cells 
which secrete an extracellular matrix rich in collagen and other macromolecules’.4 
Cardiac fibroblasts produce collagen types I, III, IV, V and VI as well as other ECM 
proteins such as elastin, laminin and fibronectin (Bosman and Stamenkovic, 2003).  
 
Despite this definition, ECM synthesis and deposition are not commonly used to 
identify fibroblasts, but instead they are identified by morphological characteristics 
and cellular markers. Fibroblasts are flat cells with elongated processes that lead to 
their characteristic spindle shape. They contain a single oval nucleus and an extensive 
rough endoplasmic reticulum and Golgi apparatus. In cardiac tissue, fibroblasts are the 
only cells that do not have a basement membrane (Krenning et al., 2010). The 
identification of fibroblasts by cellular markers is difficult due to the lack of truly 
specific markers (discussed in more detail in section 1.3.1). However, in general, 
fibroblasts can be stained for vimentin (Figure 1.1). This also marks smooth muscle and 
endothelial cells but these can be discriminated by the different morphology (Camelliti 
et al., 2005) 
 
 
                                                 
4
 Unified medical language system, National Institute of Health (https://uts.nlm.nih.gov/home.html) 
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Figure 1.1: Fibroblasts within the myocardium and in vitro 
A) Transverse myocardial section of sheep left ventricle with myocytes in red 
(myomesin) and fibroblasts in blue (vimentin) showing the diffuse distribution of 
fibroblasts throughout the myocardium. Connexin 43 in green and nuclei in pale yellow 
(DAPI) are also stained. Scale bar: 20µm. (reproduced with permission from (Kohl et 
al., 2005)) B) Canine cardiac fibroblasts stained for vimentin (green) and nuclei marked 
with propidium iodide (red) in culture. 
 
 
1.2.1. Source of fibroblasts in physiology 
The major source of fibroblasts in the normal myocardium is cells that arise from the 
proepicardium during embryonic development. Proepicardial cells migrate as an 
epithelium over the heart to produce the epicardium. The epicardial cells then 
undergo epithelial to mesenchymal transformation into epicardial derived cells, which 
invade the myocardium walls during the late embryonic and foetal periods. These 
epicardial-derived cells then differentiate into fibroblasts (Lie-Venema et al., 2007). 
 
Further to the recruitment of cells during development, the contribution of 
hematopoietic stem cell derived cells to the fibroblast population in normal 
myocardium has also recently been demonstrated (Visconti and Markwald, 2006). 
These may represent a post-natal source of fibroblasts in the normal heart. 
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Fibroblasts are also found in the cardiac valves which are derived from a different 
source. They arise from endothelial-to-mesenchymal transformation of cells in the 
cardiac endothelium which invade the cardiac jelly and mature into fibroblasts (de 
Lange et al., 2004). 
 
1.2.2. Source of fibroblasts in pathology 
Increased levels of fibrosis are common to many cardiac pathologies and are 
associated with an increased number of fibroblasts (Weber, 1989, Vliegen et al., 1991). 
However, the source of these fibroblasts is not fully established. 
 
Despite the large number of resident fibroblasts in the normal heart and their ability to 
proliferate, their contribution to the increased fibroblast numbers in pathological 
conditions may be small. Resident fibroblasts may be activated by mechanical or 
humoral factors in pathology but their proliferation appears to be very limited 
(Mandache et al., 1973). Instead, the recruitment of new cells accounts for most of the 
increase in fibroblasts observed in disease (Zeisberg et al., 2007). 
 
The source of these recruited fibroblasts has been investigated by transplanting 
fluorescent marked cells into recipient mice. Using this technique, bone marrow 
derived cells were identified as a major source of fibroblasts in cardiac pathology. After 
pressure overload, 21% of fibroblasts in the heart were derived from bone marrow 
cells (Zeisberg et al., 2007). van Amerongen et al (2008) found that 24% of fibroblasts 
in the heart were bone marrow-derived 7 days after myocardial infarction and 
although the number then reduced, some cells were still present at 28 days. The 
transfer of fluorescent monocytes into recipient mice showed that they may also 
contribute to the fibroblast population after myocardial infarction (Fujita et al., 2007). 
In addition, Zeisberg et al (2007) showed that some cardiac fibroblasts in disease were 
derived from endothelial-to-mesenchymal transformation, the process that gives rise 
to valve fibroblasts during development. 
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Evidently, various sources of fibroblasts exist in cardiac disease. It is possible that they 
produce distinct end products with different roles in the disease process. For example, 
it has been shown that fibroblasts within the scar and remote regions are dominated 
by fibroblasts from different origins (Crawford et al., 2012). This is an interesting 
proposition that may allow more targeted approaches to intervening in cardiac 
fibrosis.  
 
1.3. Difficulties associated with investigating fibroblasts 
Before discussing the role of fibroblasts in the myocardium, the difficulties associated 
with studying them need to be examined. 
 
1.3.1. Molecular Identification of fibroblasts 
One difficulty when working with fibroblasts is the identification of the cells. To date, a 
truly specific marker has not been identified. As mesenchymal cells fibroblasts stain 
positive for vimentin, which has been used to identify cardiac fibroblasts in tissue 
sections (Camelliti et al., 2004a). However, vimentin also marks endothelial cells, 
smooth muscle cells and other mesenchymal cell types and therefore for accurate 
identification these cells need to be excluded (e.g. (Chang et al., 2002)).  
 
Early targets for the development of specific antibodies for fibroblast identification 
were based around the ECM proteins produced by the cells. For example, an antibody 
was produced against the cleaved carboxy terminus of pro-collagen (McDonald et al., 
1986). However, this was found to identify active, dividing fibroblasts only and did not 
identify quiescent cells. ECM markers are still used to identify fibroblasts. 
Commercially available fibroblasts are selected for by the expression of fibronectin5, 
although fibronectin is also expressed by endothelial and other cells (Jaffe and Mosher, 
1978). 
 
                                                 
5
 ScienCell research laboratories, USA (http://www.sciencellonline.com/) 
 26 
More recently, further putative specific fibroblast markers have been suggested. 
Discoidin domain receptor 2 (DDR2) and fibroblast specific protein 1 (FSP1) have both 
been reported as being fibroblast-specific within the myocardium. 
 
DDR2 is a collagen receptor tyrosine kinase that was initially reported as a fibroblast 
specific marker (Goldsmith et al., 2004). It is involved in transferring signals from the 
ECM to cells, and its absence reduces fibroblast proliferation and collagen production 
(Labrador et al., 2001, Olaso et al., 2011). However, others have reported DDR2 
expression in smooth muscle cells (Ferri et al., 2004). Therefore use of DDR2 as a 
marker for fibroblasts still requires the exclusion of smooth muscle cells by the 
absence of desmin (Rohr, 2011). 
 
FSP1 was also initially reported to be fibroblast-specific in the heart (Strutz et al., 
1995). However, it appears to only stain a sub-population of fibroblasts (Iwano et al., 
2002). Another report questioned its specificity as in the liver it did not mark 
fibroblasts and instead stained a population of macrophages (Osterreicher et al., 
2011). 
 
Other markers have been used for fibroblasts in different tissues. TE-7, an antibody 
raised against thymus stroma (Haynes et al., 1984), has been reported to specifically 
mark fibroblasts (Goodpaster et al., 2008). Other markers used include fibroblast 
surface antigen (Wartiovaara et al., 1974) and cadherin-9 (Thedieck et al., 2007). 
 
Despite these reports, a truly specific and also global marker of cardiac fibroblasts is 
still not available (Krenning et al., 2010). 
 
1.3.2. In vivo fibroblast studies 
The lack of specific markers for fibroblasts presents an even greater problem when 
trying to study fibroblasts in vivo. The production of genetically modified animals has 
provided a valuable tool for cardiovascular research, and biological research in general 
(Ramachandran et al., 2008). Further insight can be gained by the production of 
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inducible genetic modification with cre- lox technology (Nagy, 2000) as well as using 
cell specific promoters, such as α-myosin heavy chain in cardiomyocytes, to produce 
cell specific modifications (Heine et al., 2005). 
 
An established fibroblast-specific promoter to allow genetic manipulation would 
provide a platform for a far greater in vivo insight into fibroblast function. There are 
some reports of fibroblast-specific promoters. FTS-1, part of the FSP-1 promoter has 
been reported to be a fibroblast-specific promoter (Okada et al., 1998) and has been 
used to produce fibroblast-specific knockout mice (Liu et al., 2010, Kim et al., 2012). A 
fibroblast-specific regulatory sequence from the proα2(I)collagen gene has also been 
used to drive fibroblast-specific expression (Zheng et al., 2002) and has been used to 
target fibroblasts in the heart (Lother et al., 2011). Periostin has also been used to 
produce a non-myocyte specific modification in the heart (Takeda et al., 2010).  
 
Further establishment of a promoter will aid fibroblast research. Ultimately not just a 
fibroblast-specific, but a cardiac fibroblast specific promoter would be most beneficial. 
 
1.3.3. Changes to fibroblast phenotype in culture 
Due to the difficulty of studying fibroblasts in situ, they are mainly studied using 
isolated cells in culture (Rohr, 2011). Fibroblasts are readily isolated and cultured, 
although they have a limited proliferative capacity (Hayflick, 1965).The ability to 
isolate and culture fibroblasts has enabled investigations into their function, and is 
essential for the research involved in this thesis. Fibroblasts, however, are very 
dynamic cells and undergo alterations to their phenotype in culture (Rohr, 2011). 
Therefore the application of information gained from cultured fibroblasts to a specific 
in vivo setting is challenging. 
 
The most obvious and widely reported change in fibroblasts in culture is the 
development of α-smooth muscle actin (α-SMA) expression (e.g. (Benamer et al., 2009, 
Thompson et al., 2011, Dawson et al., 2012)). In vivo, α-SMA is associated with the 
differentiation of fibroblasts in disease and these α-SMA positive cells are termed 
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myofibroblasts (Weber, 2004). Throughout this thesis the term myofibroblasts will be 
avoided, as it is potentially confusing and therefore cells will be defined as fibroblasts 
with information regarding their source provided. 
 
As well as developing α-SMA expression, fibroblasts expression of ECM collagen and 
fibronectin are altered by culture (Dawson et al., 2012). Fibroblasts from control and 
myocardial infarction also alter their expression of connexins in vitro (Vasquez et al., 
2010). In addition, fibroblast electrophysiology is altered by culture (Benamer et al., 
2009). 
 
Whether fibroblasts with α-SMA expression induced in vitro are representative of 
fibroblasts from disease is debated. There are some similarities reported. For example, 
fibroblasts in culture develop an ATP-sensitive K+ current that also develops in 
fibroblasts after myocardial infarction (Benamer et al., 2009). Rohr (2011) argues that 
these cells are comparable and therefore our knowledge from cultured fibroblasts can 
be used to understand fibroblasts in disease. However, this would appear to 
oversimplify the matter. Firstly, fibroblasts in disease come from different sources (as 
discussed in section 1.2.2) whereas the α-SMA positive cells in culture come only from 
differentiation and proliferation of resident fibroblasts. Fibroblasts isolated from 
diseased hearts are themselves changed in culture (Vasquez et al., 2010, Dawson et al., 
2012). Also, the phenotypes of fibroblasts from normal and diseased hearts in culture 
are different. Various reports show these differences are maintained for prolonged 
periods of time (Flack et al., 2006, Jarvis et al., 2006, Vasquez et al., 2010), although 
others have found that cells from diseased and normal hearts rapidly lose differences 
(Dawson et al., 2012). Furthermore, cultured fibroblasts treated with transforming 
growth factor-β (TGF-β), a potent activator of fibroblasts in disease (Gordon and Blobe, 
2008), undergo further changes even after prolonged culture (Adapala et al., 2013). It 
would therefore appear that fibroblasts in culture are different from both fibroblasts in 
the normal heart and fibroblasts in cardiac disease.  
 
Various elements of culture systems have been shown to affect fibroblast phenotype. 
One of the main elements that has been investigated is the stiffness or elastic modulus 
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of the substrate on which fibroblasts are cultured. Normally fibroblasts are cultured on 
stiff plastic substrates, but the effects of using more flexible substrates have been 
investigated. Using human gingival fibroblasts, reducing the stiffness of collagen 
substrates limited the increase of α-SMA expression in response to TGF-β (Arora et al., 
1999). Also, fixing granuloma tissue to increase tension induced α-SMA expression in 
the fibroblasts (Hinz et al., 2001). In a normal rat heart, the elastic modulus is 
approximately 18kPa and increases in infarcted areas to around 55kPa (Berry et al., 
2006). This information may be useful in directing effort to adapt culture conditions. 
Culture of rat cardiac fibroblasts on substrates with a elastic modulus of 15kPa 
reduced the amount of α-SMA compared to stiffer substrates. However, this was only 
seen after the 4th passage and there was no difference during the first 3 passages. 
Also, 65% of cells were still α-SMA positive (Castella et al., 2010). Embryonic cardiac 
fibroblasts cultured on a less rigid substrate of 9.6kPa prevented the development of 
α-SMA stress fibres compared to more rigid substrates, although there was still α-SMA 
expression within the cytosol (Goffin et al., 2006). Substrate stiffness therefore has 
some effect but other factors appear to be involved. 
 
The culture medium used has been shown to affect fibroblast phenotype. Using 
Endothelial Growth Medium-2 limited the development of α-SMA in cardiac fibroblasts 
compared to using 45% DMEM, 45% F12 and 10% foetal bovine serum (Rossini et al., 
2008). The presence of foetal bovine serum also affected the production of elastin in 
ligament fibroblasts (Mecham et al., 1981). Taurine (Ren et al., 2008b) and high 
glucose levels (Neumann et al., 2002) also alter fibroblast proliferation in vitro, both of 
which are included in some culture media. 
 
The level of O2 in which cultures are kept affects fibroblasts. Supra-physiological levels 
of O2 result in increased α-SMA expression and increased contractile capacity (Roy et 
al., 2003). Hypoxic culture also affects fibroblast activity (Shyu et al., 2012). It is 
therefore clear that fibroblasts are O2 sensitive. It must however be noted that the 
definition of hypoxic, normoxic and supra physiological O2 requires better 
understanding. Shyu et al (2012) used 21% oxygen as their normoxic control, which 
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Roy et al (2003) defines as their supra-physiological level. Despite this, it is clear that 
the level of O2 during culture affects fibroblasts. 
 
ECM proteins signal to fibroblasts and their use in culture appear to alter fibroblast 
phenotype. Fibronectin and laminin are ECM proteins that are used to promote the 
adhesion of cells to culture substrates and both proteins have been shown to affect 
fibroblasts. Fibronectin fragments stimulate apoptosis in lung fibroblasts (Hadden and 
Henke, 2000), although it has also been shown to promote the proliferative response 
of alveolar fibroblasts to fibroblast growth factor (Bitterman et al., 1983). Laminin has 
been shown to affect fibroblast morphology (Lin and Bertics, 1995). The effect of 
collagen has also been investigated. Dawson et al (2012) found that culture on 
collagen I coated plastic did not alter fibroblasts compared to fibroblasts on bare 
plastic, although another study into the effect of collagen on fibroblasts found that 
collagen I and III induced proliferation and collagen IV induced α-SMA expression 
(Naugle et al., 2006). Furthermore, using dermal fibroblasts, Vozenin et al (1998) 
showed that collagen I prevented α-SMA development. The concept that ECM alters 
fibroblast phenotype in culture is made more complicated by the fact that fibroblasts 
are releasing their own ECM, and this in turn is affected by other elements of the cell 
culture system.  
 
Further confounding factors include the density of fibroblasts in culture and the 
isolation protocol itself. Confluency leads to quiescence and reduced elastin expression 
in ligament fibroblasts (Mecham et al., 1981) and the protein expression profile of 
cardiac fibroblasts is different after using different methods of isolation (Xin et al., 
2012). 
 
This variety of contributing factors highlights the difficulty of producing a culture 
system that would not induce changes in isolated fibroblasts and therefore allow more 
applicable study of their properties in vitro. Alongside the development of fibroblast-
specific genetic modification in vivo, such a culture system would be highly beneficial 
for the study of cardiac fibroblasts. 
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1.4.  Fibroblast function: modulation of the extracellular matrix 
The traditional function of fibroblasts is the modulation of the ECM. Cardiac fibroblasts 
are responsible for the production of the ECM, producing interstitial collagens, elastin, 
fibronectin and other molecules. Fibroblasts also control ECM degradation through 
balancing the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of 
matrix metalloproteinases (TIMPs) (Figure 1.2A) (Porter and Turner, 2009).  
 
In the healthy myocardium fibroblasts are arranged in a network of cells throughout 
the myocardium, and produce a structural scaffold of ECM. The ECM scaffold is 
essential for maintaining structural integrity, distributing mechanical force and co-
ordinating the contraction of individual myocytes into whole heart contraction (Figure 
1.2B). However, it is not a static structure and approximately 5% of the ECM is 
replenished each day (McAnulty and Laurent, 1987). It is the job of the network of 
fibroblasts throughout the heart to maintain and moderate the ECM structure in 
response to chemical and mechanical stimuli (Souders et al., 2009). 
 
In disease states, for example after myocardial infarction, fibroblasts become 
increasingly active and produce more ECM. This increase in ECM production is 
essential in the reparative fibrosis that replaces areas of myocyte loss with scar tissue. 
It also drives negative remodelling, mainly through reactive fibrosis, which produces 
interstitial fibrosis away from the initial site of injury (Figure 1.2C) (Weber, 1989). The 
scar tissue remains an active tissue with continual modification by resident fibroblasts 
(Willems et al., 1994), and the number of fibroblasts in the scar may correlate with 
improved outcomes. The activity of fibroblasts away from the scar has negative 
consequences as collagen deposition increases the stiffness of the myocardium and 
disrupts electrical communication between myocytes (Souders et al., 2009). 
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Figure 1.2: Fibroblasts control the ECM in health and disease 
A) Schematic showing the elements involved in ECM control. Fibroblasts produce ECM 
through the synthesis of collagen, fibronectin and other proteins, and degrade the 
ECM via the release of MMPs. Fibroblasts also release TIMPs as a further control of 
MMP function. B) A de-cellularised heart. The cells are removed leaving the ECM 
scaffold, demonstrating the importance of the ECM to normal heart structure 
(reproduced with permission from (Ott et al., 2008)). C) A cross section of a heart after 
myocardial infarction. The pale areas show fibrotic replacement of the dead myocytes 
predominantly produced by fibroblasts (reproduced with permission from (Mollmann 
et al., 2006)).  
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Myocardial fibrosis and remodelling have been extensively studied and the pathways 
involved are increasingly understood. The main signals that activate fibroblasts are 
mechanical strain and soluble mediators. Fibroblasts have been shown to be 
exquisitely sensitive to mechanical stress (MacKenna et al., 2000) and respond 
differently to different strain patterns (Lee et al., 1999). The pathways involved in the 
response of fibroblasts to mechanical stress are increasingly understood (e.g. (Dalla 
Costa et al., 2010)). Various mediators also activate fibroblasts, the most important of 
which appear to be angiotensin II (Ang II) and TGF-β (Eghbali et al., 1991, Hafizi et al., 
2004a). These pathways are potential targets for therapeutic intervention, and may 
account for some of the beneficial effects of current cardiovascular drugs such as 
angiotensin-converting enzyme inhibitors (Porter and Turner, 2009).  
 
This is a brief introduction into the field of myocardial fibrosis, but excellent reviews 
are available elsewhere (Porter and Turner, 2009, Souders et al., 2009, van den Borne 
et al., 2010) 
 
1.5. Fibroblast function: regulating myocyte phenotype 
A growing area of interest and the focus of this thesis is how fibroblasts may modulate 
myocytes through intracellular communication. 
 
1.5.1. Juxtacrine signalling 
Juxtacrine signalling is the communication between cells by direct contact. Direct cell 
contact between fibroblasts and myocytes has been shown to affect the myocyte 
phenotype through gap junctions and adherens junctions. 
 
1.5.1.1. Heterocellular gap junctions 
Gap junctions are intercellular channels that link the cytoplasm of adjacent cells and 
allow the rapid passage of electrical impulses and small molecules between connected 
cells. They are formed by transmembrane protein complexes called connexons, one on 
each of the connected cells. These form stable bonds with each other to create the 
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intercellular channel. Each connexon is itself formed of 6 connexins, the basic proteins 
responsible for the formation of gap junctions (Mese et al., 2007). 
 
Gap junctions are fundamental to cardiac function facilitating the rapid and direct 
transmission of action potentials between myocytes. They are thus essential in the 
coordinated and controlled stimulation of each heartbeat (Jansen et al., 2010). 
Connexin expression has been shown in the fibroblast fraction of both normal and 
diseased hearts (Vasquez et al., 2010). The expression of connexins along with the 
intimate physical proximity of myocytes and fibroblasts in the heart makes the 
presence of heterocellular fibroblast-myocyte gap junctions an interesting proposition. 
 
In vitro, investigating gap junctions between isolated fibroblasts and myocytes has a 
long history. Electrical coupling between myocytes and fibroblasts was first shown in 
culture systems as far back as the 1960s (Mark and Strasser, 1966, Hyde et al., 1969). 
In the late 1980s and early 1990s the conductance between coupled cells was 
investigated (Rook et al., 1989) and for the first time, the role of connexin 43 in 
producing the gap junctions was reported (Rook et al., 1992). 
 
There is now a considerable body of research that has investigated the properties of 
heterocellular fibroblasts-myocyte gap junctions in vitro (Figure 1.3), mainly with a 
focus on the potential arrhythmic effects of this coupling. Using strands of neonatal rat 
cells, fibroblasts were able to electrically link myocytes over extended distances 
(Gaudesius et al., 2003). This was associated with a delay in conduction which may be 
pro-arrhythmic. In unstructured cultures, the presence of increasing numbers of 
fibroblasts correlated with a depolarization of the resting membrane potential of 
neonatal myocytes from -78 to -50mV. At low numbers of fibroblasts conduction 
velocity and action potential upstroke velocity were increased, but as fibroblast 
number increased these parameters slowed (Gaudesius et al., 2003). These effects 
were found to be greater with cultured adult rat fibroblasts from a myocardial 
infarction model compared to the control fibroblasts (Vasquez et al., 2010). 
Heterocellular coupling between adult fibroblasts and adult myocytes has also been 
shown, with an intracellular dye spreading between the cell types (Chilton et al., 2007). 
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However, the action potentials of myocytes were not affected until spingosine-1-
phosphate was added which activated a current within the fibroblasts. Connexin 43 
appears to mediate heterocellular gap junction coupling as the silencing of its 
expression in fibroblasts prevented ectopic activity in neonatal cultures (Askar et al., 
2012). 
 
 
 
Figure 1.3: Immunofluorescence of heterocellular gap junction in vitro 
Fibroblasts (unlabelled) and myocytes (red) readily form gap junctions (green) in vitro. 
Red- α-actinin, Green- connexin 43, Blue- nuclear staining. Scale bar 10µm. 
(reproduced with permission from (Zlochiver et al., 2008)). 
 
 
However, the existence of gap junctions in vivo is still controversial. Using electron 
microscopy to look for gap junctions in the sino atrial node, homocellular junctions 
were regularly observed (both myocyte-myocyte and fibroblast-fibroblast) but only 
one possible small gap junction-like structure was seen between a fibroblast and 
myocyte (De Maziere et al., 1992). More recently, a search for gap junctions between 
fibroblasts and myocytes in an infarct border zone after coronary artery occlusion in 
dogs was conducted. Again, homocellular junctions were regularly seen, but no 
heterocellular junctions were observed despite extensive membrane appositions. 
Functionally, the spread of dye between myocytes and fibroblasts was also not seen 
(Baum et al., 2012). Immunohistochemistry also failed to identify any fibroblast 
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myocyte gap junctions in sheep ventricular tissue during the progression of 
remodelling following myocardial infarction (Camelliti et al., 2004a). 
 
Other reports support the presence of gap junctions in vivo. Heart transplant 
recipients sometimes develop synchronisation of host and donor tissue across the 
graft scar line (Lefroy et al., 1998). One explanation is the conductance of the electrical 
signal via fibroblasts. Immunolabelling found connexin 45 between fibroblasts and 
myocytes in the rabbit sino atrial node, and it was suggested that fibroblasts may 
contribute to dye spreading between myocytes (Camelliti et al., 2004b). Also, double 
patch clamping of myocytes and fibroblasts in frog atria showed a slight decrease in 
fibroblast membrane potential, which temporally corresponded with the myocyte 
action potential (Kamkin et al., 2005). 
 
Conclusive evidence for the existence of fibroblast and myocyte heterocellular gap 
junctions in vivo is still required. However, if they exist, the regional variations in 
fibroblasts often observed in disease would be pro-arrhythmic, with regional effects on 
conduction promoting wave front fractionation and re-entry (Kohl et al., 2005). The 
potential effects of the connections have been subject to computer modelling and 
highlight the arrhythmic potential of heterocellular gap junctions (Jacquemet and 
Henriquez, 2007, Sachse et al., 2008, Xie et al., 2009). 
 
1.5.1.2. Adherens junctions 
Adherens are another type of intercellular junction and produce tight junctions 
between adjacent cells (Niessen, 2007). They were traditionally seen as structural 
proteins but have now been attributed a variety of signalling properties (Matter and 
Balda, 2003). 
 
Adherens junctions are essential for fibroblast function. They allow the coordination of 
mechanical force between cells (Hinz et al., 2004). They are also important in signalling 
in fibroblasts; synchronised Ca2+ oscillations within contacting fibroblasts were 
prevented by dissociation of adherens junctions (Follonier et al., 2008). 
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A role of adherens junctions in the modulation of myocyte electrophysiology by 
fibroblasts has recently been demonstrated. Thompson et al (2011) showed fibroblasts 
decreased neonatal myocyte conduction velocity and action potential upstroke 
velocity. However, these effects were decreased when mechano-sensitive channels 
were blocked. The effects were also evident when using connexin-43 silenced 
fibroblasts to confirm that this was not a gap junction-induced effect. The authors 
conclude that fibroblasts are causing the activation of mechano-sensitive channels 
through mechanical connections with the myocytes, altering their electrophysiology. 
 
1.5.2. Signalling through the extra cellular matrix 
The ECM provides a framework for the heart, but is also a bioactive material involved 
in cell signalling (Imanaka-Yoshida et al., 2004). The major receptors involved in ECM 
signalling to myocytes are the integrins. They were initially identified as adhesion 
proteins (Hynes, 1987) but the signalling properties of integrins are now widely studied 
(Brancaccio et al., 2006). 
 
Integrins are transmembrane proteins with a large extracellular portion that binds to 
the ECM, and a small intracellular tail that is associated with actin in the cytoskeleton 
(Humphries, 2000). Each integrin is a heterodimer between α and β subunits and in the 
heart there is a variety of α subunits, which combine with a β1 subunit and have 
different properties (Ross and Borg, 2001). Bridging between the ECM and the 
myocyte, integrins signal to myocytes upon binding to an ECM substrate and also act 
as a sensor for mechanical tension (Ross and Borg, 2001). They are crucial in the 
development and the disease response of the heart. The proliferation of human foetal 
myocytes in response to epidermal growth factor was blocked by an antibody against 
the integrin β1 subunit (Hornberger et al., 2000). Knockout models have also shown 
the importance of integrins in development, and specifically in the heart. For example, 
α4 subunit null mice have defects in the development of the epicardium (Yang et al., 
1995). In the adult heart, integrin signalling produces a hypertrophic response (Ruwhof 
and van der Laarse, 2000) and also affects cell function. For example, the binding of 
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laminin to αβ1 integrin attenuated the response of the L-type Ca2+ current to 
acetylcholine (Wang et al., 2000). 
 
The direct link between fibroblasts, the ECM and myocytes has been neatly highlighted 
using in vitro preparations. Culturing neonatal myocytes on a fibroblast-derived ECM 
produced more rapid adhesion and spontaneous beating activity (VanWinkle et al., 
1996), as well as greater Ca2+ uptake and development of organelles (Bick et al., 1998). 
In similar experiments, neonatal myocytes plated on fibroblast derived ECM had higher 
glucose usage, ATPase activity and sarcoplasmic reticulum Ca2+ ATPase (SERCA) 
expression (Zeng et al., 2013). Fibroblast-derived ECM also promotes the maturation of 
embryonic stem cell-derived cardiomyocytes improving cell ultrastructure and 
spontaneous beating properties (Baharvand et al., 2005). 
 
It is therefore clear that as the major cell type involved in ECM regulation, fibroblasts 
can affect myocyte properties by modulating the ECM. 
 
1.5.3. Paracrine communication 
Paracrine communication is ‘cellular signalling in which a factor secreted by a cell 
affects other cells in the local environment’.6 Fibroblasts release a large number of 
mediators and the paracrine effects of these fibroblast-released factors are 
increasingly recognised in many fields of research. For example, fibroblasts associated 
with cancer stroma have paracrine effects that promote cancer progression (e.g. (Ao et 
al., 2007)). In dermal wound healing and intestinal research, paracrine mediators 
released from fibroblasts have been shown to affect epithelial cells (Visco et al., 2009, 
Peura et al., 2012). 
 
In cardiovascular research there has been a growing interest in the paracrine effects of 
fibroblast-released factors. Research has mainly focused on the effect of fibroblasts on 
myocyte size, with more limited research into the functional effects. The majority of 
                                                 
6
 http://www.ncbi.nlm.nih.gov/mesh/68019899 
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this research has used rat neonatal cells in vitro. During this discussion it is highlighted 
when adult cells have been used. 
 
1.5.3.1. In vitro 
The hypertrophic response of myocytes to fibroblast paracrine mediators was first 
suggested over 20 years ago. Increasing the number of fibroblasts in myocyte cultures 
correlated with an increase in myocyte volume (Long et al., 1991). This heterocellular 
culture is unable to differentiate between paracrine effects and the effects induced by 
direct cell contact, but Long et al (1991) suggest it is paracrine mediated and identified 
a putative novel paracrine factor ‘non-myocyte derived growth factor’ released from 
the fibroblasts. 
 
Since this initial experiment a large number of studies have shown myocyte 
hypertrophy or increased protein expression in response to fibroblast-derived 
paracrine mediators. A direct hypertrophic response to mediators released from 
fibroblasts has been observed in multiple studies, in neonatal, dedifferentiated adult 
mouse and adult rat myocytes. Harada et al (1997) showed that the size of neonatal 
myocytes was increased when myocytes were exposed to medium conditioned with 
neonatal fibroblasts. Guo et al (1998b) also showed an increase in neonatal myocyte 
size as well as in total protein production in response to neonatal fibroblast 
conditioned medium. The rise in protein synthesis in neonatal myocytes in response to 
neonatal fibroblasts conditioned medium was also shown by Booz et al (1999) and the 
increase in cell size was further shown by LaFramboise et al (2007). Fredj et al (2005b) 
used adult mouse dedifferentiated myocytes, and found that co-culture with 
fibroblasts increased the volume of these cells. Finally, work previously carried out in 
our lab showed that co-culture with fibroblasts increased the volume of adult rat 
myocytes (Cartledge et al., 2011).7 
 
                                                 
7
 This work was mainly carried out by a previous PhD student, and I finished it off when I joined the lab. 
I presented this work as an oral presentation at the American Heart Association Scientific Sessions 2011. 
The abstract is available online. 
http://circ.ahajournals.org/cgi/content/meeting_abstract/124/21_MeetingAbstracts/A10255 
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In other studies the presence of fibroblasts has been shown to be essential for the 
hypertrophic response of myocytes to classical hypertrophic stimuli. Harada et al 
(1997) found that Ang II and TGF-β did not induce myocyte hypertrophy unless 
fibroblasts were present in the culture. In pure myocyte cultures these classical 
hypertrophic stimuli did not induce hypertrophy. Ponicke et al (1997), Gray et al (1998) 
and Sano et al (2000) also showed that Ang II drives hypertrophy through the 
stimulation of downstream mediators from fibroblasts rather than through direct 
effects on myocytes. Bhavsar et al (2010) found that fibroblasts were also required for 
the hypertrophic response of clenbuterol, another hypertrophic agent. The 
hypertrophic effect of cultured fibroblast-derived mediators is therefore well 
documented. 
 
The effects of fibroblasts derived factors on the function of myocytes are less 
extensively studied. Guo et al (1998b) first showed that fibroblasts could affect 
myocyte electrical properties through paracrine communication. Fibroblast 
conditioned medium prolonged the action potential and caused a reduction in the 
transient outward K+ current (Guo et al., 1998b, Guo et al., 1999). More recently the 
effects on electrical properties have been examined further (Pedrotty et al., 2009, 
Vasquez et al., 2010). Supporting the earlier findings, fibroblast conditioned medium 
prolonged the action potential. The myocyte resting membrane potential was also 
raised, the upstroke velocity of the action potential was slowed and conduction 
velocity in a confluent monolayer of myocytes was reduced. This was underpinned by 
a reduction in the Na+ current, the rapid delayed rectifier K+ current and the transient 
outward K+ current (Pedrotty et al., 2009). A further study looked at the effect of adult 
fibroblasts isolated from a model of myocardial infarction and control hearts (Vasquez 
et al., 2010). In this study only fibroblasts from the myocardial infarction model slowed 
the conduction velocity and decreased the duration of the action potential. These 
differences were observed despite culturing fibroblasts for up to one month. The 
different effects to the previous reports could be due to adult source of the fibroblasts, 
or the protocol used for conditioning the medium. 
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The effect of fibroblast conditioned medium on myocyte contractility has also been the 
subject of a single study where fibroblast conditioned medium reduced the 
spontaneous rate of contraction of neonatal myocytes and after 72 hours the intrinsic 
beating of the myocytes stopped (LaFramboise et al., 2007).  
 
The effects of fibroblasts on adult myocyte are even less studied. Shivakumar et al 
(2008) showed that adult rat fibroblasts exposed to hypoxic conditions reduced the 
viability of adult rat myocytes in culture. Previous work from our lab has shown that 
cultured adult rat fibroblasts caused a reduction in the Ca2+ transient amplitude and 
contractility of adult rat myocytes (Cartledge et al., 2011). A recent study has also 
looked at the effect of adult fibroblast conditioned medium on adult myocyte 
electrophysiology. Kaur et al (2013) showed that fibroblast conditioned medium 
increased the voltage gated Na+ current and reduced the transient outward K+ current. 
These changes are similar to those observed in neonatal myocytes, and show that 
fibroblasts are capable of affecting adult myocyte electrophysiology. 
 
These studies into the paracrine effects of fibroblast on myocytes in vitro have mainly 
exposed myocytes to fibroblast conditioned medium. However, various paracrine 
effects of myocytes on fibroblasts have also been demonstrated. Paracrine mediators 
released from neonatal myocytes or HL-1 cells (an atrial cancer cell line that maintains 
myocyte features (Claycomb et al., 1998)) increase fibroblast proliferation (Fredj et al., 
2005b, Panse et al., 2012, Tsoporis et al., 2012), α-SMA expression (Burstein et al., 
2007, Dolmatova et al., 2012) and ECM protein expression (Burstein et al., 2007, Tsai 
et al., 2011, Zhang et al., 2011, Panse et al., 2012). It is therefore important to consider 
this whole relationship as a bidirectional, dynamic communication.  
 
1.5.3.2. In vivo 
The use of genetic modification to examine fibroblasts is still limited (as discussed in 
section 1.3.2). However, it has started to allow investigations into fibroblast paracrine 
communication and its importance in vivo. These studies, in support of the findings in 
vitro, show that cardiac hypertrophy is limited when the activity of fibroblasts is 
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suppressed and this appears to be due to paracrine communication (Pellieux et al., 
2001, Jaffre et al., 2009, Takeda et al., 2010, Accornero et al., 2011). 
 
Pellieux et al (2001) found that fibroblast growth factor-2 knock out (FGF-2-/-) mice had 
a dilated heart which did not hypertrophy in response to hypertension. As fibroblasts 
are the main source of FGF-2 (although myocytes also release FGF-2 (Jimenez et al., 
2004)), and Pellieux et al (2001) showed that FGF-2-silenced fibroblasts do not induce 
myocyte hypertrophy in vitro, it was argued that the in vivo findings were due to the 
lack of paracrine release of FGF-2 from fibroblasts. 
 
Jaffre et al (2009) examined the role of serotonin receptor 2b in non-myocyte cells by 
crossing a global knockout with a myocyte specific transgenic mouse line. Expression 
of serotonin receptor 2b in myocytes was recovered but it was still absent in other 
cells including fibroblasts. The transgenic animals did not develop cardiac hypertrophy 
in response to isoproterenol infusion and had decreased cytokine levels. These effects 
were recapitulated with fibroblasts in vitro and therefore it was argued that fibroblasts 
were involved in the effects observed in vivo. 
 
Selective knockout of the transcription factor Krüppel like factor 5 (KLF-5) under the 
control of the periostin promoter (Klf5fl/fl;Postn-Cre) was used to look at the role of 
KLF-5 in fibroblasts. These animals did not have a hypertrophic response to pressure 
overload in part due to downstream paracrine signalling (Takeda et al., 2010). 
 
Conversely, the overstimulation of fibroblast paracrine mediator release increases the 
hypertrophic response in vivo. The over expression of placental growth factor (PGF) 
stimulated the release of cytokines in fibroblasts in response to pressure overload and 
this correlated with a greater hypertrophic response (Accornero et al., 2011). 
 
It is clear that fibroblasts have the ability to induce myocyte hypertrophy and that this 
appears to be important in the hypertrophic response of the heart. Although it is not 
as widely demonstrated, the available data suggest that fibroblast paracrine mediators 
have a negative effect on myocyte function, with reduced conduction velocity, 
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contractility and Ca2+ transient amplitude, which may also play a role in cardiac 
pathology. To gain a better understanding of these processes the underlying paracrine 
mediators need to be understood. 
 
1.6. Paracrine signalling pathways 
The investigation and understanding of the mediators and pathways involved in 
paracrine communication between fibroblasts and myocytes is complex. Firstly, both 
fibroblasts and myocytes release mediators. Secondly, both fibroblasts and myocytes 
can respond to these mediators in an autocrine (responding to a signal derived from 
themselves) or paracrine fashion. Thirdly, the mediators released are altered by the 
biochemical and physical signals received. Finally, there are complex interactions 
between different mediators rather than just additive effects (van Nieuwenhoven et 
al., 2013). It is therefore important to realise that there is a bidirectional, dynamic 
communication between the two cell types. There are also many potential mediators 
involved, and they are summarised here. A full overview of all the mediators involved 
is beyond the capacity of this introduction. Therefore a detailed overview of some of 
the potentially important mediators is provided, followed by a summary of the direct 
research into the paracrine effects of other mediators. A particular focus is paid to 
TGF-β which is the main mediator that has been investigated in this thesis. 
 
1.6.1. TGF-β 
TGF-β exists as three isoforms TGF-β1, TGF-β2 and TGF-β3 (Leask and Abraham, 2004). 
Within the cardiovascular system it is viewed mainly in its role as a pro-fibrotic 
mediator (Leask, 2007). TGF-β is increased in human heart failure tissue (Li et al., 1997, 
Sivakumar et al., 2008) and in animal models of cardiac disease (Li and Brooks, 1997, 
Hao et al., 1999, Hao et al., 2000). The role of TGF-β in the progression of heart disease 
appears to be biphasic. Early after myocardial infarction TGF-β is associated with 
improved outcomes, but in later stages it promotes progression to heart failure (Lefer 
et al., 1990, Ikeuchi et al., 2004, Okada et al., 2005).  
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1.6.1.1. Release 
TGF-β is produced in a latent form which is then activated by changes in pH or by 
proteases (Lim and Zhu, 2006). It is released by both fibroblasts (Zhao and Eghbali-
Webb, 2001) and myocytes (Thompson et al., 1989, Taimor et al., 1999). The level of 
TGF-β production is increased by Ang II (Lee et al., 1995, Campbell and Katwa, 1997) 
and other mediators (Fisher and Absher, 1995, Thaik et al., 1995) and mechanical 
stretch also induces TGF-β release from fibroblasts (van Wamel et al., 2001). 
 
1.6.1.2. Effects 
TGF-β has three receptors type I, type II and type III and all three TGF-β receptor 
subtypes are present on both cardiac fibroblasts (Sigel et al., 1996) and myocytes 
(Engelmann and Grutkoski, 1994). TGF-β type III receptors are non-signalling and their 
role is to bind TGF-β and then transfer it to type II receptors. Type II and type I 
receptors then form hetero-tetramers that transfer the signal across the cell 
membrane (Lim and Zhu, 2006). Activation of TGF-β receptors phosphorylates Smad 2 
and Smad 3 which form a complex with Smad 4. This complex then translocates to the 
nucleus where they alter gene transcription (Heldin et al., 1997). The genetic targets of 
this Smad complex include Smad 6 and 7 which form a negative feedback loop, 
inhibiting the activation of Smad 2 and 3 (Park, 2005) (Figure 1.4). TGF-β receptors also 
signal through Smad-independent pathways including TGF-β-activated kinase 1, 
extracellular signal-regulated kinase, c-Jun-N-terminal kinase, and p38 mitogen-
activated protein kinase pathways (Derynck and Zhang, 2003). 
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Figure 1.4: Diagram of TGF-β Smad signalling 
TGF-β binds to the type II receptor resulting in the formation of a hetero-tetrameric 
signalling complex of type I and II receptors. This phosphorylates the Smad 2 and Smad 
3 complex, which interacts with Smad 4 and translocates to the nucleus where it 
affects gene transcription. Smad 6 and 7, which are induced by the Smad 2, 3 and 4 
complex, block the activation of Smad 2 and 3 in an auto inhibitory feedback loop. 
(Adapted by permission from Macmillan Publishers Ltd: Nature (Heldin et al., 1997), 
copyright (1997)). 
 
 
 
TGF-β stimulates ECM production in fibroblasts (Eghbali et al., 1991, Heimer et al., 
1995, Agocha et al., 1997, van Nieuwenhoven et al., 2013). It also reduces the 
degradation of the ECM by fibroblasts, by decreasing collagenases and increasing their 
inhibitors (Chua et al., 1991, Overall et al., 1991, Seeland et al., 2002) although this is 
not ubiquitously observed (Stawowy et al., 2004). In addition, TGF-β drives the 
development of α-SMA, which is associated with increased activity in fibroblasts 
(Lijnen and Petrov, 2002, Adapala et al., 2013, van Nieuwenhoven et al., 2013). 
Reports of TGF-β effects on migration and proliferation of fibroblasts are conflicting. 
TGF-β may or may not increase migratory capacity (Stawowy et al., 2004, Brown et al., 
2007) and in different studies it has been found to increase (Squires et al., 2005) or 
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decrease proliferation (Agocha et al., 1997). In another report the effect was 
dependent on the level of TGF-β. At low levels of TGF-β proliferation was increased 
slightly, but at higher levels proliferation decreased slightly (Sigel et al., 1996).  
 
In myocytes, TGF-β induces hypertrophy (Gray et al., 1998) and in vivo over expression 
of TGF-β induces a mild cardiac hypertrophy (Rosenkranz et al., 2002). TGF-β also 
increases and stabilises the beating rate in neonatal myocytes (Roberts et al., 1992). 
This is possibly achieved through regulation of Ca2+ handling properties. TGF-β reduces 
neonatal atrial myocyte L type Ca2+ current (ICa,L) (Avila et al., 2007) and also improves 
sarcoplasmic reticulum (SR) Ca2+ handling, as without TGF-β SR Ca2+ oscillations are lost 
in neonatal myocytes (Neylon et al., 1994). In adult myocytes, TGF-β slows the Ca2+ 
transient and reduces contractility (Li et al., 2008). It also affects myocyte 
electrophysiology. The reported effects are different in neonatal and adult myocytes. 
In neonatal myocytes TGF-β reduces the voltage gated Na+ current and the inward 
rectifier and outward sustained K+ currents, but not the transient outward K+ current 
(Ramos-Mondragon et al., 2011). In adult myocytes TGF-β prolongs the action 
potential with an associated increase in the voltage gated Na+ current and decrease in 
the transient outward K+ current (Kaur et al., 2013). The effects of TGF-β on myocytes 
and fibroblasts are summarised in Figure 1.5. 
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Figure 1.5: Summary of the effects of TGF-β on myocytes and fibroblasts 
↑: Increased. ↓: Decreased. __: Unchanged. ?: Conflicting reports. 
 
 
TGF-β has been directly investigated in the paracrine effects of fibroblasts on 
myocytes. Gray et al (1998) found that neutralising TGF-β in the conditioned medium 
of fibroblasts stimulated with Ang II prevented the hypertrophic response in myocytes. 
Neutralising TGF-β in conditioned medium from stretched fibroblasts also prevented 
hypertrophy (van Wamel et al., 2001). In vivo, TGF-β-deficient mice do not develop 
cardiac hypertrophy in response to a sub-pressor dose of Ang II infusion (Schultz Jel et 
al., 2002). Although this effect has not been shown to be fibroblast-mediated, in 
combination with the work carried out by Gray et al (1998), it can be hypothesised that 
TGF-β release from fibroblasts is important in the cardiac hypertrophic response to 
Ang II. The effects of fibroblast conditioned medium on adult myocyte 
electrophysiology have also been shown to be due to TGF-β signalling. The increase in 
the voltage gated Na+ current and the decrease in the transient outward K+ current 
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were blocked when a TGF-β neutralising antibody was added to the conditioned 
medium (Kaur et al., 2013). 
 
1.6.2. Angiotensin II 
Ang II is the effector of the renin-angiotensin system that has pleiotropic effects on the 
cardiovascular system. Initially characterised as a potent vasoconstrictor, it was later 
shown that Ang II has direct effects on myocardial remodelling, stimulating myocardial 
hypertrophy and fibrosis (Dostal and Baker, 1992, Brilla et al., 1993). Ang II is increased 
in cardiovascular disease and levels of Ang II in heart failure patients correlate with 
mortality (Dzau et al., 1981). 
 
1.6.2.1. Release 
Ang II can be produced both systemically and locally in the heart. Systemically, renin 
released from the kidneys converts angiotensinogen in the liver to angiotensin I. This is 
subsequently converted to Ang II by angiotensin converting enzyme. Within the heart, 
both fibroblasts and myocytes produce all the components necessary to produce Ang II 
(Dostal et al., 1992, Katwa et al., 1997).  
 
1.6.2.2. Effects 
Ang II acts via either AT-1 or AT-2 receptors, both of which are found in the heart 
(Gullestad et al., 1998). Both receptor subtypes are found on myocytes but in 
fibroblasts the expression of AT-2 is uncertain. Fibroblast AT-2 expression has been 
identified in some studies (Tsutsumi et al., 1998) but not in others (Crabos et al., 1994, 
Hafizi et al., 1998). 
 
In fibroblasts, Ang II causes an increased expression of ECM protein which is blocked 
by AT-1 receptor antagonists (Crabos et al., 1994, Brilla et al., 1997, Hafizi et al., 1998). 
Ang II also has a proliferative effect on fibroblasts through an AT-1 receptor mediated 
pathway (Samuel et al., 2004, Wang et al., 2013) whereas overexpression of the AT-2 
receptor did not alter proliferation (Warnecke et al., 2001). However, whether this 
 49 
increased proliferation is a direct effect of AT-1 stimulation or via the release of 
secondary autocrine mediators is unclear (Bouzegrhane and Thibault, 2002). 
Fibroblasts respond to Ang II by secreting an array of mediators including TGF-β (Lee et 
al., 1995, Campbell and Katwa, 1997), endothelin 1 (ET-1) (Ito et al., 1993, Cheng et al., 
2003), interleukin 6 (Il-6) (Sano et al., 2000) and tumour necrosis factor α (TNF-α) 
(Yokoyama et al., 1999).  
 
Initially Ang II was thought to produce hypertrophy in myocytes (Aceto and Baker, 
1990); however, this direct effect was later questioned (Ponicke et al., 1997). The 
presence of fibroblasts was found to be essential for the hypertrophic effect of Ang II 
on myocytes (Harada et al., 1997, Ponicke et al., 1997, Gray et al., 1998). Ang II also 
increases myocyte contractility through increased myofilament sensitivity to Ca2+ 
(Ikenouchi et al., 1994). 
 
Ang II therefore appears to drive myocyte hypertrophy through paracrine mediators 
released from fibroblasts. ET-1 and TGF-β have been investigated as downstream 
mediators and are discussed in the relevant sections. Interestingly, myocyte and 
fibroblast specific aldosterone receptor knockout mice have been produced, which is 
another downstream mediator of Ang II signalling (Fraccarollo et al., 2011, Lother et 
al., 2011). Early studies show that the myocyte specific knockout of aldosterone 
receptors prevent hypertrophy in response to pressure overload, whereas fibroblast-
specific knockout does not have an effect (Lother et al., 2011). This suggests that 
aldosterone induces myocyte hypertrophy directly in vivo and, although a role of 
fibroblasts in this relationship has not been studied, may also represent indirect Ang II 
signalling through downstream mediators.  
 
1.6.3. Endothelin 1 
ET-1 was initially identified as a potent long lasting vasoconstrictor released by 
endothelial cells (Masaki, 2004). The level of ET-1 is raised in heart disease (Parker and 
Thiessen, 2004) and inversely correlates with patient outcome (Motte et al., 2006). 
Long term treatment with an antagonist improved outcomes in a rat myocardial 
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infarction model (Sakai et al., 1996), although clinical trials have produced varied 
results (Motte et al., 2006). 
 
1.6.3.1. Release 
Both fibroblasts and myocytes are able to produce ET-1 (Suzuki et al., 1993, Katwa, 
2003), and the level of expression is sensitive to external factors including mechanical 
stimuli (Yamazaki et al., 1996) and biochemical mediators such as Ang II and other ET-1 
(Fujisaki et al., 1995). 
 
1.6.3.2. Effects 
ET-1 acts through two receptors ETA and ETB. Fibroblasts and myocytes express both, 
with a higher level of ETB in fibroblasts (Katwa et al., 1993) and a higher level of ETA in 
myocytes (Fareh et al., 1996). 
 
ET-1 causes an increase in collagen production and decrease in collagenase activity in 
fibroblasts acting through both ETA and ETB receptors (Guarda et al., 1993, Hafizi et al., 
2004b). The reported effects of ET-1 on fibroblast proliferation have been conflicting. 
Although ET-1 has been reported to increase proliferation (Piacentini et al., 2000), 
other reports show no direct effect (Turner et al., 2004) and others report a reduction 
in DNA synthesis (Hafizi et al., 2004b). 
 
In myocytes, ET-1 stimulates hypertrophy (Inada et al., 1999) and increases protein 
synthesis (Guo et al., 1998a). It also increases individual myocyte contractility (Kelly et 
al., 1990, Kramer et al., 1991), although this effect appears to be reversed in pathology 
(Suzuki et al., 1998). It also affects myocyte Ca2+ handling, resulting in an increased 
Ca2+ transient amplitude in healthy adult myocytes (Kohmoto et al., 1993), although 
this effect is reversed in heart failure myocytes where ET-1 reduces the Ca2+ transient 
amplitude (Suzuki et al., 1998). In neonatal myocytes ET-1 also results in a smaller and 
slower Ca2+ transient (Kohmoto et al., 1993, Uehara et al., 2012).  
 
 51 
There was early interest in ET-1 in the paracrine communication of fibroblasts and 
myocytes. In heterocellular cultures, the myocyte hypertrophic response induced by 
Ang II was blocked by an ETA antagonist (Ponicke et al., 1997). The hypertrophic 
response to fibroblast conditioned medium was also blocked by ETA antagonists. This 
was observed with untreated fibroblasts (Harada et al., 1997, Kuwahara et al., 1999), 
when fibroblasts were treated with Ang II (Gray et al., 1998), and when fibroblasts 
were stimulated with cyclic stretch (van Wamel et al., 2001). However, this effect is 
not ubiquitously observed; another report found that an ETA antagonist did not block 
an increase in protein expression resulting from fibroblast conditioned medium (Booz 
et al., 1999). 
 
1.6.4. Insulin like growth factor 1 
Insulin like growth factor 1 (IGF-1) is an important mediator of normal growth 
throughout the body. There are conflicting data regarding IGF-1 in heart failure. Both 
high and low levels of IGF-1 have been linked with cardiovascular disease (Andreassen 
et al., 2009, van Bunderen et al., 2010). However, acute administration of IGF-1 
improves cardiac function in heart failure patients (Donath et al., 1998) and long term 
overexpression is protective in animal models (Welch et al., 2002). 
 
1.6.4.1. Release 
IGF-1 is released in the liver and kidneys in response to growth hormone (Castellano et 
al., 2009). However, it can also be produced within the heart by fibroblasts (Horio et 
al., 2005) and myocytes (Reiss et al., 1993). The amount of IGF-1 released from 
fibroblasts is increased upon mechanical stretch (Hu et al., 2006) and although it has 
not been shown in fibroblasts, IGF-1 expression is regulated by mediators such as Ang 
II in smooth muscle cells (Delafontaine et al., 2004). 
 
1.6.4.2. Effects  
IGF-1 acts via the IGF-1 receptor that is found on fibroblasts and myocytes with 
increased expression in myocytes in disease (Reiss et al., 1994b, Reiss et al., 1995). 
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IGF-1 increases ECM production from fibroblasts (Butt et al., 1995, Horio et al., 2005). 
IGF-1 also appears to promote fibroblast proliferation (Reiss et al., 1995, van Eickels et 
al., 2000, Samuel et al., 2004), although this is not always detected (Butt et al., 1995). 
IGF-1 also promotes fibroblast migration (Kanekar et al., 2000) and contraction (Diaz-
Araya et al., 2003). 
 
In myocytes, IGF-1 has been shown to be hypertrophic (Guo et al., 1999) and increases 
general protein synthesis (Guo et al., 1998a, Horio et al., 2005). It increases the 
contractility of normal myocytes (Freestone et al., 1996, Cittadini et al., 1998) and 
heart failure myocytes (Kinugawa et al., 1999). Interestingly, it has also been suggested 
that IGF-1 may promote mitotic division of surviving myocytes after myocardial 
infarction (Reiss et al., 1994a).  
 
IGF-1 possibly mediates the hypertrophic paracrine effect of fibroblasts. Antibodies 
against IGF-1 or the IGF-1 receptor prevented, at least partially, the hypertrophic effect 
of fibroblast conditioned medium (Guo et al., 1999, Horio et al., 2005). IGF-1 
antagonists also blocked the hypertrophic effect of clenbuterol. Clenbuterol is a partial 
β-adrenoceptor agonist that induces myocyte hypertrophy. In vitro this was found to 
be via stimulating the release of IGF-1 from fibroblasts, which in turn exerted paracrine 
hypertrophic effects on the myocytes (Bhavsar et al., 2010). Furthermore, IGF-1 was 
identified as a paracrine mediator stimulating myocyte hypertrophy downstream of 
KLF (Takeda et al., 2010). IGF-1 does not seem to contribute to the paracrine 
prolongation of myocyte action potentials (Guo et al., 1999). 
 
1.6.5. Other mediators 
The Il-6 family of cytokines have been implicated in the hypertrophic response of 
myocytes to fibroblast conditioned medium. Il-6 expression was increased in myocytes 
in response to fibroblast conditioned medium and induced hypertrophy by autocrine 
signalling (Fredj et al., 2005a). A neutralising antibody against cardiotropin-1, another 
member of the Il-6 family, partially prevented the hypertrophic response of myocytes 
to fibroblast conditioned medium (Kuwahara et al., 1999). Il-6 was also increased in 
 53 
fibroblasts in response to PGF, which may be linked to an increased hypertrophic 
response in PGF transgenic mice (Accornero et al., 2011).  
 
FGF-2 deficient fibroblasts do not induce hypertrophy in myocytes although this 
appears to be mainly through autocrine regulation of a secondary mediator that 
induces hypertrophy (Pellieux et al., 2001). FGF-2 deficient mice did not have a 
hypertrophic response to pressure overload, highlighting the potential importance of 
this pathway in the whole heart. 
 
Fibroblast released Il-1b is putatively involved in down-regulation of myocyte 
connexin-43 in the border zone after infarction (Baum et al., 2012). It is also increased 
in fibroblasts by PGF, was decreased in PGF knockout mice and increased in PGF over-
expressing mice in response to pressure overload. The level of Il-1b correlated with the 
level of hypertrophy observed in these animals (Accornero et al., 2011).  
 
Another possible paracrine mediator is TNF-α. TNF-α was identified in the conditioned 
medium of hypoxic fibroblasts, which caused a reduction in viability of adult myocytes. 
The addition of TNF-α to normoxic fibroblast conditioned medium mimicked these 
effects (Shivakumar et al., 2008). 
 
A recent publication suggests a novel role for matrix metalloproteinase-13 (MMP-13) 
as a paracrine mediator. MMP-13, which is released by fibroblasts, can activate 
protease activated receptor-1 and blocking MMP-13 or protease activated receptor-1 
prevents cardiac dysfunction upon isoproterenol infusion (Jaffre et al., 2012). 
 
Various mediators have also been identified in the signalling from myocytes to 
fibroblasts. Some of the effects of tachypaced myocyte conditioned medium on 
fibroblasts were blocked by an AT-1 receptor antagonist. Burstein et al (2007) found 
the induction of α-SMA was blocked, and Tsai et al (2011) found that TGF-β and 
collagen release from fibroblasts were prevented.  
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Connective tissue growth factor (CTGF) from myocytes also induced fibroblast 
proliferation and collagen synthesis (Zhang et al., 2011). Another report suggests CTGF 
is a binding partner with follistatin-like 3 in paracrine effects of myocytes on fibroblasts 
(Panse et al., 2012). 
 
The release of vascular endothelial growth factor from myocytes has also been 
reported to drive fibroblast proliferation (Tsoporis et al., 2012). Stressed myocytes 
have also been found to induce α-SMA expression in fibroblasts through the release of 
ATP (Dolmatova et al., 2012). 
 
This research into these various paracrine mediators (summarised in Table 1.1) 
highlights the complexity of these paracrine interactions and also their potential 
importance. 
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Mediator Released by Receptor expression Main paracrine effects investigated References 
 
TGF-β 
 
Both 
 
Both 
 
Myocytes: Hypertrophy 
                   Changes in electrophysiology 
 
Fibroblast: α-SMA expression 
                  ↑ ECM production 
 
 
Thompson et al., 1989, Eghbali et al., 1991, 
Engelmann and Grutkoski, 1994, Sigel et al., 1996, 
Gray et al., 1998, Zhao and Eghbali-Webb, 2001, 
Lijnen and Petrov, 2002, Kaur et al., 2013. 
 
Ang II 
 
Both 
 
AT-1: Both 
 
AT-2: Myocytes 
           Fibroblasts? 
 
 
Myocytes: ↑ Contractility 
                   Direct hypertrophy? 
 
Fibroblasts: ↑ ECM production 
                     ↑ Proliferation  
                     Secretion of mediators  
 
 
Dostal et al., 1992, Ikenouchi et al., 1994,  
Lee et al., 1995, Ponicke et al., 1997,  
Gullestad et al., 1998, Hafizi et al., 1998,  
Tsutsumi et al., 1998, Samuel et al., 2004. 
 
ET-1 
 
Both 
 
Both 
 
Myocytes: Hypertrophy  
 
Fibroblasts: ↑ ECM production 
                     ↓ ECM breakdown 
 
 
Katwa et al., 1993, Suzuki et al., 1993,  
Fareh et al., 1996, Inada et al., 1999,  
Katwa, 2003, Hafizi et al., 2004. 
 
IGF-1 
 
Both 
 
Both 
 
Myocytes: Hypertrophy 
                   ↑ Contractility 
 
Fibroblasts: ↑ ECM production 
                     ↑ Migration 
 
 
Reiss et al., 1993, Reiss et al., 1994,  
Butt et al., 1995, Reiss et al., 1995,  
Freestone et al., 1996, Guo et al., 1999,  
Kanekar et al., 2000, Horio et al., 2005. 
 
Il-6 
 
Both 
 
Both 
 
Myocytes: Hypertrophy 
 
Fibroblasts: Proliferation 
 
 
Fredj et al., 2005. 
 
FGF-2 
 
Both, but 
mainly 
fibroblasts 
 
Both 
 
Myocytes: Direct hypertrophy? 
 
Fibroblasts: Release of other mediators          
       
 
Pellieux et al., 2001. 
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Il-1β 
 
Predominantly 
fibroblasts
 
 
 
Both
 
 
 
Myocytes: Hypertrophy 
                   Reduction in connexin 43 
 
Fibroblasts: ↑ ECM degradation 
                    ↓ α-SMA expression 
  
 
Long, 2001, Baum et al., 2012,  
Accornero et al., 2011, Turner et al., 2010, van 
Nieuwenhoven et al., 2013. 
 
TNF-α  
 
Both
 
 
 
Both
 
 
Myocytes: Apoptosis 
 
Fibroblasts: ↑ Proliferation 
                    ↑ MMP expression  
    
 
Comstock et al., 1998, Shivakumar et al., 2008, 
Awad et al., 2010, Porter et al., 2004. 
 
 
MMP-13 
 
Both 
 
 
Both
 
 
 
Whole heart: ↓ fractional shortening 
 
 
Steinberg, 2005, Awad et al., 2010,  
Jaffre et al., 2012. 
 
 
CTGF 
 
Both
 
 
 
Both 
 
 
Fibroblasts: ↑ ECM production 
                     ↑ Proliferation 
 
 
Chen et al., 2000, Hayata et al., 2008,  
Zhang et al., 2011. 
 
VEGF 
 
Both
 
 
 
Both 
 
 
Fibroblasts: ↑ Proliferation 
 
 
LaFramboise et al., 2007, Zentilin et al., 2010, 
Tsoporis et al., 2012. 
 
 
ATP 
 
 
Both
 
 
 
Both
 
 
 
Fibroblasts: ↑ α-SMA expression 
 
 
Saini et al., 2005, Dolmatova et al., 2012,  
Lu et al., 2012. 
 
Table 1.1: Summary of mediators investigated in the paracrine interaction between fibroblasts and myocytes, and their main effects 
1(Long, 2001). 2(Comstock et al., 1998). 3(Awad et al., 2010). 4(Steinberg, 2005). 5(Chen et al., 2000). 6(Hayata et al., 2008). 7(LaFramboise et al., 2007). 
8(Zentilin et al., 2010). 9(Lu et al., 2012). 10(Saini et al., 2005).(Turner et al., 2010, van Nieuwenhoven et al., 2013) (Porter et al., 2004)
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This thesis examines the effect of fibroblasts on myocyte function, and specifically 
myocyte excitation contraction coupling. In addition it looks at myocyte volume and a 
possible hypertrophic response. An introduction to these aspects of myocyte 
physiology is provided here. 
 
1.7. Cardiomyocyte function: Excitation contraction coupling 
The primary function of the heart is to pump blood around the body. On a cellular level 
this is achieved by the contraction of individual myocytes acting as a coordinated 
syncytium. Myocyte contraction is produced out of an electrical stimulus by excitation 
contraction coupling (expertly reviewed in (Bers, 2002)).  
 
The electrical stimulus is the action potential. This activates the voltage dependent L-
type Ca2+ channel (LTCC) and Ca2+ flows into the myocyte in the form of the ICa,L. This 
influx of Ca2+ triggers the release of further Ca2+ from the sarcoplasmic reticulum (SR), 
which raises the intracellular Ca2+ concentration. Ca2+ binds to troponin C allowing the 
cross-bridging of myofilaments, which produces the force for contraction. Ca2+ is then 
rapidly removed to allow relaxation, and is extruded from the cell by the Na+/Ca2+ 
exchanger (NCX) and taken into the SR by SERCA (Figure 1.6). 
 
The elements of excitation-contraction coupling are therefore the action potential, the 
transient rise in cytoplasmic Ca2+ (the Ca2+ transient) and the contraction of the 
myofilaments and the whole cell. 
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Figure 1.6: Simplified overview of excitation contraction coupling 
 
 
 
1.7.1. The action potential 
First described by Hodgkin and Huxley (1952) in a giant squid axon, the action potential 
is a voltage waveform produced by multiple currents flowing across the membrane of 
excitable cells (DiFrancesco and Noble, 1985). The resting membrane potential of a 
ventricular myocyte is approximately -85 to -90mV and an action potential is triggered 
when this is depolarised to a threshold. Once this threshold is reached, positive 
feedback of the voltage gated Na+ current initiates a full action potential.  
 
Excitation of the heart is initiated in the sino atrial node. Myocytes within the sino 
atrial node have particular currents that steadily depolarise the membrane potential 
towards threshold (Satoh, 2003). The action potential then self propagates through the 
myocardium. This propagation is facilitated throughout the heart by the electrical 
coupling of cardiomyocytes by gap junctions, producing an electrical syncytium and 
allowing the coordinated contraction of the tissue. 
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In ventricular myocytes, the action potential has a rapid upstroke due to the inward 
Na+ current, then a characteristic plateau phase due to a balance between the ICa,L 
and repolarising outward currents such as the delayed rectifier current, before 
repolarisation when inactivation of ICa,L and increasing activation of repolarising 
currents then returns the cell to the resting membrane potential (Varro et al., 1993). 
During this plateau phase, Ca2+ enters the cell as ICa,L through the open LTCC. 
 
1.7.2. The L-type Ca2+ Current 
Ringer (1883) first showed the importance of extracellular Ca2+ to cardiac contraction 
and Reuter (1967) first described a long lasting Ca2+ current, by which Ca2+ enters 
cardiomyocytes. 
 
ICa,L flows through the LTCC which are voltage sensitive Ca2+ channels that maintain a 
prolonged open state at depolarised potentials. This characteristic distinguishes it from 
the T-type Ca2+ channel which rapidly inactivates (Bean, 1985). The T-type Ca2+ channel 
is at a very low density in ventricular myocytes and is much less important in excitation 
contraction coupling. 
 
The LTCCs open in response to the depolarisation of the membrane by the action 
potential at a threshold of -40mV (in physiological conditions) (Rosenberg et al., 1988). 
It then allows Ca2+ entry into the cells before it inactivates. Inactivation of ICa,L 
depends on the membrane potential, time and the local intracellular Ca2+ 
concentration (Lee et al., 1985). The dependence of inactivation on local Ca2+ allows an 
auto-feedback mechanism to control the amount of Ca2+ entry. Replacing extracellular 
Ca2+ with Ba2+ prolongs the current (Hofer et al., 1997). Also, buffering intracellular 
Ca2+ does not prevent inactivation suggesting it is the Ca2+ that is entering through the 
channel which causes inactivation (Hofer et al., 1997). In another feedback control, SR 
Ca2+ release can also inactivate ICa,L (Sipido et al., 1995). 
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Ca2+ entry via ICa,L is not sufficient to activate the myofilaments and myocyte 
contraction but rather acts as the trigger for Ca2+ induced Ca2+ release (CICR) and 
amplification of the Ca2+ signal. 
  
1.7.3. Ca2+ induced Ca2+ release  
CICR was first described by Fabiato (1983). In skinned Purkinje fibres, the application of 
Ca2+ produced a larger release of Ca2+ from the SR, the basic principle of CICR (Fabiato, 
1985b, Fabiato, 1985a). In cardiac myocytes, Ca2+ from ICa,L stimulates the opening of 
the ryanodine receptor (RyR) on the SR, which is a Ca2+ release channel, thus 
producing amplification of the Ca2+ signal in a positive feedback loop. The importance 
of Ca2+ to the opening of the RyR was shown, as no SR Ca2+ release occurred when 
extracellular Ca2+ was replaced with Ba2+ (Nabauer et al., 1989). Also, when clamping 
the voltage of the membrane, increases in Ca2+ were still able to stimulate SR Ca2+ 
release (Niggli and Lederer, 1990). This shows CICR is in fact Ca2+-induced and not 
voltage dependent. 
  
Due to the high buffering of Ca2+ in the cytoplasm of myocytes, this process is highly 
dependent on the close spatial interaction of LTCCs and RyRs. This relationship is 
achieved by the transverse tubule (t-tubule) system and junctional SR complexes. T-
tubules are regular invaginations of the cell membrane and LTCC are concentrated to 
the t-tubules (Ibrahim et al., 2011). Close to the t-tubule the SR is expanded so that 
there is a close interaction of LTCCs on the t-tubule and RyRs on the SR (Cheng and 
Lederer, 2008). The t-tubule system is therefore essential for effective excitation 
contraction coupling. 
 
Although the recorded Ca2+ transient is a whole cell event, it is actually a summation of 
thousands of local events (Cannell et al., 1994). These local events can be visualised in 
resting myocytes and are termed Ca2+ sparks. Ca2+ sparks are the release of Ca2+ from 
functional clusters of LTCC and RyRs (Cheng et al., 1993). The identification and study 
of sparks has provided insight into CICR, as its control is at this microdomain local level. 
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The process of CICR is a positive feedback loop and therefore requires a specific event 
to terminate it. Three possibilities have been suggested: stochastic attrition (the 
concept that at some point, by chance, all LTCCs and RyRs within the cluster will be 
closed), depletion of SR Ca2+ and RyR inactivation (Stern et al., 1997). 
 
Stochastic attrition cannot explain the repeated termination of Ca2+ release with each 
heart beat. In rat myocytes only 55% of SR Ca2+ is released and therefore depletion of 
the SR also does not appear to be the cause (Delbridge et al., 1997). The inactivation 
and reduced sensitivity to Ca2+ of RyRs have both been reported (Gyorke and Fill, 1993, 
Sham et al., 1998), and therefore appear to play a role in termination of Ca2+ release. 
However, this is still an active area of research and not fully understood. 
 
1.7.4. Contraction 
The myofilaments are the contractile machinery of the cell. Ca2+ facilitates contraction 
by binding to troponin C. This causes a conformational change to reveal the myosin 
head binding site on the actin filament and allows cross-bridge cycling, the production 
of mechanical force and myocyte contraction (Solaro, 1999). 
 
The contractile force is graded to the Ca2+ concentration, although this is not linear, 
and the Ca2+ sensitivity can also be altered by factors, such as pH (Fabiato and Fabiato, 
1978) and drugs, such as β-adrenergic agonists (Gambassi et al., 1992). Therefore the 
control of the Ca2+ transient is a major, although not the sole, way of regulating 
myocyte and thus cardiac contraction. 
 
1.7.5. The removal of Ca2+ from the cytoplasm 
To terminate contraction and allow relaxation of the myocytes, and diastole of the 
whole heart, Ca2+ has to be removed from the cytoplasm. The two major pathways are 
NCX which pumps Ca2+ out of the cell and SERCA which pumps Ca2+ back into the SR. 
Two other pathways exist to remove Ca2+, sarcolemmal Ca2+-ATPase and mitochondrial 
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Ca2+ uniport, although, together these account for approximately 1% of Ca2+ removal 
and therefore have minimal involvement in the Ca2+ transient (Bers, 2002). 
 
Although SERCA is responsible for the majority of Ca2+ removal, the relative 
contributions of SERCA and NCX vary between species. In rat myocytes SERCA removes 
over 90% of Ca2+ (Bassani et al., 1994), whereas in humans it removes approximately 
60% (Pieske et al., 1999). The relative contributions vary depending on other factors 
such as the resting membrane potential (Bridge et al., 1988) and heart rate (Pieske et 
al., 1999). 
 
1.7.6. Excitation contraction coupling in disease 
All aspects of myocyte excitation contraction coupling are altered in cardiovascular 
disease (Tomaselli and Marban, 1999, Hasenfuss and Pieske, 2002). 
 
The action potential is prolonged due to changes in the current profile of the 
myocytes, particularly a decrease in the transient outward K+ current (Beuckelmann et 
al., 1993, Tomaselli et al., 1994, Santos et al., 1995). There is also increased 
heterogeneity of action potential duration which is highly pro-arrhythmic (Misier et al., 
1995). 
 
Ca2+ handling is also deranged in pathology. The ICa,L current has been found to be 
reduced in some studies (Ouadid et al., 1995, Santos et al., 1995) but unchanged in 
others (Beuckelmann et al., 1992, Gomez et al., 1997). However, the Ca2+ transient 
amplitude is consistently decreased and the rate of Ca2+ removal from the cytoplasm is 
reduced (Beuckelmann and Erdmann, 1992, Beuckelmann et al., 1992).  
 
This can at least in part be explained by Ca2+ cycling in the SR. SERCA activity is 
decreased in heart failure, a possible explanation for the slowed removal of Ca2+ 
(Schwinger et al., 1995, Lehnart et al., 1998) and for the observation that SR Ca2+ 
content is reduced (Lindner et al., 1998, Pieske et al., 1999). This also explains why Ca2+ 
transients are smaller as less SR Ca2+ is available for release. An additional explanation 
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may be the disruption of the spatial relationship between LTCCs and RyRs which would 
reduce the efficiency of CICR (Gomez et al., 1997).  
 
Myocyte contractility is reduced in heart failure (Litwin et al., 1991, Davies et al., 1995) 
which may be a result of the reduced Ca2+ transient but also a reduction in 
myofilament sensitivity to Ca2+ (Morgan et al., 1990). 
 
1.8. Myocyte hypertrophy 
Myocyte hypertrophy can be simply defined as an increase in myocyte volume. 
However, it is the complex result of a large array of different signals including pressure 
overload and numerous soluble mediators (Shah and Mann, 2011). Myocyte 
hypertrophy is traditionally sub-divided into physiological hypertrophy and 
pathological hypertrophy (McMullen and Jennings, 2007) but this is not a clear 
distinction. There is considerable overlap between the signals involved in the 
physiological hypertrophy associated with pregnancy or exercise, and the pathological 
hypertrophy associated with cardiovascular disease. 
 
In disease, hypertrophy is associated with detrimental changes in myocyte and whole 
heart function and co-exists with increased myocardial fibrosis, which increases the 
functional decline of the heart (Cohn, 1995). However, the initial hypertrophic 
response of myocytes to pathological stimuli is protective of heart function. If the 
initial hypertrophic response is prevented then ventricular dilatation and heart failure 
develop rapidly (Takeda et al., 2010). It is only after cardiovascular disease develops 
that the hypertrophic response is no longer protective but starts to contribute to 
disease progression.  
 
The role of myocyte hypertrophy in protection against functional deterioration, and 
then disease progression, is therefore complicated. Furthermore, whether the effects 
of fibroblasts on myocyte volume are beneficial or detrimental to cardiovascular 
health requires careful investigation. 
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1.9. Hypothesis 
In summary, several studies have shown that fibroblasts are capable of affecting 
properties of myocytes through juxtacrine and paracrine intercellular communication.  
Fibroblasts can induce myocyte hypertrophy through paracrine mediators, and there is 
growing evidence that this may be important in the heart’s hypertrophic response to 
pressure overload. The effect of fibroblast-derived paracrine mediators on myocyte 
function is less extensively studied, but the available evidence suggests fibroblasts may 
have a detrimental effect on myocyte electrophysiology and contraction. 
  
Among myocyte properties, excitation contraction coupling is crucial in cardiovascular 
function and disease. However, the factors that regulate excitation contraction 
coupling and drive its dys-regulation in disease are not fully understood. It is possible 
that fibroblasts act as a sensor to pathological situations that in turn drive myocyte 
dysfunction. Therefore, we set out to test the hypothesis that fibroblasts can 
modulate excitation contraction coupling via the release of paracrine mediators, and 
that these effects are altered by pressure overload of the left ventricle. 
 
Due to the alteration in fibroblast phenotype in culture, we also set out to limit the 
effects of culture in order to gain a closer representation of the fibroblasts in vivo 
(although this was not possible with the dog work described in chapter 7). 
 
In particular the following specific hypotheses were tested. 
 
1. Normal fibroblasts exert paracrine effects on excitation contraction coupling 
of myocytes. 
This hypothesis is tested in Chapters 4 and 7. To test this hypothesis a co-culture 
system was used that allows paracrine communication, but prevents direct cell 
contact.  
 In Chapter 4, adult rat cardiac fibroblasts from healthy rat hearts are co-
cultured with adult rat myocytes. 
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 In Chapter 7, cultured dog fibroblasts are co-cultured with dog myocardial 
slices (multicellular preparations of the adult myocardium). 
 
2. The paracrine effects of fibroblasts on myocyte excitation contraction 
coupling are altered by chronic overload. 
 In Chapter 5, adult rat cardiac fibroblasts from a model of pressure overload 
and sham operated controls are co-cultured with adult rat myocytes from healthy 
hearts. 
 
3. TGF-β released from fibroblasts is responsible for the paracrine effects of 
fibroblasts on myocytes. 
 In Chapter 6, the TGF-β type 1 receptor antagonist SB 413542 was used to 
investigate the role of TGF-β in the paracrine effects observed. 
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CHAPTER 2.  
General methods 
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2.1. Source of cardiovascular tissue 
The experiments in this thesis involved the use of rat and dog tissue. The source of 
tissue was an important consideration due to the pronounced differences in 
cardiovascular physiology between species. The most evident of these differences is 
the heart rate. Mice have a heart rate of approximately 600 beats per minute (Mitchell 
et al., 1998), ten times more than human heart rate. This is underpinned by 
differences in excitation contraction coupling of myocytes between species (Bassani et 
al., 1994, Su et al., 2003). The applicability of information obtained to human 
physiology and disease is therefore a major consideration when choosing a species to 
use (Hasenfuss, 1998, Yarbrough and Spinale, 2003). However, a second and often 
conflicting consideration is the availability of the tissue and the ability to manipulate 
the species to allow for more in depth study.  
 
This thesis used beagle dog hearts (8-12 months of age) that were supplied by 
GlaxoSmithKline (Ware site, UK). The hearts were collected from control toxicology 
dogs that were being euthanized. Dog hearts are a good model for human 
cardiovascular electrophysiology with greater similarity to humans than other species 
(Lompre et al., 1981, Su et al., 2003). 
 
However, the supply of this tissue was inconsistent. Also, we did not have the capacity 
to produce a disease model in dogs. This side of cardiovascular research is where small 
animals, particularly the mouse and rat, are far more useful. Small mammals are 
comparatively cheap to buy and maintain compared with large animals. It was also 
possible to produce models of disease using these animals. The lab had extensive 
experience with rat models of cardiovascular disease and therefore the rat was used 
for the majority of the experiments. 
 
2.2. Rat model 
As a source of fibroblasts from a pathological situation, the investigations involved in 
this thesis used a rat thoracic aortic constriction (TAC) model. TAC produced a 
chronically raised afterload of the heart akin to an aortic stenosis in humans. 
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There are a number of ways to produce models of heart disease, including coronary 
artery ligation, tachypacing, chemical insult and TAC (Hasenfuss, 1998, Bader, 2010). 
Both coronary artery ligation and TAC were established in the Terracciano lab (Lee et 
al., 2009, Ibrahim et al., 2012) and therefore were considered for these experiments. 
Both models will eventually lead to heart failure although coronary artery ligation 
produces this faster than TAC (Molina et al., 2009, Navaratnarajah et al., 2013). 
Coronary artery ligation produces a myocardial infarction, albeit without reperfusion 
which is normally achieved in human myocardial infarction. Myocardial infarction is a 
major presentation of cardiovascular disease in humans (Rosamond et al., 1998), and 
was therefore considered a good source of pathological fibroblasts. However, coronary 
artery ligation produces different populations of fibroblasts associated with the infarct 
zone and remote regions (Squires et al., 2005). Fibroblasts from the infarct zone 
exhibited greater α-SMA expression and proliferation than fibroblasts from the remote 
zone. TAC produces a homogenous effect on the left ventricle (LV) and has been 
shown to cause changes in left ventricular fibroblast phenotype. Fibroblasts isolated 
from TAC hearts were more proliferative and migrated faster than controls (Stewart et 
al., 2010). To avoid the issue of different populations of fibroblasts from different 
areas of the LV, TAC was chosen as the source of pathological fibroblasts. A 10-week 
TAC model was used as it had been previously characterised within the lab (Ibrahim et 
al., 2012). This model produces myocyte hypertrophy, and also disruption of the t-
tubule network and Ca2+ handling properties of isolated myocytes. Myocardial fibrosis 
was not measured in these experiments, although similar models have shown 
increased fibrosis throughout the LV (Perlini et al., 2005, Ciobotaru et al., 2008, Chen 
et al., 2011). Considering this, along with the evidence of altered fibroblast function in 
vitro, TAC was chosen as the most suitable model for use in these experiments. 
 
All operations were performed under licence by the UK Home Office, in accordance 
with the United Kingdom Animals (Scientific Procedures) Act 1986. Aseptic technique 
was used throughout.  
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2.2.1. Thoracic Aortic Constriction  
All the animals used for surgery were adult male Lewis rats (Harlan Laboratories, UK). 
This is a syngeneic strain, which allowed for better controls within experiments due to 
the lack of underlying genetic differences. Rats were kept in normal rodent cages with 
simple environmental enrichment. The animals had ad libitum access to food and 
water throughout. 
 
The operations were carried out using weight controlled animals of 200-250g. Along 
with the consistency of the size of the stenosis, the size of the animal was important in 
maintaining the level of overload placed on the heart, particularly during the initiation 
of but also throughout the model. 
 
The rat was anaesthetised in 5% isoflurane (Abbott, USA) in pure O2 and the chest was 
shaved. To sterilise the operating area the rat was swabbed with 10% Povidone-iodine 
(Videne®, Adams Healthcare, UK). 10-15mg/kg amoxicillin trihydrate (Clamoxyl LA®, 
Pfizer, USA) and 10-20μg/kg buprenorphine hydrochloride (Vetergesic®, Reckitt & 
Colman, UK) was given subcutaneously for antibiotic prophylaxis and pain prevention. 
The rat was then moved to the operating area and anaesthesia was maintained with 
isoflurane through a nose cone. Initially 5% isoflurane was used to maintain a deep 
anaesthesia before the rat was intubated to allow for mechanical ventilation during 
the operation. A standard paediatric laryngoscope was used to visualise the larynx, and 
a light was directed at the outside of the neck to allow visualisation of the movement 
of the vocal cords. An endotracheal tube, a modified 20-gauge cannula (NHS Supply 
Chain, UK), was placed down the trachea. Correct insertion of the endotracheal tube 
was confirmed by checking for exhaled condensation using a scalpel blade, before it 
was connected to a Model 683 Rodent Ventilator (Harvard Apparatus Ltd, UK). 
Ventilation was provided at approximately 90 breaths per minute with a tidal volume 
of 1.5ml throughout the operation. After successful intubation, the anaesthesia was 
reduced to 1.5% isoflurane for the duration of the procedure. Once the animal was 
sterilely draped it was ready for the operation. 
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A right lateral thoracotomy was performed to enter the chest cavity. An incision 
through the skin was made using a scalpel, and the skin was bluntly dissected away 
from the underlying tissue and retracted to provide access. Next the pectoralis major 
and latissimus dorsi were dissected and retracted which allowed visualisation of the 
chest wall. An intercostal space was identified and the mechanical ventilation was 
paused as a needle was passed through the muscle, tracking the intercostal space and 
then back out through the same intercostal space. The ventilation was restarted and 
the muscle along the needle was cut with the scalpel. Needle holders were used to 
widen the thoracotomy which was then held open using a rodent thoracotomy 
retractor (World Precision Instruments, UK). Small swabs (approximately 5mm2) were 
placed to protect the delicate structures of the atria and lungs, and then the lobes of 
the thymus were split to provide a view of the ascending aorta. The surrounding tissue 
was bluntly dissected away and curved forceps were passed under the aorta to provide 
a path for a 3-0 silk suture. The suture was loosely tied around the aorta and a needle 
of 0.9mm external diameter was laid through the loop. The silk was pulled tight and 
locked around the needle and aorta, and then the needle was removed, leaving the 
aorta constricted to the size of the needle. An illustration of TAC is shown in Figure 2.1. 
 
The swabs were removed from the chest, increased expiratory pressure was applied to 
re-inflate the lungs, and the chest wall was closed with a mattress suture using 4-0 
prolene (Ethicon®, Johnson and Johnson, UK). The retractors were released and the 
muscles replaced before the skin was closed with a continuous suture using 2-0 silk. 
Expiratory pressure was increased again to make sure the lungs were fully inflated and 
to help alleviate any pulmonary oedema before the isoflurane was removed. The rat 
was allowed to self extubate as a clear signal of its recovery from the anaesthesia and 
then left to recover on its own before being returned to its original box. The operated 
rats were observed closely for 48 hours and wet food and analgesia were provided 
when necessary to aid recovery. The rats were weighed weekly after surgery to 
monitor their health with a humane endpoint of 20% weight loss. No rats reached this 
point. 
 
 
 71 
 
Figure 2.1: Illustration of the placement of thoracic aortic constriction on the ascending aorta 
(Courtesy of Dr Mary Curran) 
 
2.2.2. Controls 
Either sham operated or age matched animals were used as controls. The control used 
is highlighted within each experiment. Where sham operated animals were used 
exactly the same procedure was performed as detailed above, excluding the tightening 
of the suture around the ascending aorta. 
 
2.2.3. Assessment of operative outcome 
The effect of the 10 week TAC was characterised using echocardiography and heart 
weight and body weight measurements. 
 
2.2.3.1. Echocardiography 
At the point of collecting the heart, the rats were lightly anaesthetised with 1.5% 
isoflurane. The level of anaesthesia was carefully controlled as this can affect cardiac 
function (Bernard et al., 1990). The chest of the rat was shaved and warm ultrasound 
transmission gel was applied to the skin (Sonogel®, AnaWiz Ltd, UK). An ACUSON 
SequoiaTM C256 (Siemens Medical Solutions, USA) echocardiography machine with a 
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14MHz phased-array transducer (15L8-S, Siemens Medical Solutions, USA) was used to 
acquire echocardiographic data in motion mode (M-mode). 
 
In order to get comparative data it was essential to assess the same level within each 
heart. Therefore using the 2 dimensional mode, a long axis view was used to identify 
the papillary muscles, and switching to a short axis view a level just above these was 
selected for measurement. M-mode echocardiography involves repeated scanning of a 
single line over time. Therefore a line was selected across the ventricles and recorded. 
This image was used to measure LV free wall thickness and ejection fraction. Ejection 
fraction was calculated by the software from measurements of left ventricular 
dimensions in systole and diastole using the calculations in Figure 2.28 
 
 
 
Figure 2.2: Echocardiography measurements and calculations 
Measurements of systolic and diastolic LV dimensions and posterior wall thickness 
were taken from M-mode images. LV dimensions were used by the software to 
calculate ejection fraction using the equations shown. 
                                                 
8
 Echo Made Easy. Sam Kaddoura. Churchill Livingstone, Second Edition, 2009. 
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2.2.3.2. Biometric measurements 
The body weight of the animals was measured at the point of sacrifice, and before the 
heart was used for cell isolation the whole heart and LV weights were measured. This 
allowed the heart weight (HW) to body weight and LV to body weight ratios to be 
calculated which were used as indices of cardiac hypertrophy. 
 
2.3. Tissue and cell preparation 
Three in vitro preparations of cardiac cells and tissue are used in this thesis, namely 
isolated myocytes, isolated fibroblasts and myocardial slices.  
 
Isolated myocytes were prepared from rat hearts and were used to examine the 
paracrine effects of fibroblasts on myocyte Ca2+ handling, contractility, volume and 
viability. Cell isolation was achieved by enzymatic digestion of cardiac tissue to liberate 
the cells. The isolation of myocytes was widely established in our laboratory, using a 
Langendorff set up to perfuse the coronary vascular system via retrograde perfusion of 
the aorta of small animals with enzymes (Siedlecka et al., 2008). The isolation of intact 
functional myocytes from the myocardium by retrograde perfusion of the coronary 
arteries was first described by Berry et al (1970). The availability of these cells has 
been the basis of much of our understanding of the function of myocytes and the 
effects of exogenous stimuli. The isolation of fibroblasts was less well characterised, 
and various methods were tested as described in Section 3.3.1, before settling on the 
technique described below. The isolation of fibroblasts from the heart has also been 
essential for understanding their properties (Rohr, 2011). The ability to isolate these 
different cell populations is essential for the work in this thesis. 
 
Myocardial slices were prepared from the dog hearts and were used to examine the 
paracrine effects of fibroblasts on the electrophysiology of the myocardium at the 
multicellular level. Unlike isolated cells they allow the measurement of conduction 
velocity alongside the field potential (an extracellular recording of the voltage changes 
caused by the action potential). Slices are thin (approximately 300µm) viable sections 
of living tissue that can be used to study the function of intact tissue from various 
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organs (Parrish et al., 1995). The methodology for preparing myocardial slices, has 
been updated such that serial sectioning of a piece of ventricular tissue is now 
achieved with a high precision vibrating microtome and slices are cut parallel to the 
epicardial wall so as to run in the direction of the muscle fibres and thus limit damage 
by cross cutting fibres. These slices can then be used to measure the structure and 
function of the myocardium (Camelliti et al., 2011). 
 
Slices have advantages over isolated myocytes due to the presence of other elements 
of the myocardium, including other cells such as fibroblasts and endothelial cells, and 
an intact ECM. They are therefore considered a more representative model of the 
intact heart. Other methods used to study intact heart tissue include wedge, 
trabeculae, and whole heart preparations; slices also have advantages over these (de 
Boer et al., 2009). Firstly, many slices can be produced from a single heart- 
approximately 30 from a section of a canine LV. Therefore a greater number of studies 
can be carried out with fewer animals, an essential aspect of animal research 
development. Also, wedge preparations measure from the cross cut section of the 
tissue and are therefore recording from damaged fibres. They also require perfusion 
through a coronary artery which may be uneven across the tissue, whereas slices 
remain viable when kept in oxygenated normal Tyrode solution (NT). Trabeculae are 
columns of muscle that project from the endocardial surface of the LV. They can be 
detached and studied as whole sections, whereas slices allow the investigation of the 
main body of the ventricular wall. Whole heart studies are limited to recording from 
the surface of the heart whereas slices from different depths through the myocardium 
can be used to generate more information. 
 
2.3.1. Rat heart collection 
As a result of the surgery, adhesions developed within the chest and around the heart 
and therefore removing the heart required care. Terminal anaesthesia was induced 
with 5% isoflurane. The chest and abdomen was shaved along the midline of the 
animal and the skin was opened from the manubrium down to the mid abdomen with 
a scalpel. The abdominal wall was opened revealing the xiphisternum and the 
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diaphragm. Using scissors, the diaphragm was punctured and a median sternotomy 
was rapidly performed. The heart was quickly excised and placed in NT containing 100 
units of heparin (Monaparin™, CD Pharmaceuticals Ltd, UK) per ml (NT+H) at 37°C to 
prevent blood clotting. It was allowed to beat for approximately 10 seconds to remove 
the majority of the blood from within the heart and then moved into NT+H at 4°C 
which led to rapid cessation of beating to preserve the tissue. Unoperated and control 
rat hearts were collected in the same fashion for consistency. 
 
2.3.2. Rat myocyte isolation 
While in the cold NT with heparin, the heart was cleaned of excess tissue (e.g. lung, 
thymus and excess fat) in order to expose the aorta for cannulation. The aorta was 
cannulated with a 16-gauge cannula on a Langendorff perfusion set up with a constant 
flow pump (MasterFlex® L/STM Economy Drive, Cole-Parmer Instrument Company 
Ltd., UK). A flow rate of approximately 12ml per minute was used throughout. The 
heart was retrogradely perfused with oxygenated NT at 37°C until the heart was clear 
of blood and contracting well. Perfusion was switched to oxygenated low Ca2+ solution 
(LC) at 37°C for 5 minutes. It was then switched to oxygenated Buffer A containing 
0.6mg/ml collagenase type II (Worthington Biochemical Corporation, USA; Cat. No. 
4176) and 0.4mg/ml hyaluronidase type I-S (Sigma Aldrich, UK; Cat. No. H-3506) for 8 
minutes. In total 35ml of Buffer A with collagenase and hyaluronidase was used. 
The heart was removed from the Langendorff and the LV was then removed from the 
rest of the heart and cut into small pieces of approximately 2mm3. These pieces were 
shaken in 10ml of oxygenated re-circulated collagenase/hyaluronidase containing 
Buffer A for 5 minutes at 37°C. The solution was collected by filtering through a 400-
µm nylon mesh to remove the remaining tissue, which was shaken again in oxygenated 
fresh collagenase/hyaluronidase containing Buffer A at 37°C for another 5 minutes. At 
the end of this digestion the tissue was agitated using a Pasteur pipette to encourage 
the separation of single myocytes from the tissue and the solution was collected again. 
The remaining tissue was shaken in oxygenated Buffer A at 37°C for a further 5 
minutes before agitating the tissue and collecting the solution a final time. 
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To acquire myocytes, the collected solution which contained the cells in suspension 
was centrifuged at 500rpm for 1 minute and the supernatant was removed. The pellet 
of cells was re-suspended in 8ml of Buffer A and re-centrifuged to wash off any 
remaining enzyme. The supernatant was removed and the cells were finally re-
suspended in fresh Buffer A ready for use. 
 
2.3.3. Rat fibroblast isolation 
To isolate rat fibroblasts, the heart was hung on the Langendorff set up and perfused 
with oxygenated LC at 37°C for 10 minutes. The heart was then removed from the 
Langendorff and the LV was dissected from the rest of the heart and cut into small 
pieces of approximately 2mm3. These pieces were shaken in 10ml of oxygenated 
Buffer A containing 0.36mg/ml proteinase type XXIV (Sigma Aldrich, UK; Cat. No. 
P8038) for 40 minutes at 37°C. The solution was collected by filtering it through a 400-
µm nylon mesh and the remaining tissue was shaken in 10ml of oxygenated Buffer A 
containing 1mg/ml collagenase type V (Sigma Aldrich, UK; Cat. No. C9263) for 45 
minutes at 37°C. The tissue was then vigorously agitated with a Pasteur pipette to help 
liberate the cells from the tissue, and then the remaining tissue was removed by 
filtration. Fibroblasts were collected at both time points by centrifuging at 620g for 5 
minutes and removing the supernatant. The pellet of cells and debris was re-
suspended in sterile phosphate buffered saline (PBS) and re-centrifuged to wash the 
cells. Finally it was re-suspended in fibroblast culture medium (FB medium (82% 
DMEM, 15% foetal bovine serum, 100U/ml penicillin, 100µmol/l streptomycin, 4mM L-
alanyl-L-glutamine)) and placed in culture in 25cm2 culture flasks (Corning, USA) in 
humidified air at 37°C, 5% CO2. After two hours the medium was changed to remove 
any debris leaving the fibroblasts attached to the culture dish. This medium change is 
also important in preventing contamination of the fibroblast population. Fibroblasts 
attach preferentially compared to endothelial and smooth muscle cells and therefore 
these potential contaminating cells are washed away by changing the medium 
(Gustafsson and Brunton, 2000). 
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2.3.4. Dog fibroblast isolation 
Dogs were euthanized with intravenous pentobarbital at GlaxoSmithKline. The whole 
heart was rapidly removed and immediately submerged in ice cold cardioplegia 
(Plegivex®, Ivex pharmaceuticals, UK). Hearts were couriered to the lab on ice and 
arrived between 60-90 minutes after they were removed. The sharing and utilisation 
of this precious tissue, which would have been otherwise wasted, was in line with the 
3 R’s (Replace, reduce and refine) of animal research.9 
 
To isolate fibroblasts, 0.5g of LV tissue was cut into small pieces of approximately 
2mm3. These pieces of tissue were shaken in 10ml of oxygenated LC at 37°C for 3 
minutes. The LC was removed and fresh LC was added and the tissue was shaken for a 
further 3 minutes. This was done a total of 4 times. It was then treated the same way 
as the rat tissue by digesting it with proteinase XXIV and collagenase type V and 
collecting the cells by centrifuging at 620g. 
 
2.3.5. Dog myocardial slices preparation 
The preparation of dog slices was established within the lab (Camelliti et al., 2011) 
based on the protocol for the preparation of slices from rodent hearts described by 
Bussek et al (2009). The LV free wall was removed from the rest of the heart and a 
10mm2 transmural block was cut free from the rest of the tissue using clean cuts with 
a sharp razor blade. The block was mounted on an agar coated specimen holder of a 
high precision vibrating microtome (7000smz, Campden Instruments Ltd., UK) using 
surgical glue (Histoacryl®, Braun, Germany) in cold oxygenated slicing solution. This 
solution contained the excitation-contraction un-coupler 2,3-butanedione monoxime 
which is used to prevent the tissue contracting while being cut which would damage 
the tissue. 
 
Slices were cut using a stainless steel blade (Campden Instruments Ltd., UK), set to 
vibrate at 75 Hz with amplitude of 2mm and deflection in the Z plane of less than 1µm. 
The advancing speed of the blade was set to 0.04mm/second and slice thickness to 
                                                 
9
 http://www.understandinganimalresearch.org.uk/how/the-three-Rs 
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300µm. These settings were used to limit tissue damage as previously optimised by 
Camelliti et al. (2011). Care was taken to keep the tissue covered in solution at all 
times, and the solution was kept at 4°C to help preserve the tissue and prevent 
damage while slicing. Once cut, the slices were incubated in oxygenated slicing 
solution at room temperature for at least 1 hour before being used. 
 
2.3.6. Fibroblast cell culture 
Fibroblasts remain viable and proliferate in culture over prolonged periods of time, 
although they have a limited proliferative capacity (Hayflick, 1965). Although the 
majority of the studies included in this thesis used fibroblast within 48 hours of 
culture, for some experiments long term culture was required. During maintenance of 
fibroblast cultures, they were cultured in FB medium. They were split 1:2 when 
reaching confluency, which normally happened after about 5 days in culture and then 
approximately twice a week. To achieve this, the medium was removed, and the 
culture flask was washed with sterile PBS and 2ml of 0.25% Trypsin-EDTA (Gibco®, Life 
Technologies, USA) was added to detach the cells from the flask. This was left in the 
incubator for 5 minutes. 5ml of FB medium was added which inactivated the trypsin. 
The medium and trypsin contained the cells in suspension and was collected and 
centrifuged at 620g for 5 minutes. The supernatant was then discarded and the pellet 
re-suspended in FB medium. Half the medium was then put back into the flask to 
achieve a 1:2 split. The other half was either discarded or put in a new flask if more 
fibroblasts were needed. 
 
2.4. Rat cell studies 
The culture of fibroblasts and myocytes was essential to complete the experiments in 
this thesis. This has inherent problems as both cell types are altered by culture. 
Fibroblast begin to express α-SMA, which in vivo is associated with pathological 
myofibroblasts, and also undergo other changes in protein expression and cell 
characteristics (Rohr, 2011). These changes were tracked over time in culture 
(described in Section 3.3.3.) and the final experimental design was produced so that all 
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experiments were completed within 48 hours of fibroblast isolation to limit and 
control for any changes. Adult myocytes also de-differentiate in culture (Mitcheson et 
al., 1998) and therefore neonatal myocytes are often used in experiments that require 
in vitro myocytes (Chlopcikova et al., 2001). However, these cells have an inherent 
immature phenotype (Yin et al., 2004). For these experiments, it was therefore 
necessary to use adult cells where the machinery for Ca2+ handling and contractility are 
fully developed. 
 
The focus of this work was the paracrine interaction of fibroblasts and myocytes. 
However, it has been widely shown that direct cell contact in vitro between fibroblasts 
and myocytes result in alterations to the myocyte phenotype (e.g. (Miragoli et al., 
2006) and discussed in detail in Section 1.5.1.). Therefore a culture system that 
allowed paracrine communication but prevented direct cell contact was required. 
There are two ways in which this could be done, either by using conditioned medium 
or by physically separating the cells within the same culture medium. Conditioned 
medium involves exposing medium to one cell type and then transferring it onto the 
target cell type (Harada et al., 1997, Pedrotty et al., 2009, Vasquez et al., 2010). 
However, this removes the bidirectional aspect of paracrine communication, and 
therefore a system to physically separate the two cell types within the same medium 
was used. This system made use of Transwells® (Corning Incorporated ,USA).  
 
Transwells are inserts with a semi permeable membrane (with 0.4µm pores) that allow 
co-culture of cells in a common media while maintaining physical separation. This 
allows dynamic bidirectional paracrine communication between the fibroblasts and 
myocytes. A diagrammatic representation and photos of the set up are shown in 
Figure 2.2. 
 
All cultures were kept in humidified air at 37°C in 5% CO2 using a Galaxy S incubator 
(Wolf laboratories, York, UK) and cell culture work was performed under sterile 
conditions in a Class II safety cabinet (NuAire, USA). 
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Figure 2.3: Illustration and photos of the co-culture set up. 
1. A glass bottom dish, on which the myocytes were plated. 2. The Transwell on which 
the fibroblasts were plated, which is suspended into the medium of the myocytes. 3. 
Support for the Transwell to prevent it hitting the base of the glass bottom plate. 
These were made by cutting a hole into the top of a normal glass bottom dish lid. 4. A 
lid to produce a fully enclosed environment was fashioned out of a normal 35mm 
dish. 
 
 
2.4.1. Co-culture set up 
The identification of a suitable medium for co-culture was essential for this work and is 
described in detail in Section 3.3.4. Ultimately, ITS medium was used (M-199 (without 
l-glutamine), 100U/ml penicillin, 100µmol/l streptomycin, 1:1,000 dilution ITS 
supplement (PAA, Austria; Cat. No. F01-015). 
 
Fibroblasts were collected from culture after 20 hours using 0.25% Trypsin-EDTA and 
counted using a Neubauer Improved Haemocytometer. They were then plated in 
6.5mm Transwells with 0.4µm pores, at a density of 10,000 cells/Transwell, in 200µl of 
ITS medium. These were left for 4 hours to settle and recover from the trypsin 
exposure before use. 
 
Freshly isolated myocytes were plated at a density of 5,000 cells/dish on laminin 
(Sigma-Aldrich, UK) coated glass bottom dishes (MatTek, USA). The myocytes were left 
to attach for 5 minutes and then 2ml of ITS medium was added. 30 minutes later this 
was replaced with 2ml of fresh ITS medium before they were used. Glass bottom 
dishes were used as they allowed the use of an inverted microscope to study the 
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myocytes. They had a thin glass base, so the focal distance between the objective and 
the cells was smaller. Therefore a more powerful oil immersion objective could be 
used and a more detailed image recorded. 
 
The Transwells containing the fibroblasts were suspended over the myocytes in the 
glass bottom dish, so that the base of the Transwell sat within the culture medium on 
the myocytes but did not touch the base of the dish. This was important to prevent 
nanotube projections from fibroblasts from protruding through the membrane and 
contacting with the myocytes (He et al., 2011). As a control 5,000 myocytes were 
plated in Transwells above the 5,000 myocytes in the glass bottom dishes. This was 
used to control for the possibility that the extra cells were depleting nutrients from the 
medium, which could affect the cell phenotype. 
 
The co-culture set ups were incubated for 24 hours before experimental analysis. To 
characterise the effects of paracrine communication on the myocyte phenotype cell 
viability, cell volume, the transverse tubule (t-tubule) network, Ca2+ transients and 
contractility were analysed.  
 
Cell viability, volume, the t-tubule network and Ca2+ transients were all measured using 
confocal microscopy. An Axiovert 200M microscope with a LSM 510 confocal laser 
attachment (Carl Zeiss AG, Germany) was used throughout. Myocyte contractility was 
recorded using an IonOptix system (IonOptix Corp, USA) to track stimulated sarcomere 
shortening.  
 
2.4.2. Cell viability 
Healthy myocytes have a characteristic rod shape and thus a simple way to assess 
myocyte viability was to classify cells as either rod shaped (viable) or rounded up (non-
viable). To achieve this, 3-5 normal light images per co-culture set up were taken of 
the cells at 20 times magnification. The number of rod and rounded up cells were 
counted and the percentage of viable rod cells per set up was calculated. The culture 
of myocytes itself causes changes in cell shape with some rounding of the normal 
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sharp rod shape. Examples of freshly isolated, viable cultured, dying and dead cells are 
shown in Table 2.1. Cells that fell into the dying or dead cell categories were 
considered non-viable. 
 
 
Viable Non-Viable 
Freshly Isolated 1 day cultured Dying Dead 
 
 
  
Rod shaped with 
sharp edges and 
corners, clear 
sarcomeric structure 
Maintained rod 
shape, with 
softening of the 
edges, retains 
sarcomeric 
structure 
Formation of 
characteristic 
‘cauliflower’ ends 
or blebbing of 
membrane 
Rounded up, no 
sarcomeric 
structure 
Table 2.1: The characteristics of viable and non-viable myocytes when visualised microscopically 
These were important in determining cell viability but also when determining which 
cells to select for data acquisition. 
 
2.4.3. Cell volume and t-tubule network 
Changes in cell size can be quantified by looking at a cross sectional area (Lee et al., 
2009). However, this is limited to measuring any changes in 2 dimensions. Using a 
membrane binding dye and confocal microscopy, it is possible to reconstruct the 
volume of the cell in 3 dimensions allowing a more accurate measurement. Staining 
the membrane also marks out the t-tubule membrane invaginations, and it is therefore 
possible to characterise this system which is important in Ca2+ handling in myocytes 
(Ibrahim et al., 2011). 
 
Di-8-ANEPPS (Molecular Probes, Life Technologies, USA), a membrane binding voltage 
sensitive dye, was used to visualise the membrane for these experiments. It was 
excited at 488nm using an argon laser set at 5% transmission and emission was 
collected through a 505nm long pass filter. Data was acquired using unidirectional 
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scanning at 12 bit depth. All handling and recording of di-8-ANEPPS was carried out in 
the dark to prevent photo-bleaching of the fluorescent molecules. 
 
After co-culture, the myocytes were stained in situ on the glass bottom dishes. The ITS 
medium was removed and 1ml of Buffer A was added to the dish. This was 
subsequently removed and 10µM di-8-ANEPPS in 500µl of Buffer A was added for 10 
minutes at room temperature. The remaining dye was then removed and fresh Buffer 
A solution added.  
 
The cells were visualised using a 40 times oil-immersion objective using the confocal 
microscope, and viable cells were systematically selected and imaged. Non-viable cells 
as defined in Table 2.1 were not imaged, nor were cells that were in contact with 
another cell or debris due to the difficulty in defining the cell limits upon analysis. Once 
a cell was selected the microscope was put into laser scanning mode and a single 
image of the cell was taken. The area of interest was cropped in the x and y axes 
around the cell. Using the ‘mark first and last’ z stack function it was also cropped in 
the z axis to the upper and lower limits of the cell. The area of interest was therefore 
limited to the area occupied by the cell. A z stack of this area was then recorded with 
an image interval of 2µm. The images were recorded at 4 image averaging for 
improved quality (Figure 2.3A). 
 
The di-8-ANEPPS stained area was then reconstructed using ImageJ software (U.S. 
National Institutes of Health) and cell volume and t-tubule density were analysed using 
custom written software (provided by Dr Mark Stagg). The images were converted to 
8-bit and using auto-threshold were converted into binary images (Figure 2.3B). For t-
tubule density, the macro measured the percentage of di-8-ANEPPS staining in the 
middle 80% of each slice (the 10% at each end were ignored to exclude the cell end 
membranes). This was done for each slice of the z stack and an average was generated 
and used to represent t-tubule density. 
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For cell volume, a second macro was used. The total area within the images that was 
enclosed by staining was marked positive and measured (Figure 2.3C). The depth of 
the slice is known and therefore the total volume of the cell can be calculated. 
 
 
 
Figure 2.4: Example of the process of recording cell volume and t-tubule density 
A) Original recording of di-8-anepps staining showing 1 slice of a z-stack. B) A binary 
image after auto threshold was applied. The % area stained in the middle 80% of the 
image is used as a measure of t-tubule density. C) Any area enclosed by staining was 
marked positive. The cell can therefore be reconstructed in 3 dimensions and the 
volume calculated. 
 
2.4.4. Ca2+ transients 
Ca2+ transients were measured using the Ca2+ sensitive dye Fluo-4 and the line scanning 
mode of the confocal microscope. Fluo-4 fluorescence is altered by binding of Ca2+ and 
therefore can be used to record changes in the cytoplasmic [Ca2+]. The myocytes were 
loaded with Fluo-4-acetoxymethyl ester (AM) (Molecular Probes, Life Technologies, 
Oregon, USA) which easily crosses the cell membrane whereupon it is de-esterified to 
Fluo-4. This is membrane-impermeable and therefore remains within the cell and 
reports the cytoplasmic [Ca2+]. Fluo-4 was excited at 488nm using an argon laser set at 
5% transmission and emission was collected through a 505nm long pass filter. Data 
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were acquired using bidirectional scanning for increased time resolution and at 12 bit 
depth. As Fluo-4 is a non-ratiometric dye it does not report the absolute Ca2+ level and 
therefore it is important that the offset and gain of the channel is kept as constant as 
possible. Detector gain was set between 750 and 850 in all experiments, amplifier 
offset was set between 0.05 and 0.08 and amplifier gain was 1. All handling and 
recording of Fluo-4 was carried out in the dark to prevent photo-bleaching of the 
fluorescent molecules. 
 
The myocytes were loaded in situ on the glass bottom dish after co-culture. The 
culture medium was removed and 1ml of Buffer A was added and removed to wash off 
any remaining medium. The cells were then incubated in 500µl of Buffer A containing 
5μM Fluo-4-(AM) for 5 minutes at room temperature. After the incubation, this was 
replaced with fresh Buffer A and left for 20 minutes to allow for de-esterification 
before being mounted on the confocal microscope. 
 
During these experiments the cells were perfused with NT at 37°C. NT was delivered to 
the dish by gravity and removed by a suction system. An insert for 35mm dishes was 
modified with platinum wires attached to a bipolar stimulus generator to field 
stimulate the cells with 20V at 1Hz.  
 
Once mounted on the confocal, the cells were perfused and stimulated for 5 minutes 
before recording to allow them to equilibrate with the conditions. Viable contracting 
cells were then selected and their Ca2+ transients were measured in line scan mode. A 
line was selected along the longitudinal axis of a cell and scanned repetitively. This 
recorded the Ca2+ levels over the passage of time for a specific point of the cell 
(illustrated in Figure 2.4). 
 
The time taken to scan a single line and the spacing sample (the relationship between 
a pixel and real distance) needed to be recorded as they were required for analysis. To 
analyse the transients, the raw images were cropped to within the cell boundaries 
using AimImageBrowser (Carl Zeiss AG, Germany) and the green signal was isolated 
from the red and blue using ImageJ. Custom-written Matlab® R2006b (The 
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MathWorks, Inc., USA) protocols (provided by Dr Mark Stagg) were used to analyse 
this image and provide the time to peak, the time to 50% and 90% decline and the 
amplitude of the Ca2+ change. 
 
 
 
Figure 2.5: Illustration of a line scan output of a stimulated Ca
2+
 transient from a Fluo-4 loaded 
myocyte 
A) A cell loaded with fluo-4. A line is drawn through a myocyte along its longitudinal 
axis. This is repetitively scanned over time, tracking changes in the cytoplasmic Ca2+ 
levels. B) An original output of a Ca2+ transient in a line scan. The red marks show 
the stimulation point. C) Output of the analysis of the signal. This allows analysis of 
the parameters of the Ca2+ transient. D) A 2 dimensional trace of the Ca2+ transient. 
 
 
2.4.5. Ca2+ sparks 
Ca2+ sparks are another element of myocyte Ca2+ handling that can be investigated 
using Fluo-4. Ca2+ sparks are spontaneous focal releases of Ca2+ from the SR (Cheng et 
al., 1993) and can be measured by scanning a non-stimulated, quiescent cell. Cells 
were loaded with Fluo-4 and the dishes were set up on the confocal in the same 
fashion as for the Ca2+ transient recordings. A cell and a line through the cell were 
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selected. After selecting a line, stimulation was stopped for 30 seconds and then a line 
scan was recorded for 15,000 lines. This recorded changes in the cytoplasmic Ca2+ in a 
quiescent cell. 
 
Analysis was carried out using a custom written Matlab protocol (provided by Mark 
Stagg) which reports spark frequency, amplitude, duration and width. 
 
2.4.6. Contractility 
Myocyte contractility was measured by tracking stimulated sarcomere shortening. 
Average sarcomere length was calculated by measuring the peak of the power 
spectrum output of a fast Fourier transform of myocyte striations within a specified 
area in real time. This could then be tracked over time while the cell was stimulated 
and contracting, and provided an indication of myocyte contractility. 
 
After co-culture, the glass bottom dishes were placed on an Olympus IX-71™ inverted 
microscope and viewed through a 63-time magnification oil immersion objective. They 
were perfused with NT at 37°C throughout the experiment and field stimulated with a 
20V pulse using a bipolar stimulus generator. Sarcomere length was tracked in real 
time using IonOptix IonWizard™ data acquisition software (Version 5.0. IonOptix 
Corp.). Viable, contracting cells were randomly selected and a section of the cell was 
identified for input into the fast Fourier transform. By rotating the camera, care was 
taken that the z lines were lying vertically within this section for accurate assessment. 
Sarcomere shortening was recorded while stimulating the cells at 1, 2 and 3Hz. 
Approximately 30 seconds of data was recorded at each frequency before switching to 
the next to allow the contractions to reach a steady state. 
 
Analysis was conducted using IonWizard™ software. About 10 contractile cycles were 
averaged for each cell at each frequency, and amplitude, time-to-90% peak, time-to-
50% relaxation and time-to-90% relaxation were calculated using the inbuilt analysis 
(Figure 2.5).  
 
 88 
 
Figure 2.6: Example trace of sarcomere shortening and the parameters measured 
 
 
2.5. Dog slice studies 
Dog myocardial slices were assessed using a 60 electrode multi electrode array (MEA) 
system (Multi Channel Systems, Germany) to record the field potential of each slice. 
These are plates that contain a regular 8 by 8 array of electrodes (missing the 4 
corners) that can be individually used to stimulate and record electrical activity. Each 
electrode has a 100µm diameter and they are spaced at 700µm. Each electrode 
records the field potential of the point of tissue surrounding the electrode. A field 
potential is the electrical activity recorded from the extracellular solution of a number 
of cells and is used to represent the action potential. The minimum peak of the field 
potential correlates with the upstroke of the action potential, and the peak of the 
second wave form (akin to the T wave of an electrocardiogram) is used to mark the 
repolarisation of the cells. This can then be used to calculate the conduction velocity of 
the slice and the field potential duration (FPD). An example of the output of the MEA is 
shown in Figure 2.6. 
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Figure 2.7: Example of the output from an MEA 
The 60 electrode recordings are shown along with a zoomed in image of electrode 24 
(boxed in red). This clearly shows the points recorded to enable the measurement of 
FPD and conduction velocity. 
 
 
2.5.1. Multi electrode array measurements 
Glass MEA plates, a MEA 1060 amplifier and TC01/02 temperature controller were 
used throughout these experiments (Multi Channel Systems, Germany). MC_Stimulus 
(Multi Channel Systems) was used to control stimulation, which was provided as a 
bipolar pulse of 500μs duration, 1-4 V and 1 Hz. The minimum voltage needed to 
stimulate the slice was used and normally this was between 1 and 2 V. This is 
important to minimise the stimulation artefact and also to ensure point stimulation 
rather than field stimulation of the area surrounding the stimulation electrode. The 
stimulation electrode was selected using MEA_Select and data was recorded using 
MC_Rack (both are software from Multi Channel Systems).  
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The slice was placed in a MEA dish and held down by a slice holder to maintain contact 
with the electrodes. Throughout the experiment the dish was perfused with 
oxygenated recording solution at 37°C. The slice was point-stimulated from any 
electrode and left to equilibrate for 10 minutes before any recordings were made. Due 
to the anisotropy of cardiac tissue, the slice was stimulated from 4 electrodes such 
that the slice was stimulated in 4 different directions (Figure 2.7). This allowed 
identification of the maximum conduction velocity (longitudinal conduction velocity, 
which runs in the direction of the muscle fibres), and the minimum conduction velocity 
(transverse conduction velocity, which represents conduction in the direction 
perpendicular to the muscle fibre orientation). This was essential for the accurate 
comparison between slices. The stimulation electrodes were always selected at the 
edge of the array to allow correct analysis of conduction velocity. Between each 
recording the slice was stimulated for 5 minutes to allow equilibration to the point of 
stimulation. About 20 seconds of data was recorded for each point. 
 
 
 
 
Figure 2.8: The directions of stimulation recorded for each slice 
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2.5.2. Slice co-culture 
Various set ups for the culture of slices were tested (described in Section 3.3.6.). 
Finally, slices were cultured at the interface of culture medium and air as previously 
reported (Brandenburger et al., 2012). Therefore the co-culture system was reversed 
compared to the cellular co-culture, with fibroblasts plated on the base of the plate 
and the slice kept in the transwell (Figure 2.8). Canine fibroblasts were plated at a 
density of 40,000 cells per well in a 6 well plate and left to attach for 4 hours in 2ml of 
H.ITS medium (M-199 (without l-glutamine), 100U/ml penicillin, 100µmol/l 
streptomycin, 10µg/ml insulin (Sigma Aldrich, UK), 5.5µg/ml apo-transferrin (Sigma 
Aldrich, UK), 0.005µg/ml Na+ selenite (Sigma Aldrich, UK)). The slices were then 
suspended above the cells within the medium with 24mm Transwells with 0.4µm 
pores (Corning Incorporated, USA). It was important that the slices were laid flat on 
the Transwells and not folded up, and were also wet but not covered in medium; 
therefore in addition to the 2ml of medium in the wells, 200µl was added to the slices 
in the Transwells. 
 
The control used for these experiments was to culture the slices either alone or with 
40,000 human embryonic kidney 293 cells (HEK 293) (provided by Dr Nicola Hellen). 
These cells have very limited intrinsic activity (Thomas and Smart, 2005) and therefore 
were ideal to use to control for the presence of extra cells, without the release of 
potential paracrine effectors.  
 
The co-culture was incubated in humidified air at 37°C in 5% CO2 for 24 hours before 
MEA recordings were repeated as described above. 
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Figure 2.9: Slice co-culture set up 
The fibroblasts were seeded on the base of a plate and the slice was suspended in a 
Transwell so that the slice is at the interface of the culture medium and air. 
 
2.5.3. Analysis 
The data was analysed using MC_Rack, MatLab with MEATools (University of Freiburg, 
Germany), MC_DataTool (Multi Channel Systems), Clampfit (Molecular Devices, USA) 
and Microsoft Excel (Microsoft, USA) as described below. 
 
Using MC_Rack a trigger was added to each trace. This aligned each field potential 
according to the stimulation artefact, which allowed the averaging of traces from the 
same electrode over the 20 seconds of recording. 
 
2.5.3.1. Conduction velocity 
The data was opened using MEATools within Matlab, and Extract LFP Features was 
used to determine the time from the stimulation artefact to the minimum peak of the 
field potential for each electrode recording. This was then visually checked to ensure 
accurate acquisition, and the values were put into an Microsoft Excel matrix which 
arranged them back into the 60 electrode configuration. The local conduction velocity, 
the velocity at which the field potential travels between electrodes 2 electrodes apart 
for each electrode, was calculated using an Excel template (provided by Dr Cesare 
Terracciano). This figure was calculated for each of the four stimulation points for each 
slice, and the maximum value was considered as the longitudinal conduction velocity 
and the minimum value was taken as the transverse conduction velocity. 
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2.5.3.2. Field potential duration 
Using MC_DataTool, recordings from 16 electrodes were converted into an .abf file for 
use with Clampfit (Molecular Devices, USA). The recording that related to the 
longitudinal conduction velocity was used for each slice, and the 16 electrodes used 
were predetermined and constant as shown in Figure 2.9. 
 
The .abf file produced was then opened in Clampfit and the recorded field potentials 
for each electrode were averaged. Then the time point of the minimum peak of the 
field potential and the maximal peak (either positive or negative) of the repolarisation 
wave were measured, and the time between the two was calculated. The recordings of 
the 16 points were averaged to give the FPD of the slice, and the standard deviation of 
the 16 points was used as a representation of FPD heterogeneity. 
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Figure 2.10: The predetermined 16 electrodes used for the measurement of field potential duration 
 
 
2.6. Immunofluorescence 
Immunofluorescence was used to characterise and quantify cells and was conducted 
using both isolated cells and tissue sections.  
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2.6.1. Cells 
To stain cells, they were plated on multispot glass slides (Hendley Essex , UK) and left 
for at least 2 hours to allow them to attach. The culture medium was then washed off 
with PBS and the cells were fixed and permeabilised with 1ml of ice cold methanol for 
5 minutes. The methanol was thoroughly washed off with PBS (at least 5 times over 15 
minutes) and the cells blocked with 250μl 1% bovine serum albumin (BSA) in PBS for 1 
hour at room temperature. During this and subsequent incubation, the slide was kept 
in a humidified chamber to prevent the cells from drying out. Care was taken during 
washing the slide to this same end. After 1 hour in 1% BSA, the primary antibody was 
then put on the cells in 100μl of 0.5% BSA in PBS for either 24 hours at 4°C, 4 hours at 
room temperature or 1 hour at 37°C. Cells were then washed with PBS (at least 5 times 
over 15 minutes) to remove any unbound primary antibody before the secondary 
antibody was added in 100μl of 0.5% BSA in PBS at room temperature for 1 hour. The 
primary and secondary antibodies and dilutions used are shown in Table 2.2. The 
secondary antibody was linked to a fluorescent probe (alexa 488) and therefore all 
work was carried out in low light conditions to prevent degradation. The cells were 
washed thoroughly again with PBS (at least 5 times over 15 minutes) to remove any 
unbound secondary antibody, and then any excess PBS was removed before the cells 
were mounted with a propidium iodide-containing mounting medium (Vectashield®, 
Vector, USA). Propidium iodide stains the nucleus allowing clear identification of cells. 
A cover slip was then placed carefully over the cells, excess solution was blotted away 
and the cover slip was fixed in place using nail varnish. The staining was imaged at high 
resolution with 16 image averaging on the confocal microscope. The alexa-488 
fluorescent probe associated with the secondary antibody was excited at 488 nm using 
an argon laser and emission was collected through a 500-550 nm band-pass filter. The 
propidium iodide was excited at 453 nm using a helium neon laser and emission was 
collected through a 565-615 nm band-pass filter. A negative control was used for each 
secondary antibody. This was achieved by incubating the cells with the secondary but 
not the primary antibody. 
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Target Primary Antibody Dilution Secondary antibody Dilution 
α-SMA Monoclonal Mouse Anti 
Human (Dako, Denmark; Cat. 
No. M0851) 
1:200 Goat anti mouse A488 
(Molecular Probes®, Life 
technologies; Cat. No. 
A21121) 
1:500 
Vimentin Monoclonal Mouse (Sigma, 
USA; Cat. No. 6630) 
1:1000 Goat anti mouse A488 1:500 
Desmin Monoclonal Mouse Anti 
Human (Dako, Denmark; Cat. 
No. M0760) 
1:50 Goat anti mouse A488 1:500 
CD-31 Monoclonal Mouse Anti 
Human (Dako, Denmark; Cat. 
No. M0823) 
1:40 Goat anti mouse A488 1:500 
DDR-2 Polyclonal Goat Anti Human (R 
and D systems, USA; Cat. No. 
AF2538)  
1:50 Donkey anti goat A488 
(Molecular Probes, Life 
technologies; Cat. No. 
A-11001) 
1:500 
Table 2.2: Antibodies used for immunofluorescence. 
 
2.6.2. Tissue 
To stain sections of tissue, it was embedded in OCT and frozen. Cryosections of 15µm 
thickness were cut and placed on glass slides. These were washed with PBS (at least 5 
times over 15 minutes). 1ml ice cold acetone was then added for 5 minutes to fix the 
tissue. This was washed off with PBS (at least 5 times over 15 minutes) and then the 
tissue was incubated with 1% BSA and 0.1% Triton X-100 in PBS for 1 hour at room 
temperature. After this step the cryosections were stained using the same method as 
with cells (except that 0.1% Triton X-100 was present in all solutions) i.e. incubation 
with the primary antibody, washing, incubation with the secondary antibody, washing 
and then mounting with propidium iodide. 
 
The stained section was imaged using the confocal microscope. A z stack of images was 
recorded to allow a 3-dimensional reconstruction of the staining.  
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2.7. Enzyme-linked immunosorbent assay (ELISA) 
ELISAs were used to measure the level of mediators within the culture medium. ELISAs 
involve the recognition of specific antigens by an immobilised antibody (Engvall and 
Perlmann, 1971). A solid surface is pre coated with an antibody specific for an antigen 
on the target molecule, which binds and immobilises the target molecule. A second 
specific antibody, linked to an enzyme detection system, is then added and binds to 
the target. Finally a substrate is added. The enzyme reaction produces a signal, 
normally a colour change, and the level of signal can then be measured and is 
proportional to the concentration of the target molecule. A standard curve is produced 
using a number of known concentrations and therefore the concentration within the 
unknown can be determined. ELISAs have advantages over other techniques such as 
cytokine arrays because they give an absolute value for the concentration of 
mediators. 
 
The co-culture medium was collected, centrifuged at 620g to remove any cellular 
debris, and frozen immediately at -20°C. The medium from each experimental 
condition was collated each day and frozen in 2 portions. When required for the ELISA 
it was thawed slowly on ice to prevent degradation and undiluted aliquots were used 
following the manufacturer’s instructions. The protocol is outlined below: 
- As well as preparation of the samples to be measured, standards were 
prepared by serial dilution of the standard provided in the kits. The positive control 
supplied with the ELISA kit was also prepared. For measurement of TGF-β the samples 
required activation with HCl. 
- The standards, samples and positive control were added to the 96 well capture 
antibody coated plate for 2 hours. Standards were run in duplicates and samples in 
triplicates. 
- After the wells were washed using the supplied wash buffer, the supplied 
horseradish peroxidase conjugated detection antibody was added to the wells and 
incubated for 2 hours. 
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- After another wash, the substrate mixture was added to the wells and 
incubated in the dark for 30 minutes. The horseradish peroxidase catalyses the 
oxidation of the substrate changing it from colourless to yellow. 
- The reaction was stopped by adding HCl and the optical density of each well 
was measured with a μQuantTM micro-plate reader (Bio-Tek Instruments Inc., USA) at 
450 nm with wavelength correction set to 570 nm. A standard curve was produced and 
the concentrations in the test samples were calculated from this. 
 
2.8. SDS PAGE and western blotting 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and western 
blotting allows for quantification of the level of specific proteins. SDS is an anionic 
detergent that binds to protein at a specific ratio of 1.4g of SDS per 1g of protein and 
therefore produces a structure that has a large negative charge proportional to the 
mass of the protein. The size of the electrical charge can then be used to separate the 
proteins, according to their size, using PAGE. Western blotting then allows the quantity 
of a specific protein within the sample to be detected by the appropriate selective 
antibodies. 
 
2.8.1. Sample preparation 
Tissue was snap frozen in liquid nitrogen and then stored at -80°C. The tissue was then 
ground into a powder in liquid nitrogen and lysed in solubilisation buffer (SB20) at a 
ratio of 10µl per mg of tissue. The tissue lysates were vortexed and then sonicated (LSL 
sonicator, Heat systems-Ultrasonics, Inc) at high power for approximately 10 seconds. 
The solution was then centrifuged at 15000rpm for 30 minutes to remove any 
remaining tissue particles. The supernatant was removed from the pellet and was 
ready for use. 
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2.8.2. Calculation of the sample protein concentration 
The concentration of protein within the samples was measured using the PierceTM BCA 
protein assay kit (Thermo Scientific, USA). The kit is based on the reduction of Cu2+ to 
Cu+ by proteins and a colourimetric detection of Cu+ (Smith et al., 1985). A standard 
curve of known protein concentrations is produced and then the concentration of 
protein in unknown samples can be calculated. 
 
The samples were diluted 1:20 with Milli-Q water. The supplied standard was serially 
diluted to produce a standard curve from 20-2000µg/ml as well as a blank of 0µg/ml. 
25µl of sample or standard was added to a 96 well plate and 200µl of the supplied 
working solution was added to each well. The solutions were mixed thoroughly and 
then incubated at 37°C for 30 minutes after which the plate was allowed to cool to 
room temperature and the absorbance of each well was measured at 560nm. The 
reading for the blank was subtracted from all the values and then a standard curve was 
produced. The concentration of each sample was calculated from the standard curve. 
 
2.8.3. Sample preparation for SDS-PAGE 
The samples were prepared in loading buffer. This has three functions. SDS binds the 
protein and adds a negative charge proportional to the protein size, 2-
mercaptoethanol breaks the disulphide bridges and bromophenol blue loading dye 
allows protein migration through the gel to be visualised. The samples were diluted in 
loading buffer to the desired concentration and incubated at 37°C for 30 minutes to 
allow the 2-mercaptoethanol to fully denature the proteins. 
 
2.8.4. SDS PAGE 
A two layered gel was used as first described by Laemmli (1970). The top layer of the 
gel is a stacking layer which concentrates the protein into a tight space so that their 
separation in the lower level, the separating gel, has improved resolution. 
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Gels were prepared using a Hoefer Mini Gel system. For the separating gel, a 12.5% 
acrylamide gel was prepared and poured into the Hoefer mini gel system leaving 
approximately 3.5cm at the top for the later addition of the stacking gel. 1ml of 
propan-2-ol was added to the top of the gel to produce a level top. Once the gel had 
polymerised the propan-2-ol was washed off with Milli-Q water and the stacking gel 
was poured on top with an 18-well combs inserted. The stacking gel was a 4.5% 
acrylamide gel. After the stacking gel had polymerised the gels was ready for use. 
 
The gels were transferred to a Hoefer gel running apparatus (Mighty Small II 
SE250/SE260) which was filled with electrophoresis running buffer. 10µl of each 
sample was added to a well, as well as a molecular weight ladder diluted in 10µl 
loading buffer (Precision Plus Protein Kaleidoscope standards, Bio-Rad). The remaining 
wells were filled with 10µl loading buffer. Electrophoresis was run at 60V until the 
bromophenol blue dye reached the separating gel at which point the voltage was 
increased to 180V. Electrophoresis was stopped when the dye was 0.5cm from the end 
of the gel. 
 
2.8.5. Protein transfer 
To blot for proteins, they needed to be electrophoretically transferred from the 
polyacrylamide gel onto polyvinylidene fluoride (PVDF) membranes (Millipore) using a 
wet transfer system. The PVDF membrane were cut to match the size of the gel and 
equilibrated in transfer buffer for 1 hour before use. The gel and membrane were 
sandwiched between blotting paper and nylon scouring pads in between two 
electrode plates (illustrated in Figure 2.10). This was placed in a transfer tank 
containing pre-cooled transfer buffer with a cooling block. The protein transfer was 
powered at 6V/cm for 1.5 hours at 4°C. 
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Figure 2.11: Illustration of the set up for protein transfer 
 
 
2.8.6. Protein blotting 
The PVDF membrane was removed from the transfer set up, rinsed in Milli-Q water 
and then incubated for 1 hour at room temperature in blocking solution. The 
membrane was then incubated overnight at 4°C with the primary antibody diluted in 
blocking solution. The membrane was then washed for 5 minutes in tris-buffered 
saline (TBS)-Tween buffer to remove any unbound primary antibody. This was 
repeated 4 times before the secondary antibody (Pierce, USA), diluted in blocking 
solution, was added to the membranes and incubated at room temperature for 1 hour. 
The membrane was washed again with TBS-Tween 4 times for 5 minutes each and 
then TBS (20mM tris, 150mM sodium chloride; pH 7.6) 4 times for 5 minutes.  
 
Alkaline phosphatase buffer containing 165µg/ml 5-bromo-4-chloro-3-indolyl-
phosphate (Promega, USA) and 330µg/ml nitro-blue-tetrazolium (Promega, USA) was 
used to develop the membrane. The membrane was covered in the solution for 30 
minutes at room temperature. This was then washed off with Milli Q water and the 
membrane was left to dry before it was imaged using a GENE Genius imager and 
Genesnap software (Syngene, UK). The optical density of the bands was then 
measured using inbuilt analysis routines of ImageJ software. 
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2.9. Statistical analysis 
Data are represented as mean ± standard error of the mean. Statistical analysis was 
carried out using GraphPad Prism 4 software (GraphPad Software Inc., USA). Analysis 
of two data sets was performed by unpaired t-tests, and for before and after 
measurements paired t-tests were used. When comparing multiple groups of data a 
Kruskall-Wallis test with Dunn’s post test analysis was performed. 
 
P<0.05 was taken as significant and on graphical representation of data, one star 
indicates p<0.05, two stars indicates p<0.01 and three stars indicates p<0.001. 
 
2.10. Solutions 
The following solutions were used throughout this work. They are described in mM 
unless stated otherwise. All chemicals were provided by VWR international or Sigma 
Aldrich. The solutions were made up in Milli-Q water except low Ca2+ solution and 
enzyme solution which used AnalaR water. Fresh solution was made when required 
and used for a maximum of 2 weeks. 
 
Normal Tyrode (NT): 140 NaCl, 4.5 KCl, 10 glucose, 10 HEPES (free acid), 1 MgCl2, 1 
CaCl2; pH 7.4 
 
Low Ca2+ solution (LC): 120 NaCl, 5.4 KCl, 5 MgSO4, 5 Na
+ pyruvate, 20 glucose, 20 
taurine, 10 HEPES (free acid), 5 nitrilotriacetic acid, 0.04 CaCl2; pH 6.96 
 
Buffer A: 120 NaCl, 5.4 KCl, 5 MgSO4, 5 Na
+ pyruvate, 20 glucose, 20 taurine, 10 HEPES 
(free acid), and 0.2 CaCl2; pH 7.4 
 
Slicing solution: 140 NaCl, 6 KCl, 10 glucose, 10 HEPES (free acid), 1 MgCl2, 1.8 CaCl2, 
10 2,3-butanedione monoxime; pH 7.4 
 
Recording solution: 140 NaCl, 4.5 KCl, 10 glucose, 10 HEPES (free acid), 1 MgCl2, 1.8 
CaCl2; pH 7.4 
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Cardioplegia (Plegivex, Ivex Pharmaceuticals, UK): 147 NaCl, 16 KCl, 16 MgCl2, 1.2 
CaCl2, 1 Procaine hydrochloride; pH 7.8 
 
Solubilisation buffer (SB20): 20% SDS w/v, 0.1M Tris, 10mM 
ethylenediaminetetraacetic acid (EDTA); pH 6.8 
 
Loading buffer: 96.5% SB20, 2.5% 2-mercaptoethanol, 1% bromophenol blue 
 
Electrophoresis running buffer: 0.192mM glycine, 25mM trizma base, 0.1% SDS. 
 
Transfer buffer: 192mM glycine, 25mM trizma base, 10% methanol, 0.01% SDS 
 
Blocking solution: 20mM tris, 150mM sodium chloride, 0.1% tween20, 4% non fat 
dried milk; pH 7.6 
 
Tris-buffered saline Tween (TBS-Tween): 20mM tris, 150mM sodium chloride, 0.1% 
tween20; pH 7.6 
 
Tris-buffered saline (TBS): 20mM tris, 150mM sodium chloride; pH 7.6 
 
Alkaline phosphatase buffer: 100mM tris, 100mM sodium chloride, 5mM magnesium 
chloride; pH 9.5 
 
Below is the make up of the culture medium used throughout these experiments. All 
products were supplied by Gibco® (Life technologies, USA) or Sigma Aldrich. Fresh 
culture medium was made in 50ml batches when required. 
 
Fibroblast culture medium (FB medium): 82% DMEM, 15% foetal bovine serum, 
100U/ml penicillin, 100µmol/l streptomycin, 4mM L-alanyl-L-glutamine 
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Cell co-culture medium (ITS medium): M-199 (without l-glutamine), 100U/ml 
penicillin, 100µmol/l streptomycin, 1:1,000 dilution ITS supplement (PAA, Austria; Cat. 
No. F01-015) 
 
Slice co-culture medium (H.ITS medium): M-199 (without l-glutamine), 100U/ml 
penicillin, 100µmol/l streptomycin, 10µg/ml insulin, 5.5µg/ml apo-transferrin, 
0.005µg/ml Na+ selenite. 
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CHAPTER 3. 
Optimisation of culture 
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3.1. Introduction 
The experiments conducted in this thesis involved the preparation and culture of three 
separate preparations, namely isolated fibroblasts, isolated myocytes and myocardial 
slices, and it was necessary to optimise these processes.  
 
3.1.1. Fibroblasts 
It was necessary to optimise the isolation of fibroblasts to provide the largest 
immediate yield, and to avoid contamination with other cell types. It was also 
important to track the development of α-SMA in fibroblasts in culture. 
 
A reliable way of producing cardiac fibroblasts is by using an outgrowth method (Etzion 
et al., 2002, Messina et al., 2004). This involves plating small pieces of tissue 
(approximately 2mm2) in culture, and after a few days fibroblasts start to grow out of 
the tissue chunks. However this takes a number of days to provide usable fibroblasts. 
Alternatively, fibroblasts can be isolated by enzymatically digesting the tissue and 
collecting the cells from the solution by centrifugation to provide an immediate yield 
of cells. Enzymatic digestion of cardiac tissue can be achieved in many different ways, 
for example using trypsin and/or collagenase type II (Hafizi et al., 1998, Vasquez et al., 
2010). Our lab had experience using enzymatic digestion of cardiac tissue for the 
isolation of myocytes using a Langendorff set up (Siedlecka et al., 2008) and also from 
human tissue using a protocol that shakes the tissue with protease and collagenase 
(Terracciano et al., 2003). It is then possible to collect fibroblasts by centrifuging the 
supernatant following these protocols. 
 
Once isolated, it was necessary to check the purity of the cell population. This was 
essential in order to attribute any observed effects of co-culture to the fibroblasts, 
rather than as a result of contaminating cells. Also, although fibroblasts can be readily 
cultured, culture is known to alter their characteristics (as discussed in Section 1.3.3.). 
α-SMA is used as a marker for these changes and therefore it was necessary to track 
the time frame of these changes by characterising the development of α-SMA in order 
to direct the time course of future experiments.  
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3.1.2. Myocytes 
The isolation of myocytes is well established within our lab (Siedlecka et al., 2008), and 
although the culture of myocytes has been regularly conducted (Lee et al., 2008) 
various considerations were necessary for this work. Previously, a culture medium 
containing foetal bovine serum had been used. However, serum contains high and 
inconsistent levels of various biologically active molecules (Honn et al., 1975) and 
some foetal bovine serums contain TGF-β (Zheng et al., 2006). The presence of TGF-β 
in the culture medium may mask the release of TGF-β from fibroblasts. Optimisation 
studies on culture medium for adult myocytes have identified possible alternatives 
that allow better control over the contents of the culture medium which help to 
maintain the myocyte phenotype (Volz et al., 1991, Viero et al., 2008). It was therefore 
necessary to identify an ideal medium, based on these previous reports, for the co-
culture experiments.  
 
3.1.3. Myocardial slices 
The preparation of thin slices of viable tissue has been widely used in brain research 
(Gahwiler et al., 1997). The use of the technique to study the heart has developed 
more slowly, but the preparation of viable myocardial slices has now been described in 
detail (Bussek et al., 2009). The preparation of slices is also well established within our 
lab (Camelliti et al., 2011). However, the culture of slices was not established and 
therefore needed developing.  
 
3.1.4. Chapter aims 
- Fibroblasts: 
- Identify an optimal technique for isolation 
- Characterise the cell type 
- Characterise the time course of α-SMA development in culture 
- Myocytes: 
- Identify a suitable serum free medium 
- Characterise the effects of culture on the myocytes phenotype 
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- Myocardial slices: 
- Identify a culture set up for slices 
- Characterise the effects of culture on the electrical activity of myocardial 
slices   
 
3.2. Methods 
3.2.1. Fibroblast isolation and cell counting 
Three protocols for the isolation of fibroblasts were tested to identify a method to 
provide the maximal yield of fibroblasts. 0.5g of rat ventricular tissue was used for 
each isolation procedure.  
 
1. Isolation from the supernatant after myocyte isolation using the Langendorff 
set up (the isolation of myocytes is described in Section 2.3.2.). Once the heart was 
removed from the Langendorff, the ventricular tissue was weighed and 0.5g was used 
for the rest of the protocol. 
The supernatant removed from the myocyte pellet was re-centrifuged at 620g for 5 
minutes to collect the fibroblasts, which were washed in sterile PBS and then put into 
culture with FB medium. 
 
2. Isolation using digestion with protease type XXIV and collagenase type V as 
described under fibroblast isolation in Section 2.3.3.  
 
3. Isolation using collagenase type II. 
The tissue was prepared by perfusing the heart with LC for 10 minutes and then 
cutting the LV into 2mm3 pieces as in Protocol 2. These pieces were then digested with 
500units/ml collagenase type II in 10ml of Buffer A for two 1-hour periods. Fibroblasts 
were collected from the solution as described for Protocol 1.  
 
To assess the efficacy of each method, the cells were counted after 48 hours in culture 
using an Improved Neubauer Haemocytometer. The culture medium was removed, 
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and the culture flask was washed with PBS. 2ml of 0.25% Trypsin-EDTA was added and 
the flask was left at 37°C for 5 minutes. 5ml of FB medium was then added to 
inactivate the trypsin and the solution was centrifuged at 620g. The supernatant was 
carefully removed and the cell pellet was re-suspended in 3ml of FB medium. 80µl of 
the cell suspension was taken and mixed with 20µl 0.4% trypan blue solution. This 
marked the dead cells and therefore allowed identification of the living cells. 10µl of 
this mixture was added to the Haemocytometer and viewed using 20 times 
magnification for counting. The number of cells per ml was calculated. Three cell 
counts were made for each isolation and the average was recorded as the number of 
cells per ml from the isolation. As the cells were re-suspended in 3ml this was 
multiplied by three to give the total number of cells from the isolation. 
 
3.2.2. Immunofluorescent characterisation of fibroblasts 
To examine the purity of the isolated cell population, the cells were stained on Day 3 
after isolation for vimentin, DDR2 and desmin. Vimentin is used to mark cells of a 
mesenchymal origin. Most vimentin-positive cells within the heart are fibroblasts, 
although endothelial and smooth muscle cells also express vimentin (Camelliti et al., 
2005). DDR2 is a putative fibroblast specific marker, although it may stain smooth 
muscle cells and therefore desmin was also used to exclude the presence of smooth 
muscle cells (Rohr, 2011).  
 
To characterise the effect of culture on the rat fibroblasts, they were stained on Day 1, 
3, 5 and 7 after isolation for α-SMA. The final experimental protocol involved 24 hours 
in FB medium and then 24 hours in ITS medium, and therefore fibroblasts were also 
stained for α-SMA after exposure to these conditions. 
 
Cells from three isolations were stained for each marker. The protocol for 
immunofluorescence is described in Section 2.6.1. 
 
 109 
3.2.3. Testing different myocyte culture media 
To test the suitability of different culture media for the co-culture set up, Ca2+ 
transients were recorded from freshly isolated myocytes and from myocytes cultured 
in different media for 24 hours.  
 
The culture media tested were: 
 
1. Neonatal Rat Ventricular Myocyte medium (NRVM): 67% DMEM, 16% medium-
199, 10% horse serum, 4% FBS, 2% 1 M HEPES and 1% penicillin/streptomycin.  
 
2. ITS medium: M-199 (without l-glutamine), 100U/ml penicillin, 100µmol/l 
streptomycin, 1:1,000 dilution ITS supplement (PAA, Austria; Cat. No. F01-015). 
 
3. Volz medium: M199 (without l-glutamine), 0.2% (weight/volume) bovine serum 
albumin, 100mM ascorbate, 5mM creatine, 5mM taurine, 2mM carnitine, 0.1µM 
insulin, 100U/ml penicillin, 100µmol/l streptomycin. 
 
To record Ca2+ transients in freshly isolated myocytes they were loaded with Fluo-4 in 
solution and then plated on laminin coated glass bottom dishes for recording. 
Myocytes were suspended in 1ml of Buffer A containing 10mM Fluo-4-AM for 10 
minutes. After 10 minutes the myocytes had settled on the base of the test tube and 
the solution was removed and replaced with 1ml of Buffer A. The cells were left for 20 
minutes to allow the de-esterification of the Fluo-4-AM before a couple of drops were 
placed on a laminin coated glass bottom dish. The cells were left for 5 minutes to 
adhere to the dish and then visualised and recorded in the same fashion as for 
cultured cells. 
 
To record Ca2+ transients after 24 hours in culture, freshly isolated myocytes were 
plated at 5,000 cells per dish on laminin-coated glass bottom dishes and 2ml of culture 
medium was added. After 24 hours in culture, the Ca2+ transients were recorded as 
described in Section 2.4.4. 
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3.2.4. Effects of culture on myocyte volume 
Three-dimensional reconstruction of di-8-ANEPPS staining of freshly isolated myocytes 
and myocytes after 24 hours in culture was used to assess the effects of culture on cell 
volume. 
 
To stain freshly isolated myocytes, the cells were suspended in 10µM di-8-ANEPPS in 
1ml of Buffer A for 10 minutes, which was then replaced with fresh Buffer A to remove 
the dye. Two drops of cells were then put on laminin coated glass bottom dishes and 
left to attach for 5 minutes before use. The cells were visualised and recorded in the 
same fashion as for cultured cells as described in Section 2.4.3. 
 
3.2.5. Myocardial slice culture set up 
The culture of myocardial slices was attempted in 4 different configurations using 
either ITS medium or H.ITS medium (formulations below) (Table 3.1). After 24 hours in 
culture, the ability to record an electrical signal from the slice using the MEA set up 
was used as a marker for viability. 
 
ITS medium: M-199 (without l-glutamine), 100U/ml penicillin, 100µmol/l streptomycin, 
1:1,000 dilution ITS supplement. 
 
H.ITS medium: M-199 (without l-glutamine), 100U/ml penicillin, 100µmol/l 
streptomycin, 10µg/ml insulin, 5.5µg/ml apo-transferrin, 0.005µg/ml Na+ selenite. 
 
3.2.6. The effect of culture on myocardial slice electrophysiology 
The electrical activity of slices was recorded in freshly prepared slices and then after 24 
hours in culture using the MEA system. The MEA recording allowed analysis of the 
longitudinal and transverse conduction velocity, the field potential duration and the 
variation in the field potential duration. 
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3.3. Results 
3.3.1. Isolation with protease and collagenase provide the greatest yield of cells 
To optimise the number of cells collected from each isolation, three protocols were 
tested (Figure 3.1). The number of cells produced by digestion with protease XXIV and 
collagenase type V was significantly greater than the number of cells produced when 
using collagenase type II alone.  
 
The isolation of cells using the Langendorff set up protocol did not produce a 
significantly different number of cells than using protease and collagenase, but 
appeared to produce a more variable yield of cells. Although two of the isolations 
produced a similar yield to using protease and collagenase, the other two isolations 
produced considerably fewer cells.  
 
 
Figure 3.1: The yield of cells produced by different isolation procedures 
The number of cells 48 hours after isolation. Protocol 1 n=4; protocols 2 and 3 n=3;  
3.3.2. The isolated cells were fibroblasts 
Immunofluorescence of isolated cells three days after isolation showed that all the 
cells were vimentin positive (111/111 cells) and DDR2 positive (132/132) (Figure 3.2). 
The cells were also stained for desmin due to a concern that DDR2 might also stain 
smooth muscle cells. All cells were negative for desmin (197/197 cells) supporting the 
identification of the cells as fibroblasts. 
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Figure 3.2: Immunofluorescence of isolated rat cells 
A) Isolated cells stained positive for vimentin, a marker of mesenchymal cells. B) The cells were positive for discoidin domain receptor 2. 
C) Staining for desmin was negative. This is a characteristic staining pattern of fibroblasts. Green: Target protein. Red: Propidium iodide 
nuclear marker. 
A B C
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3.3.3. α smooth muscle actin developed in culture 
To characterise the time frame of changes in fibroblast phenotype in culture, the 
isolated cells were stained for α-SMA at different time points of culture (Figure 3.3). At 
Day 1 the cells were α-SMA negative (0/47 cells). At Day 3 a minority of cells showed a 
low level of α-SMA expression (12/144 cells). At Day 5 α-SMA was expressed in the 
majority of cells (177/197 cells). However, the incorporation of α-SMA into the stress 
fibres was not evident in all the cells at Day 5. By Day 7, almost all the cells imaged 
were α-SMA positive and showed a highly organised expression with clear stress fibre 
staining of α-SMA (122/124 cells). The final experimental protocol involved keeping 
fibroblasts for 24 hours in FB medium and then 24 hours in ITS medium. At this time 
point the fibroblasts were α-SMA negative (0/95 cells). 
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Figure 3.3: The development of α-SMA 
in culture 
The development of α-SMA was 
tracked over time in culture in 
FB medium. A) At Day 1 α-SMA 
was not present in any cells. B) 
By Day 3, α-SMA was present in 
8% of cells. C) At Day 5, α-SMA 
was seen in 90% of cells imaged 
and D) by Day 7 it was well 
developed into stress fibres and 
present in 98% of cells. E) When 
exposed to the experimental 
protocol of 24 hours in FB 
medium and 24 hours in ITS 
medium the cells were α-SMA 
negative. Green: α-SMA. Red: 
Propidium iodide nuclear 
marker. 
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3.3.4. ITS medium provides a serum free medium 
It was important to identify a serum free medium to reduce myocyte de-differentiation 
and allow insight into possible paracrine mediators. Previously NRVM medium was 
used in the lab which is serum supplemented. Ca2+ transients were examined after 
culture in different culture media and compared to parameters measured in fresh cells 
(Figure 3.4). Transient amplitude was unchanged by culture or the culture medium 
used. Time to peak was also not significantly changed although it appeared to be more 
variable after culture. The interquartile range for Day 0 was 12.46 whereas for NRVM, 
ITS and Volz it was 16.46, 23.61 and 25.58, respectively. The decay of the Ca2+ transient 
was affected by the culture medium used. Time to 50% decay was faster with NRVM or 
ITS medium but unaffected by culture in Volz medium compared to Day 0. Time to 90% 
decay was prolonged with Volz medium but unaffected by NRVM or ITS medium.
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Figure 3.4: Ca
2+
 transient properties of fresh myocytes and after 24hour culture in different culture medium 
A) Representative traces of recorded Ca2+ transients. B) Ca2+ transient amplitude and C) Time to peak were not affected by the 
different culture media. D) Time to 50% decay was faster in NRVM and ITS medium compared to Day 0 and Volz medium. E) Time 
to 90% decay was prolonged with Volz medium but not changed with NRVM or ITS medium compared to Day 0. Day 0 n=27; NRVM 
n=30; ITS n=28; Volz n=25. 
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3.3.5. Myocyte volume is unchanged but Ca2+ handling is altered after 24 hour 
culture 
To understand the effects of culture on myocytes, cell volume, Ca2+ transients and Ca2+ 
sparks were compared between fresh cells and cells cultured for 24 hours in ITS 
medium. Culture of myocytes did not affect volume, which was unchanged between 
freshly isolated cells and cells cultured for 24 hours (Figure 3.5). 
 
Ca2+ handling was affected by culture. Figure 3.4 shows that the time course of the Ca2+ 
transient was affected. Time to 50% decay of the transient was shortened in myocytes 
cultured in ITS medium. Also, Ca2+ sparks were altered by culture, and only seen in 
cultured cells very infrequently. Only 6 out of 50 cells recorded showed any Ca2+ sparks 
(12%) whereas, using historical data from our lab (courtesy of Dr Michael Ibrahim), 
sparks were seen in 42% of freshly isolated cells (100/173). 
 
 
Figure 3.5: Culture for 24 hours did not affect myocyte volume 
Myocyte volume was not different between freshly isolated cells (Day 0) and cells 
cultured in ITS medium for 24 hours (Day 1). Day 0 n=75; Day 1 n=65. 
 
 
3.3.6. Myocardial slice culture 
In order to identify a methodology to culture myocardial slices, four different set ups 
were tested and in two of the set ups two different media were also tested (Table 3.1). 
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Initially slices were cultured free floating in medium. In ITS medium these slices did not 
survive. In H.ITS medium 50% of slices had recordable electrical activity. On visual 
inspection the slices had curled up and looked hyper-contracted. Therefore two 
methods were tested to maintain the structure of the slices. The slices were held in 
place on an upturned cell strainer either using surgical glue or a mesh. The perceived 
advantage of these techniques where the slice was fully submerged was that it would 
allow continual field stimulation of the slices in culture in future experiments, which 
has previously been shown to help preserve myocytes in culture (Berger et al., 1994). 
However the slices were not viable after culture in these set ups with H.ITS medium. 
The final set up tested was culturing the slices at the interface of the culture medium 
and air, as used in a previous study (Brandenburger et al., 2012). This was the most 
successful set up with 50% viability using ITS medium and 100% viability using H.ITS 
medium. 
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Table 3.1: Culture set ups tested for myocardial slices and relative viability of the slices at 24 hours. 
Viability was quantified as the ability to record an electrical signal from the slice using 
a MEA and is shown as viable number/total number. 
 
 
 
 Survival 
Set up Diagram ITS medium H.ITS medium 
Free floating in 
medium 
 
0/6 3/6 
Glued to 
upturned cell 
strainer 
 
- 0/3 
Held down on 
upturned cell 
strainer with a 
mesh 
 
- 0/3 
At the culture 
medium/air 
interface 
 
 
 
2/4 8/8 
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3.3.7. Myocardial slice electrophysiology is affected by culture 
The effect of culturing slices for 24 hours at the interface of H.ITS medium and air was 
assessed using the MEA. The field potential of slices cultured for 24 hours was longer 
compared to freshly prepared slices (Figure 3.6). This effect appeared to be 
homogeneous as the variation in the length of the field potential within each slice was 
unchanged by culture. The longitudinal conduction velocity was increased after 
culture, but there was no effect on the transverse conduction velocity (Figure 3.7). 
 
 
 
 
Figure 3.6: The field potential duration of myocardial slices was longer after 24 hours culture 
A) Representative recordings of the field potential at a single electrode of the MEA. B) 
Field potential duration was longer after culture, but C) the standard deviation of the 
field potential duration between the 16 analysed electrodes from each slice was not 
altered. n=4. 
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Figure 3.7: Longitudinal conduction velocity was increased after 24 hours in culture 
A) The longitudinal conduction velocity of myocardial slices was increased after 24 
hours in culture, but B) the transverse conduction velocity was not changed. n=4. 
 
 
 
3.4. Discussion 
The results presented in this chapter are essential to the planning and understanding 
of the work presented in the rest of this thesis. 
 
3.4.1. Fibroblasts 
These results show that a pure population of fibroblasts can be reliably isolated from 
ventricular tissue of the rat. The protocol used for the isolation of cardiac fibroblasts 
varies between published studies and therefore different protocols were tested. The 
identification of a reliable high yield method for the isolation of cells was important in 
allowing the use of fibroblasts at an early time point of culture. The rat co-culture set 
ups used for the following experiments required 10,000 fibroblasts per set up and 
therefore the availability of approximately 300,000 fibroblasts at 48 hours post 
isolation showed that it would be possible to produce multiple co-culture set ups from 
each isolation at an early time point. 
 
The identification of the purity of the cells once isolated and put into culture was also 
important. The cells stained positive for vimentin and DDR2 but were negative for 
desmin. This staining profile supports the conclusion that these cells were fibroblasts. 
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Previously, a similar protocol has also been reported to produce a population of 
fibroblasts with only very limited potential contamination (Gustafsson and Brunton, 
2000). Fibroblasts are the most numerous cells within the rat heart and also attach to 
the culture flask more rapidly than endothelial or smooth muscle cells. Therefore, 
changing the medium after plating the cells reduces potential contamination 
(Gustafsson and Brunton, 2000). Importantly, only a section of the total isolated cells 
were stained and imaged and therefore it cannot be definitively concluded that minor 
numbers of contaminating cells were not present. The purity of the cells was important 
for this work as endothelial and smooth muscle cells are also capable of releasing 
paracrine mediators (Pintavorn and Ballermann, 1997, Coutts et al., 2001, Justewicz et 
al., 2012, Yin et al., 2013). Thus, it was important that smooth muscle and endothelial 
cell contamination was minimal to associate any observed effects with fibroblasts.   
 
The characterisation of α-SMA development in culture was also important in directing 
the design of these experiments. In the culture conditions used here, α-SMA 
developed in most cells by Day 5. Although α-SMA is only one marker of fibroblast 
differentiation in vitro, there is evidence that other properties of fibroblasts track 
these changes, making it a good marker to use. Changes in ECM protein expression 
occur in the same time frame as α-SMA development (Dawson et al., 2012). The 
development of an ATP-sensitive K+ current also develops over the same time course 
as α-SMA in culture (Benamer et al., 2009). Furthermore, a study of α-SMA negative 
and positive cells from skin, subcutaneous tissue and lung found distinct phenotypes in 
fibroblasts depending on their α-SMA expression irrespective of the source of the cells 
(Dugina et al., 1998). 
 
Previous reports have found differences in the time course of α-SMA development. α-
SMA development in mouse ventricular fibroblasts has been reported to evolve 
between 5 and 9 days in culture (Benamer et al., 2009). Adapala et al (2013) used rat 
ventricular fibroblasts at passage 2-3, stating that these had not undergone culture-
induced differentiation (no exact time point was given, although in our experience this 
takes approximately 8-12 days). In canine atrial fibroblasts, α-SMA was evident after 
48 hours in culture (Dawson et al., 2012). The same group reported that rat atrial 
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fibroblasts developed α-SMA within 3 days of isolation (Harada et al., 2012). These 
differences may be explained by differences between species, which has been 
reported previously (Dawson et al., 2012), or differences between atrial and 
ventricular cells. Burstein et al. (2008) reported that atrial fibroblasts were more 
reactive than ventricular fibroblasts. The time frame identified in our set up generally 
fits with these previous reports. 
 
This rapid development of α-SMA meant that the planned time frame of the 
experiments was kept to a minimum to limit the possible culture-induced changes in 
fibroblast phenotype. Due to the number of cells produced by each isolation, it was 
possible to complete the experiments with rat fibroblasts within 48 hours of isolation. 
During this time the fibroblasts were kept in FB medium for 24 hours and in ITS 
medium for 24 hours. At this time point α-SMA expression had not developed in the 
fibroblasts. 
 
In the literature to date the amount of time fibroblasts were cultured for before use in 
paracrine studies is very variable. In some experiments it is reported in number of 
days. Fredj et al. (2005) used fibroblasts up to 12 days after isolation. Harada et al. 
(1997) used cells up to 5 days after isolation. Others report the number of passages 
providing limited information about the actual amount of time spent in culture. 
Shivakumar et al. (2008) used fibroblasts from passage 2 or 3 and Kaur et al (2013) 
used fibroblasts from passages 3-5. Pedrotty et al. (2009) allowed fibroblasts to reach 
confluency, then collected them with trypsin and used the cells at passage 1. 
LaFramboise et al. (2007) also allowed fibroblasts to reach confluency and then 
collected the medium to use as conditioned medium. Although the process of 
passaging fibroblasts may in itself have effects on their function, the lack of reported 
specific time points makes it difficult to compare different studies. Further to these 
variations in the reporting of the length of culture, none of these studies report 
whether there is expression of α-SMA in the fibroblasts at the point of use. The 
experiments included in this thesis may be the first to use fibroblasts at a time point 
before the induction of α-SMA expression by culture. 
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3.4.2. Myocytes 
All aspects of myocyte excitation contraction coupling have been shown to be altered 
over time in culture. Action potentials progressively become more variable in culture 
with a loss of the notch and plateau phase (Mitcheson et al., 1996). The Ca2+ handling 
of adult myocytes reverts to that of neonatal myocytes over 7 days in culture with a 
shift in reliance from SR Ca2+ to extracellular and nuclear Ca2+ as the source for Ca2+ 
transients (Poindexter et al., 2001). Other parameters including cell volume, the t-
tubule network and contractility also decrease progressively over 5 days in culture 
(Banyasz et al., 2008). 
 
The Volz and ITS media were designed to preserve myocyte function in culture (Volz et 
al., 1991, Viero et al., 2008). Despite using these media there were changes in Ca2+ 
handling of cells in culture. The decline of the Ca2+ transient was altered by culture. In 
Volz medium it was prolonged whereas with ITS medium it was shortened. It was 
reasoned that although these were different effects they were of similar importance, 
and ultimately, ITS medium was selected for use because it did not contain taurine. 
Taurine is used in the formulation of Volz medium and is known to affect fibroblast 
function (Ren et al., 2008b).  
 
Further experiments showed that Ca2+ sparks were also markedly reduced in cultured 
myocytes. Therefore, Ca2+ sparks were not recorded in the co-culture experiments. 
 
3.4.3. Slices 
The results reported in this chapter show that canine myocardial slices can be 
successfully cultured for the 24 hours necessary for the completion of the co-culture 
experiments. The most successful culture of slices was achieved by culturing the slices 
at the interface of air and culture medium. This corresponds with previously published 
reports of cardiac and brain slices culture (Stoppini et al., 1991, Brandenburger et al., 
2012). However, even in this set up the electrophysiology is altered with culture with 
changes in the longitudinal conduction velocity and the field potential duration. 
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Brandenburger et al (2012) maintained human myocardial slices in culture for 28 days, 
but also found that there was rapid remodelling. 70% of cells lost their typical 
striations. The authors also found that only 67% of the cultured slices still showed 
cardiomyocytes-like action potentials, and contractility was substantially reduced. 
Much of the loss of contractility was seen after 1 day. The electrophysiology was more 
stable with changes to the upstroke velocity and amplitude of the action potential, but 
no change in the action potential duration, unlike the prolongation seen in our 
experiments. Although after 28 days the conduction velocity had fallen, the conduction 
velocity at an earlier time point was not reported which meant we were unable to 
compare this with our work. Despite the changes observed by Brandenburger et al 
(2012) and in the results reported in this chapter, the ability to maintain viable slices of 
adult myocardial tissue in culture provides an exciting platform for cardiovascular 
research. 
 
3.4.4. Summary 
The results included in this chapter show that a pure population of fibroblasts can be 
produced from the rat LV and that it is possible to use these fibroblasts before they 
begin to express α-SMA in culture. Also, an optimal culture medium that is serum free 
and produces limited changes in myocytes in culture was identified. Finally, the culture 
of myocardial slices has been developed, although there are changes in the 
electrophysiology after 24 hours in culture. The optimisation of these processes was 
essential for the following work investigating the paracrine effects of fibroblasts on 
myocyte properties. 
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CHAPTER 4. 
The paracrine effects of fibroblasts from normal hearts on 
myocyte volume and Ca2+ transients. 
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4.1. Introduction 
Fibroblasts within the un-diseased myocardium have been viewed as passive 
bystanders. However, they are constantly active cells, responsible for the maintenance 
and turnover of the ECM. The on-going activity of normal fibroblasts is highlighted by 
the fact that 5% of the cardiac extracellular matrix is replaced every day (McAnulty and 
Laurent, 1987). Whether fibroblasts have a role in modulating myocyte structure and 
function in the normal myocardium is unclear. 
 
The baseline data of in vivo studies can provide an insight into the potential role of 
fibroblast in the normal myocardium. Fibroblasts-specific knock down of KLF-5 
prevented the adaptation of the heart to pressure overload in mice, but there were no 
apparent differences at baseline (Takeda et al., 2010). KLF-5 expression is upregulated 
in pathological stimulation of fibroblasts and therefore may only be important in 
pathology (Manabe et al., 2002). PGF overexpression or knock out, which affected 
hypertrophy in response to pressure overload through fibroblast paracrine mediators, 
also did not affect the baseline phenotype of the heart (Accornero et al., 2011). In mice 
expressing the 5-HT2B serotonin receptor in myocytes only, the mice appear to have 
slightly lower LV weights and reduced function as assessed by echo (although this was 
not directly analysed or discussed in the paper). Paracrine signalling from non-
myocytes was important in the heart’s hypertrophic response to isoproterenol and 
therefore it is possible it may also be involved in these potential changes in the 
baseline characteristics (Jaffre et al., 2009). Also, global FGF-2 deficient mice had a 
dilated heart at baseline (Pellieux et al., 2001). Fibroblasts are the main source of FGF-
2 and these effects are possibly due to changes in ECM maintenance by fibroblasts but 
may also be partly due to paracrine signalling from fibroblasts to myocytes. These 
studies do not investigate any potential effects on individual myocytes and their 
function. 
 
The in vitro study of fibroblasts from normal hearts is flawed by the changes induced in 
culture (discussed in detail in Section 1.3.3.) (Rohr, 2011). All the studies to date 
looking at paracrine communication in vitro have used fibroblasts from normal hearts 
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(e.g. (Harada et al., 1997, LaFramboise et al., 2007, Shivakumar et al., 2008)). However, 
they have all been kept in culture for prolonged periods of time. Although the changes 
associated with the culture of fibroblasts are not fully understood, it is clear that 
cultured fibroblasts have different properties from fibroblasts in the normal 
myocardium (Dawson et al., 2012). Therefore the results of these studies do not aid in 
our understanding of the role of fibroblasts under physiological conditions. The 
methodology used in this thesis requires the co-culture of fibroblast and myocytes for 
24 hours and therefore the culture of fibroblasts could not be eliminated completely. 
However, the optimisation of techniques described in Chapter 3 shows that it is 
possible to use fibroblasts before they begin to express α-SMA, a marker of culture-
induced differentiation, to investigate paracrine communication.  
 
4.1.1. Chapter aims 
The work described in this chapter aims to investigate the effects of isolated 
fibroblasts from normal hearts on isolated adult myocyte volume and Ca2+ handling. 
Fibroblasts were used within 24 hours and the experiments were completed within 48 
hours of isolation to avoid culture-induced changes. 
 
4.2. Methods 
A schematic of the experimental protocol is shown in Figure 4.1. 
4.2.1. Cell isolation and co-culture set up 
Cardiac fibroblasts were isolated from the LV of adult male Lewis rats weighing 250-
300g. They were kept in culture in FB medium for 20 hours before being plated at 
10,000 cells per well in Transwells in 200μl of ITS medium ready for co-culture. 
 
Myocytes were isolated from adult male Lewis rats weighing 175-225g and plated 
immediately on laminin-coated glass bottom dishes for co-culture at 5,000 cells per 
dish in 2ml of ITS medium and co-culture of fibroblasts and myocytes was set up as 
described in Section 2.4.1. 
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Fibroblasts and myocytes were each isolated from 3 hearts. Each parameter was 
recorded from multiple co-culture set ups per round of cell isolation. 
 
4.2.2. Assessment of myocyte phenotype 
The paracrine effects of the fibroblasts on the myocytes were assessed by measuring 
the following parameters after 24 hours of co-culture: 
- Cell viability  
- Cell volume 
- Ca2+ transients  
- T-tubule density 
 
The detailed methodology for measuring these parameters is described in Section 2.4. 
 
4.2.3. Statistical analysis 
The data was analysed by unpaired t-test. N numbers represent the number of cells 
measured unless stated otherwise. 
 
 
Figure 4.1: Schematic of the experimental protocol 
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4.3. Results 
4.3.1. Fibroblasts reduced myocyte viability 
The viability of myocytes was assessed by calculating the percentage of myocytes that 
retained their classic rod shape structure. Myocyte viability was reduced after co-
culture with normal fibroblasts (Figure 4.2). The percentage of rod shaped cells was 
reduced from 64% in control to 53% in co-culture with fibroblast. There is a loss of cell 
viability in both groups with culture, as the percentage of viable cells at the start of 
culture was 84.7 ± 1.28% (n=7 set ups). 
 
 
 
Figure 4.2: Co-culture with fibroblast reduced myocyte viability 
A) Representative images used for assessing viability. B) The percentage of myocytes 
retaining their rod shape was reduced by co-culture with fibroblasts compared to 
control. CM+CM n= 8 set ups; FB+CM n=10 set ups. 
 
 
4.3.2. Fibroblasts induced myocyte hypertrophy 
Myocyte cell volume was measured using 3-dimensional reconstruction of di-8-ANEPPS 
staining. The volume of myocytes co-cultured with fibroblasts was increased by 8.5% 
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compared to control (Figure 4.3). Myocyte volume did not change in culture (as 
demonstrated in Section 3.3.5.). Thus the increase in cell volume induced by co-culture 
with fibroblasts is a marker of myocyte hypertrophy and not an effect on culture-
induced volume remodelling.  
 
 
 
Figure 4.3: Co-culture with fibroblast led to myocyte hypertrophy 
A) Representative recordings of di-8-ANEPPS staining. B) Myocyte volume was 
significantly increased after co-culture with fibroblasts compared to control. CM+CM 
n=73; FB+CM n=46.  
 
 
4.3.3. Fibroblasts increased the amplitude of the Ca2+ transient 
Stimulated Ca2+ transients were recorded from the myocytes using the Ca2+ sensitive 
dye Fluo-4. The peak amplitude of the Ca2+ transient was increased in myocytes co-
cultured with normal fibroblasts compared to control (Figure 4.4). The time course 
parameters of the transient were unchanged by the presence of fibroblasts in co-
culture. Time to peak, time to 50% decay and time to 90% decay were not significantly 
different in control myocytes and myocytes co-cultured with fibroblasts. 
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Figure 4.4: Fibroblasts increased the Ca
2+
 transient amplitude 
A) Representative Ca2+ transients. B) Myocyte Ca2+ transient amplitude was increased after co-culture with normal fibroblasts compared to 
control. C) Time to peak, D) time to 50% decay and E) time to 90% decay were not affected by co-culture with fibroblasts. CM+CM n=39; 
FB+CM n=61. 
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4.3.4. Fibroblasts did not affect the t-tubule density 
Di-8-ANEPPS staining also allowed the study of the t-tubule network, which is an 
important system in the control of Ca2+ handling in ventricular myocytes (Ibrahim et al., 
2011). The density of the t-tubule network was represented as the % of the cellular 
area stained positive for di-8-ANEPPS. T-tubule density was unaffected by co-culture 
with fibroblasts compared to control (Figure 4.5).  
 
 
 
Figure 4.5: Fibroblasts did not affect the t-tubule density 
T-tubule density was unaffected by co-culture with fibroblasts. CM+CM n=73; FB+CM 
n=46. 
 
 
4.3.5. The variance of data was unaffected by the reduced viability seen in co-culture 
The decrease in the number of viable myocytes after co-culture with fibroblasts raised 
the question of whether there was a selection pressure towards larger cells or cells 
with larger Ca2+ transient amplitude. That is to say, are the fibroblasts causing the 
selective loss of smaller cells, or cells with smaller Ca2+ transient amplitudes, that 
would result in an apparent increase in these parameters? To look into this potential 
confounding factor, the variance of the data was examined (Table 4.1). If the reduced 
viability of the myocytes was due to the selective death of smaller cells or cells with 
smaller Ca2+ transient amplitudes then a lower variance would be expected. The 
variance of the recordings from each day was therefore calculated to allow a statistical 
comparison between the two groups.  
C M + C M F B + C M
0
5
1 0
1 5
2 0
2 5
3 0
3 5
4 0
4 5
T
-t
u
b
u
le
 d
e
n
s
it
y
(%
 s
ta
in
e
d
 a
r
e
a
)
 134 
The variance of the cell volume was unchanged and the variance of the Ca2+ transient 
amplitude was increased in myocytes co-cultured with fibroblasts compared to 
control. This supports the conclusion that fibroblasts are inducing these changes and 
they are not just an effect of selective survival. 
 
 
 CM+CM FB+CM 
Cell volume (x107) 7.73 ± 1.38 7.34 ± 2.05 
Ca2+ transient amplitude  0.252 ± 0.03 0.709 ± 0.10* 
 
Table 4.1: Variance of cell volume and Ca
2+
 transient amplitude 
The variance of cell volume is unchanged and the variance of the Ca2+ transient 
amplitude is increased after co-culture with fibroblasts. n=3. * p<0.05 vs. control. 
 
 
4.4. Discussion 
The results reported in this chapter show that fibroblasts isolated from normal hearts, 
used before they are activated to express α-SMA by culture, exert paracrine effects on 
adult myocytes. Co-culture with fibroblasts reduced myocyte viability, increased 
myocyte volume and increased the amplitude of the Ca2+ transient. 
 
4.4.1. Viability 
The percentage of myocytes that maintained their rod shape after culture was used as 
a marker for viability. This was reduced after co-culture with fibroblasts compared to 
control. The loss of viability is conceivably due to apoptotic or necrotic cell death or 
uncontrolled hyper-contraction of the cells.  
 
A previous study to look at the effects of fibroblasts on adult myocytes was focused on 
myocyte survival. Shivakumar et al (2008) exposed adult rat myocytes to conditioned 
medium from hypoxic and normoxic fibroblasts and after 5 hours incubation the 
number of dead cells was increased in the hypoxic fibroblast group. Addition of TNF-α 
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to the normoxic fibroblast conditioned medium mimicked this effect. This increased 
myocyte death was linked to an increased sensitivity to reactive oxygen species which 
may explain the loss of cell viability due to myocyte apoptosis. Although Shivakumar et 
al. (2008) report that changes in viability were only seen with hypoxic fibroblasts, the 
effect was seen in our experiments with normal fibroblasts. Fibroblasts were kept in a 
normal 5% CO2 incubator without any specific O2 control. Therefore, the culture 
conditions were not hypoxic and O2 levels were close to atmospheric levels of 21%. 
However, in these experiments co-culture of fibroblasts and myocytes was used, 
whereas Shivakumar et al (2008) used fibroblast conditioned medium. Also we kept 
the co-cultures for 24 hours whereas Shivakumar et al (2008) only kept the myocytes 
in conditioned medium for 5 hours. These differences in the protocols used may 
explain the differences observed. 
 
The possibility of myocyte hyper-contraction or necrosis has not been investigated. 
Hyper-contraction of myocytes occurs when there is loss of control of the intracellular 
Ca2+ concentration. This can be due to spontaneous entry of Ca2+ through ICa,L or 
release from the SR, or due to the reversal of NCX to pump Ca2+ into the cell. 
Alternatively, disruption of the cell surface membrane would allow uncontrolled entry 
of Ca2+. Increased sensitivity of the myofilaments to Ca2+, for example due to changes 
in intracellular pH, could also result in hyper-contraction (Piper and Garcia-Dorado, 
1999). Paracrine mediators released from fibroblasts can depolarise the resting 
membrane potential which could result in opening of the ICa,L allowing Ca2+ entry and 
stimulating hyper-contraction of the cells (Vasquez et al., 2010). Necrotic cell death 
involves the uncontrolled rupture of the cell membrane (Piper and Garcia-Dorado, 
1999). Whether this is involved in these results is not clear.  
 
4.4.2. Volume 
Co-culture with fibroblasts increased the cell volume of myocytes. Fibroblasts have 
previously been shown to induce hypertrophy by paracrine mediators in neonatal rat 
myocytes (Harada et al., 1999, Fredj et al., 2005a, LaFramboise et al., 2007) and also in 
de-differentiated adult mouse cells (Fredj et al., 2005a). Work carried out in our lab 
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has previously reported that cultured fibroblasts induce hypertrophy in adult rat 
myocytes (Cartledge et al., 2011). Osmotic swelling could also explain the increased 
cell size observed. However, although not studied here, the link between increased cell 
size and hypertrophy is supported by raised levels of atrial natriuretic peptide and 
brain natriuretic peptide in myocytes exposed to fibroblast conditioned medium 
(Harada et al., 1999). 
 
4.4.3. Ca2+ transients 
Myocyte Ca2+ transient amplitude was increased after co-culture with fibroblasts. The 
paracrine effects of fibroblasts on myocyte function are less studied than the effects 
on cell volume. In neonatal myocytes fibroblast conditioned medium reduced 
contractility (LaFramboise et al., 2007). Work carried out in our lab showed cultured 
fibroblasts could affect adult myocyte function in co-culture, depressing the Ca2+ 
transient and contractility (Cartledge et al., 2011). Interestingly the opposite effect on 
the Ca2+ transient was observed here. This difference may be explained by changes in 
fibroblast activity in culture, which has been demonstrated here by the development 
of α-SMA but also affects the secretory profile of fibroblasts (Dawson et al., 2012). 
 
The basis of excitation contraction coupling has been discussed in Section 1.7. The Ca2+ 
transient is predominantly made up of Ca2+ release from the SR through RyRs. 
Therefore, the increase in the Ca2+ transient is likely to be due to an increase in SR Ca2+ 
release. This could be due to an increase in ICa,L which is the trigger for RyR opening 
and Ca2+ release, or due to a higher level of Ca2+ within the SR available for release 
(Hussain and Orchard, 1997, Eisner et al., 2012). Although the effect of fibroblasts on 
the L-type Ca2+ current has not been determined, it has previously been reported that 
fibroblast paracrine mediators prolong the action potential (Guo et al., 1999, Pedrotty 
et al., 2009). Prolongation of the action potential is associated with an increase in the 
ICa,L and therefore this may contribute to the increase Ca2+ transient amplitude 
(Wickenden et al., 1998, Hirano and Hiraoka, 2003). However, the prolongation of the 
action potential would also be expected to prolong the Ca2+ transient and this was not 
evident here. The level of SR Ca2+ is determined by the activity of SERCA which 
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removes Ca2+ from the cytoplasm into the SR, and therefore increased SERCA activity 
could result in increased SR Ca2+ content and a larger Ca2+ transient amplitude (Meyer 
and Dillmann, 1998, Miyamoto et al., 2000). However, an increase in the activity of 
SERCA would be expected to increase the speed of the decline of the Ca2+ transient. In 
these experiments there was no change in the decline of the Ca2+ transient. Further 
work is required to define what underlying mechanisms are responsible for the 
changes in the Ca2+ transient. 
 
Theoretically it is challenging that myocytes isolated from a normal heart, where they 
are surrounded by normal fibroblasts, should be altered when cultured with normal 
fibroblasts. It is therefore necessary to consider the possibility that some changes have 
been induced in the fibroblasts. More subtle changes in fibroblasts can lead to the 
formation of cells termed ‘protomyofibroblasts’ that are somewhere between 
fibroblasts and myofibroblasts (Rohr, 2011, Turner and Porter, 2013). Although the 
cells used here are α-SMA negative it cannot be excluded that other subtle changes to 
the fibroblast phenotype have occurred. Also, as well as fibroblasts affecting myocytes 
by paracrine communication, myocytes affect fibroblasts (Fredj et al., 2005a, 
Dolmatova et al., 2012, Tsoporis et al., 2012) and there may be a signal from the 
myocytes that is inducing changes in the fibroblasts. This concept is explored further in 
Chapter 6. 
 
4.4.4. Summary 
The results presented in this chapter show for the first time that fibroblasts isolated 
from normal hearts and used before α-SMA induction by culture affect adult myocytes 
via paracrine mediators. Fibroblasts reduced myocyte viability, increased myocyte 
volume and increased myocyte Ca2+ transient amplitude. 
 
This is the first time the paracrine effects of α-SMA-negative fibroblasts on myocytes 
have been explored, and raises the possibility that fibroblasts in the normal heart are 
actively regulating the activity of myocytes. A closer examination of fibroblast-targeted 
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knockout and transgenic mice under physiological conditions will allow further insight 
into this exciting possibility. 
 
Having shown these effects of fibroblasts from normal hearts, the next chapter 
investigates whether the effects are altered when fibroblasts isolated from a 
pathological situation are used. 
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CHAPTER 5. 
The paracrine effects of fibroblasts from pressure overloaded 
hearts on myocyte structure and function 
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5.1. Introduction 
There are only very scarce data regarding the effects of pathology on the paracrine 
interaction between fibroblasts and myocytes. Vasquez et al (2010) showed that 
cultured fibroblasts from a rat model of myocardial infarction had a greater effect on 
neonatal myocyte electrophysiology compared to controls, causing a significant 
shortening of the action potential and slowing of conduction. Other studies have used 
fibroblasts from normal hearts that have differentiated in culture and it has been 
argued that these studies can provide insight into the role of fibroblasts in disease 
(Rohr, 2011). However, it would appear that fibroblasts activated in culture are a 
different phenotype to those activated by disease (as discussed in detail in Section 
1.3.3.).  
 
The best insight into the role of fibroblast paracrine mediators in a disease setting 
comes from transgenic mice. Depressing fibroblast paracrine properties prevents the 
cardiac hypertrophic response to pressure overload (Takeda et al., 2010, Accornero et 
al., 2011) or to infusion of Ang II or isoproterenol (Pellieux et al., 2001, Jaffre et al., 
2009). These are classical cardiac stimuli and these studies suggest that fibroblasts may 
be important in mediating the cardiac response to these stressors through paracrine 
communication. However, the effect on the function of myocytes was not examined in 
these studies. Furthermore, these studies provide an interesting insight in to the 
importance of fibroblasts in the initial response to overload and biochemical insult, but 
not into the effects of fibroblast paracrine factors in more established pathological 
settings. 
 
5.1.1. Chapter aims: 
The work reported in this chapter aims to investigate the effects of adult fibroblasts 
from pressure overloaded hearts on myocytes structure, Ca2+ transients and 
contractility. These effects are compared with control fibroblasts from sham operated 
hearts. 
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5.2. Methods 
A schematic of the experimental protocol is shown in Figure 5.1.  
 
5.2.1. Animal model 
A 10 week model of TAC was used to produce pressure overload in rats. Adult male 
Lewis rats of 200-250g were used and the aorta was constricted to a diameter of 
0.9mm for 10 weeks as described in the Section 2.2.1.  
 
The effect of TAC was assessed using echocardiography and measurements of heart 
weight and LV weight to body weight ratios. The effect of TAC on the fibroblasts was 
examined by staining for α-SMA expression in fibroblasts 48 hours after isolation. 
 
Sham operated animals were used as a control. 
 
5.2.2. Cell isolation and co-culture 
Fibroblasts were isolated from TAC and sham operated animals 10 weeks after the 
operations were performed and co-culture was set up as described in the Section 
2.4.1.  
 
Fibroblasts were isolated from 6 TAC hearts and 5 sham hearts. Myocytes were 
isolated from 12 normal 200-250g Lewis rat hearts. 
 
5.2.3. Assessment of myocyte phenotype 
The paracrine effects of the fibroblasts on the myocytes were assessed by measuring 
the following parameters after 24 hours of co-culture: 
- Cell viability  
- Cell volume 
- T-tubule density 
- Ca2+ transients 
- Sarcomere shortening 
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Figure 5.1: Schematic of the experimental protocol 
 
 
5.3. Results 
5.3.1. 10 week thoracic aortic constriction produced a compensated hypertrophic 
response of the heart 
The in vivo effects of TAC on heart function were examined using echocardiography 
(Figure 5.2). Left ventricular posterior wall thickness was increased by 12% indicating 
hypertrophy of the left ventricle. The ejection fraction was also increased, which is 
indicative of compensated hypertrophy. The hearts have not begun to fail as once the 
compensatory response is exhausted, and the heart begins to fail, ejection fraction 
drops (Wei et al., 2010). 
 
The hypertrophic phenotype was also assessed using measurements of heart weight, 
LV weight and body weight (Figure 5.3). The heart weight to body weight ratio 
(HW:BW) and LV to body weight ratio (LV:BW) were increased confirming the 
hypertrophic response. 
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Figure 5.2: Echocardiography shows compensated hypertrophy in TAC animals 
A) Left ventricular posterior wall thickness was increased with TAC. B) Ejection 
fraction was also increased with TAC. These results are indicative of a compensated 
hypertrophic response. Sham n=5 animals; TAC n=6 animals. 
 
 
Figure 5.3: Heart and left ventricular to body weight ratios confirm a hypertrophic response to TAC 
A) Heart weight to body weight and B) left ventricle weight to body weight ratios 
were increased after TAC compared to sham operated animals. Sham n=5 animals; 
TAC n=6 animals. 
 
5.3.2. TAC induces α-SMA expression in cardiac fibroblasts 
Pressure overload of the heart has previously been shown to increase fibroblast 
migratory and proliferative properties (Stewart et al., 2010). To assess whether 
fibroblasts were altered by the 10 week model of TAC used here, the cells were stained 
for the presence of α-SMA 48 hours after isolation. The majority of TAC fibroblasts 
stained positive for α-SMA, whereas at this time point fibroblasts from normal hearts 
were α-SMA negative (Figure 5.4). This is only a single marker of fibroblast activation, 
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and not enough cells were imaged to allow quantification of this parameter. However, 
this shows that TAC is activating fibroblasts to express α-SMA which is indicative of 
fibroblasts in pathology.  
 
 
Figure 5.4: α-SMA staining in fibroblasts 48 hours after isolation from TAC and normal hearts  
TAC fibroblasts largely stained positive for α-SMA, although not ubiquitously. Normal 
fibroblasts were negative for α-SMA. Green: α-α-SMA. Red: Nuclear stain. 
 
5.3.3. Fibroblasts from both TAC and sham operated rats reduce myocyte viability 
The % of rod shaped cells was reduced in myocytes cultured with either sham or TAC 
fibroblasts (Figure 5.5). Co-culture with either group of fibroblasts reduced viability to 
a similar extent; co-culture with sham fibroblasts caused a 23% reduction and co-
culture with TAC produced a 20% decrease in the % of cells that were rod shaped 
compared to control. 
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Figure 5.5: Co-culture with either TAC or sham fibroblasts reduced myocyte viability 
A) Representative recording of myocyte viability. B) The percentage of myocytes 
retaining their rod shape was reduced by co-culture with TAC or sham fibroblasts 
compared to control. CM+CM n= 6 set ups; S FB+CM n=7 set ups; T FB+CM n=8 set ups. 
 
5.3.4. TAC and sham fibroblasts both induced myocyte hypertrophy 
The volume of myocytes was used as a marker of cellular hypertrophy, and assessed 
with 3-dimensional reconstruction of di-8-ANEPPS staining. Myocyte volume was 
increased when they were co-cultured with TAC or sham fibroblasts compared to 
control (Figure 5.6). The extent of the increase in myocyte volume was similar in both 
groups. 
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Figure 5.6: Co-culture with TAC or sham fibroblast led to myocyte hypertrophy 
A) Representative recordings of di-8-ANEPPS staining. B) Myocyte volume was 
significantly increased after co-culture with either TAC or sham fibroblasts compared 
to control. CM+CM n=68; S FB+CM n=44; T FB+CM n=41. 
 
 
5.3.5. Sham and TAC fibroblasts have different effects on myocyte Ca2+ transients 
Stimulated Ca2+ transients were recorded using the Ca2+ sensitive dye Fluo-4 (Figure 
5.7). The transient amplitude was greater after co-culture with sham fibroblasts and 
smaller after co-culture with TAC fibroblasts. Time to peak and time to 50% decay 
were unchanged in any set up. Time to 90% decay was reduced in both fibroblast 
groups.
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Figure 5.7: Sham and TAC fibroblasts have opposing effects on myocyte Ca
2+
 transient amplitude  
A) Representative Ca2+ transients. B) Myocyte Ca2+ transient amplitude was larger in myocytes co-cultured with sham fibroblasts 
compared to those co-cultured with TAC fibroblasts. C) Time to peak and D) time to 50% decay were not affected by co-culture with 
fibroblasts. E) Time to 90% decay CM+CM n=48; S CF+CM n=56; T CF+CM n=40. 
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5.3.6. Myocyte contractility was affected by both TAC and sham fibroblasts 
The Ca2+ transient drives the contraction of myocytes which is ultimately responsible 
for the function of the heart as a pump. To assess myocyte contractility stimulated 
sarcomere shortening was tracked (Figure 5.8). The amplitude of sarcomere shortening 
was not affected by either group of fibroblasts. Time to 90% peak was reduced in the 
sham fibroblast group but not altered in the TAC fibroblast group compared to control. 
The relaxation times of sarcomere contraction were altered by both fibroblast groups. 
Time to 50% and 90% decline to baseline were reduced, with TAC fibroblasts having a 
greater effect on time to 50% decline. The increased speed of relaxation can be partly 
explained by shortening of the Ca2+ transient, although the effect on relaxation of 
contractility appears to be greater than on the decline of the Ca2+ transient.  
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Figure 5.8: Myocyte contractility is altered by co-culture with sham or TAC fibroblast 
A) Representative recordings of sarcomere shortening. B) Absolute amplitude of sarcomere shortening is not different between the 
groups. C) Time to 90% peak is reduced in myocytes co-cultured with sham fibroblasts compared to control myocytes and myocytes co-
cultured with TAC fibroblasts. The time for sarcomere length to return D) 50% and E) 90% to baseline is reduced by both sham and TAC 
fibroblasts. The effect of TAC fibroblasts on time for 50% return to baseline is greater than that of sham. CM+CM n=65; S FB+CM n=51; T 
SB+CM n=65. 
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5.3.7. Neither TAC or sham fibroblasts affect t-tubule density 
The t-tubule density of myocytes was measured as the percentage di-8-ANEPPS 
stained area. T-tubule density was not significantly different between any of the three 
groups (Figure 5.9). 
 
 
Figure 5.9: Fibroblasts did not affect the t-tubule density 
T-tubule density was unaffected by co-culture with fibroblasts. CM+CM n=53; S FB+CM 
n=39; T FB+CM n=37 
 
5.4. Discussion 
The results presented in this chapter compare the paracrine effects of fibroblasts from 
pressure overloaded hearts with fibroblasts from sham operated hearts. Both sham 
and TAC fibroblasts reduced myocyte viability and induced myocyte hypertrophy in co-
cultured myocytes. The response of the Ca2+ transient was different. Sham fibroblasts 
led to an increased transient amplitude whereas TAC fibroblasts caused a diminished 
transient amplitude. The decay times of the Ca2+ transient were reduced by co-culture 
with either group of fibroblasts. This effect was also seen in the sarcomere relaxation 
time. 
 
This is the first comparison of the effects of adult fibroblasts from normal and 
pathological hearts on adult myocytes and is therefore important in our understanding 
of the paracrine effects of fibroblasts on myocyte function. Previously Vasquez et al 
(2010) compared the paracrine effects of fibroblasts from myocardial infarction and 
control hearts on the electrophysiology of neonatal cells and also showed a difference 
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between normal and pathological fibroblasts. They found that only fibroblasts from a 
rat model of myocardial infarction induced changes in conduction velocity and action 
potential duration despite keeping the fibroblasts in culture for up to 1 month. This is 
slightly different to the observations here, where we see that both normal and TAC 
fibroblasts affect myocytes, but with differences between the two groups in the effects 
on Ca2+ transient amplitude. Despite this, our results and those of Vasquez et al (2010) 
show the importance of comparing pathological and control fibroblasts when trying to 
understand the role of fibroblasts in the heart, rather than just using a single source as 
has been done in other experiments. 
 
5.4.1. TAC was a suitable source of in vivo activated fibroblasts 
TAC and coronary artery ligation were considered as the source for pathological 
fibroblasts. Both have been shown to affect fibroblast phenotype (Squires et al., 2005, 
Stewart et al., 2010). However, coronary artery ligation produces different populations 
associated with the scar and remote regions (Squires et al., 2005) whereas TAC 
produces a homogeneous effect on the LV and was therefore used (this is discussed in 
more detail in Section 2.2.). Characterisation of the model here shows that TAC 
successfully induced pressure overload of the heart. It resulted in a compensated 
hypertrophy, as evident from the echocardiography and the size of the heart. 
 
The effect of pressure overload on fibroblasts has been shown previously. In vivo there 
is an increase in the ECM which is associated with activation of fibroblasts (Doering et 
al., 1988, Weber et al., 1988) and the proliferation and migration of isolated fibroblasts 
are also altered (Stewart et al., 2010). Although we have not assessed these 
parameters, the model used here induced the expression of α-SMA, a marker of 
fibroblast alteration. 
 
It is important to note that α-SMA expression does not define a single cell type. In 
culture, although two populations of fibroblasts may both be α-SMA positive other 
characteristics can be different. Jarvis et al (2006) found that although fibroblasts from 
control and infarcted hearts both express α-SMA in culture, their response to cytokines 
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was still different. This may also be apparent in vivo and therefore just because the 
cells used here are α-SMA positive does not mean the results would be necessarily the 
same using α-SMA positive cells from other settings such as myocardial infarction. The 
relevance of our results to these settings would itself need to be studied. 
 
5.4.2. Similar effects of TAC and sham fibroblasts on myocyte viability and volume 
The reduction in viability and the increase in cell volume were similar after co-culture 
with either sham or TAC fibroblasts. The mechanisms underlying these changes have 
been discussed in Section 4.4. 
 
Although these measurements are comparable between the two groups, it is possible 
that they are produced by different pathways. For example, cardiac hypertrophy can 
be defined as either physiological or pathological (Bernardo et al., 2010) and a whole 
array of growth factors, signalling molecules and cytokines can produce myocyte 
hypertrophy (Suzuki et al., 1990, Palmer et al., 1995, McMullen et al., 2004). 
Therefore, whether these changes are the result of the same pathways with sham and 
TAC fibroblasts needs to be addressed, and is investigated in Chapter 6. 
 
5.4.3. Effects on Ca2+ cycling and contraction 
The major difference between the effects of TAC and sham fibroblasts was the change 
in Ca2+ transient amplitude. Myocytes co-cultured with sham fibroblasts had a greater 
Ca2+ transient amplitude whereas myocytes co-cultured with TAC fibroblasts had a 
reduced Ca2+ transient amplitude. Both groups also had an increased speed of decline 
of the Ca2+ transient. 
 
The decline of the Ca2+ transient is predominantly controlled by NCX and SERCA. NCX 
removes Ca2+ from the cell and SERCA takes Ca2+ into the SR. Increased activity of 
SERCA raises the level of SR Ca2+, which in turn means that more Ca2+ is available for 
the following transient (Periasamy and Huke, 2001). Therefore increased SERCA 
activity is associated with a larger Ca2+ transient and may explain the observations in 
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the sham fibroblast group. SERCA mRNA levels have previously been shown to be 
sensitive to cytokines such as Il-6 (Prabhu, 2004, Tanaka et al., 2004). SERCA activity is 
not only mediated by altering SERCA levels but also through post translational 
modification; for example, phosphorylation (Xu et al., 1993), modification by small 
ubiquitin-related modifier (Kho et al., 2011) and interaction with phospholamban 
(Rodriguez and Kranias, 2005) alter SERCA activity. These processes may also represent 
targets of paracrine mediators (McTiernan et al., 1997). 
 
Despite the increased rate of Ca2+ transient decline in the TAC group, increased SERCA 
activity does not fit due to the reduction in Ca2+ transient amplitude without other 
changes in SR Ca2+ handling parameters. If the storage of Ca2+ within the SR was 
altered, such that there was increased leakage of SR Ca2+ this could explain the 
reduced Ca2+ transient along with increased SERCA activity. Ca2+ leakage through RyR 
has been linked to the reduced SR Ca2+ and reduced Ca2+ transient amplitude in heart 
failure. This reduction in the Ca2+ transient amplitude was seen despite the level of 
SERCA activity not falling (Ai et al., 2005, Belevych et al., 2007). The increased Ca2+ leak 
may be due to alterations of the RyR or through changes in the storage of Ca2+ within 
the SR. Ai et al (2005) showed that Ca2+ leak was increased due to phosphorylation of 
RyR channels and Chopra et al (2007) showed that small decreases in calsequestrin, 
the main Ca2+ binding protein in the SR, also increased Ca2+ leak. 
 
An alternative explanation for the decreased transient amplitude is a reduction in 
ICa,L, due to a shorter action potential (Cannell et al., 1987). This could also explain the 
shortening of the Ca2+ transient as the stimulus for Ca2+ release would be removed 
sooner, although this may be expected to also reduce the time to peak. More rapid 
removal of Ca2+ through NCX could also explain the effect on transient decline. A 
combination of these changes is likely in the effects seen and further work is required 
to understand the mechanisms behind the observed changes. 
 
The increased speed of myocyte relaxation observed may be due to the faster Ca2+ 
transient decay. However, the amplitude of contraction does not follow the changes 
that are seen in the Ca2+ transient amplitude. The amplitude of the sarcomere 
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shortening is affected by the Ca2+ transient amplitude but also other factors such as 
the sensitivity of the myofilaments to Ca2+ (Puceat et al., 1990). Therefore changes in 
Ca2+ transient amplitude do not necessarily result in similar changes in contractility 
(Bing et al., 1991).  
 
5.4.4. Comparison with previous studies 
Previous studies of the paracrine effects of fibroblasts on myocyte function are limited. 
Cultured fibroblast conditioned medium reduced the contractility of neonatal myocyte 
(LaFramboise et al., 2007). A reduced contractility was also induced in adult myocytes 
in co-culture with cultured fibroblasts (Cartledge et al., 2011). This was matched by a 
reduction in the Ca2+ transient. Although a decreased amplitude of contraction was not 
observed in these experiments, the reduction in Ca2+ transient is evident with TAC 
fibroblasts where as sham fibroblasts have a comparably larger transient. In this regard 
it would appear that cultured fibroblasts are more similar to the fibroblasts from TAC 
hearts rather than fibroblasts from the normal heart. 
 
Other reports have looked at the effects of fibroblasts on action potential duration. 
This is the stimulus for the Ca2+ transient, as it produces Ca2+ influx through ICa,L. As 
the action potential lengthens, ICa,L increases and therefore the Ca2+ transient is 
longer. Fibroblasts have been shown to affect the action potential of neonatal 
myocytes. Guo et al (1998b) showed that the time-to-25% repolarisation of the action 
potential was prolonged (although time-to-80% was unchanged) and Pedrotty et al 
(2009) found that time-to-90% repolarisation was prolonged by cultured fibroblast 
conditioned medium. The prolongation of the action potential in adult myocytes by 
fibroblast conditioned medium has also been suggested by Kaur et al (2013). This 
would be expected to cause a prolongation of the Ca2+ transient, which is the opposite 
of the effect we observe. Interestingly, Vasquez et al (2010) found that the action 
potential of neonatal myocytes was shortened by fibroblast conditioned medium when 
using fibroblast from hearts after myocardial infarction. A shorter action potential 
would be expected to shorten the Ca2+ transient and therefore is more in keeping with 
our results. All of these studies have used fibroblast conditioned medium and whether 
 155 
the effects are different in a co-culture system is unknown. It would therefore have 
been interesting to look at the action potential under our experimental set up.  
 
5.4.5. Investigating other aspects of excitation contraction coupling 
Although it would have been interesting, myocyte electrophysiology was not 
successfully investigated here. Single myocyte action potentials can be recorded to 
look at myocyte excitation using whole cell perforated patch clamping. This technique 
was established in the lab (Ibrahim et al., 2010). However, patch clamping of cultured 
myocytes was found to be difficult and, due to the limited number of co-culture set 
ups it was not possible to record an adequate number of action potentials to analyse 
this parameter. The paracrine effect of fibroblasts on the electrical properties of the 
heart was therefore studied using myocardial slices (see Chapter 7). 
 
Ca2+ handling properties can also be studied in more detail by looking at Ca2+ sparks 
and SR Ca2+ content. Ca2+ sparks were not consistently detectable in culture (as 
demonstrated in Section 3.3.5.). SR Ca2+ content has previously been measured in 
cultured myocytes within the lab (Cartledge et al., 2011) but attempts to measure it 
here were unsuccessful. Some recordings were achieved but only 1 or 2 recordings are 
possible per co-culture set up and due to the limited number of set ups available and 
the inconsistent success it was not possible to produce enough data to provide 
meaningful results. 
 
5.4.6. A role of fibroblast paracrine mediators in disease progression 
Characterisation of the 10 week model of TAC used in these experiments show that 
the myocytes have a larger Ca2+ transient amplitude compared to control (Ibrahim et 
al., 2012). Other models of hypertrophy in rats have found differing effects, showing 
no changes in Ca2+ transient amplitude or reduction in the transient amplitude (Bing et 
al., 1991, Moore et al., 1991, Zhang et al., 1995). What is more consistently observed is 
the reduction in Ca2+ transient amplitude with the progression into heart failure but 
the cause of these changes is unclear (Balke and Shorofsky, 1998). Fibroblasts are 
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sensitive to mechanical strain and biological mediators that are increased in pressure 
overload and coupled with the results reported here it is therefore interesting to 
hypothesise that fibroblasts may drive the changes in Ca2+ handling associated with the 
progression to heart failure. 
 
 
5.4.7. Summary 
The results reported in this chapter show that fibroblasts activated in vivo by pressure 
overload of the heart have different effects on myocytes compared to fibroblasts from 
the normal heart, particularly in the regulation of cytoplasmic Ca2+. 
 
It is important to consider the implication of these results for fibroblast and myocyte 
interaction in vivo. These results suggest that fibroblasts have the capacity to modulate 
myocyte function, with an improved time to peak contraction and increased Ca2+ 
transient in myocytes co-cultured with sham fibroblasts. However, these effects are 
different with TAC fibroblasts, which resulted in a decreased Ca2+ transient amplitude. 
This raises the possibility that fibroblasts may switch in disease states to drive some of 
the negative effects in myocardial function. 
 
The next phase of this investigation was to look at potential mechanisms involved in 
the effects observed. The role of TGF-β, a major factor in fibroblast and myocardial 
physiology was therefore investigated.  
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CHAPTER 6. 
Investigating the role of TGF-β in the paracrine communication 
between fibroblasts and myocytes 
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6.1. Introduction 
In Chapters 4 and 5 the paracrine effects of fibroblasts on myocyte properties have 
been examined. In this chapter we set out to investigate possible mediators involved in 
these effects. Among the possible mediators in the paracrine communication between 
fibroblasts and myocytes (explored in detail in Section 1.6.) I have focused on TGF-β for 
the following reasons: 
 
Firstly, TGF-β is released by fibroblasts (Eghbali, 1989, Zhao and Eghbali-Webb, 2001). 
Secondly, myocytes express TGF-β receptors (Engelmann and Grutkoski, 1994) and 
TGF-β has effects on myocytes which include stimulating hypertrophy, driving 
apoptosis and altering Ca2+ handling and contractility (Roberts et al., 1992, Neylon et 
al., 1994, Schluter et al., 1995, Avila et al., 2007, Li et al., 2008, Heger et al., 2011). 
These are potential explanations for the observations reported in this Thesis and make 
TGF-β a good candidate to explore. Thirdly, TGF-β has been previously shown to be a 
possible paracrine mediator. In vitro, the myocyte hypertrophy induced by fibroblast 
conditioned medium has been blocked with TGF-β neutralising antibodies (Gray et al., 
1998) and in vivo TGF-β knockout mice do not develop hypertrophy in response to Ang 
II infusion (Schultz Jel et al., 2002). Fibroblast-derived TGF-β has also been shown to 
affect myocyte electrophysiology, increasing the voltage gated Na+ current and 
decreasing the transient outward K+ current (Kaur et al., 2013). 
 
SB 431542 is a potent and specific TGF-β type 1 receptor antagonist (Inman et al., 
2002). It has been shown to block the effect of TGF-β on cardiomyocyte (Heger et al., 
2011) and therefore is an ideal tool for investigation the role of TGF-β in the paracrine 
effects of fibroblasts on myocytes. 
6.1.1. Chapter aims 
The work described in this chapter set out to test the hypothesis that TGF-β is 
responsible for the paracrine effects of fibroblasts on myocyte viability, volume and 
Ca2+ transients. The role of TGF-β in the effect of TAC and age-matched control 
fibroblasts was examined.  
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6.2. Methods 
6.2.1. Measurement of potential paracrine mediators 
The level of TGF-β1 was measured in the co-culture supernatant using R&D systems 
TGF-β Quantikine® ELISA kit (R&D systems, UK; Cat. No. MB100B). 
 
6.2.2. Blocking TGF-β type 1 receptors in co-culture 
A schematic of the experimental protocol is shown in Figure 6.1A. 
 
Fibroblasts were isolated from 10 week TAC animals and age matched controls 
(without sham operation) and set up in co-cultures with normal rat ventricular 
myocytes. 10μM SB 431542 (Sigma Aldrich, UK) in DMSO (final DMSO concentration 
0.1%) was added to the co-culture to block the TGF-β type 1 receptors. 0.1% DMSO 
was added to control set-ups. 
 
The final set ups were: 
 Myocytes + Myocytes 
 Myocytes + Myocytes + SB 431542 
 Control fibroblasts + Myocytes  
 Control fibroblasts + Myocytes + SB 431542 
 TAC fibroblasts +Myocytes  
 TAC fibroblasts +Myocytes + SB 431542 
 
6.2.3.  Blocking TGF-β type 1 receptors in conditioned medium 
A schematic of the experimental protocol is shown in Figure 6.1B. 
 
Fibroblasts were isolated from 10 week TAC and age matched control rats. They were 
cultured for 20 hours in FB medium, and then plated in Transwells at 10,000 cells in 
200µl ITS medium per Transwell. After 4 hours the Transwells were suspended in 2ml 
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ITS medium in a glass bottom dish. This is the same set up as for the co-culture, except 
that myocytes were not added to the glass bottom dish. After 24 hours, the medium 
was collected and any cells were removed by centrifuging at 620g for 5 minutes. The 
medium was then frozen at -20°C ready for use.  
 
To assess the effects of conditioned medium freshly isolated myocytes were plated on 
laminin coated glass bottom dishes at 5,000 cells per dish. The conditioned medium 
was thawed at 37°C and 2ml was added to the myocytes either in the presence of 
10μM SB 431542 or 0.1% DMSO. 
 
 The final sets up were: 
 Myocytes + myocyte conditioned medium 
 Myocytes + control fibroblast conditioned medium  
 Myocytes + control fibroblast conditioned medium + SB 431542 
 Myocytes + TAC fibroblast conditioned medium  
 Myocytes + TAC fibroblast conditioned medium + SB 431542 
 
6.2.4. Assessment of myocyte phenotype 
After 24 hours of co-culture or exposure to conditioned medium, the following 
properties of the myocytes were examined: 
 Viability 
 Volume 
 Ca2+ transients 
 T-tubule density (for co-cultures only)  
The protocols are described in the Section 2.4. 
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Figure 6.1: Schematic and illustration of the experimental protocol 
A) Blocking TGF-β in co-culture. B) Blocking TGF-β in conditioned medium. 
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6.3. Results 
6.3.1. TGF-β1 was increased in co-culture medium from fibroblast co-cultures 
The level of TGF-β1 was measured in the co-culture medium using ELISAs (Figure 6.2). 
TGF-β1 was increased in both the sham and TAC fibroblast groups compared to 
control. The level in the sham fibroblast group was higher compared to the TAC 
fibroblast group.  
 
Due to the raised levels of TGF-β1, we investigated its role in the changes in myocyte 
phenotype using the TGF-β type 1 receptor antagonist SB 431542.  
 
 
 
Figure 6.2: The levels of TGF-β1 in co-culture supernatant 
A) TGF-β1 was increased in co-culture with either sham or TAC fibroblasts compared to 
the control. The level was higher in the sham fibroblast co-culture compared to the 
TAC fibroblast co-culture. CM+CM n=8; S FB+CM n=10; T SB+FM n=10 (number of 
ELISA measurements). 
 
6.3.2. Blocking TGF-β type 1 receptors prevented the loss in myocyte viability 
Both normal and TAC fibroblasts reduced the viability of co-cultured myocytes (Figure 
6.3). This reproduced the results found in Chapters 4 and 5. SB 431542 blocked the 
reduction in myocyte viability in both fibroblast groups. In the presence of the 
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antagonist, the viability in both the fibroblast groups was not different from control 
levels.  
 
 
Figure 6.3: Antagonism of TGF-β type 1 receptors blocked the reduction in viability 
A) Representative recordings of myocyte viability. B) Co-culture with normal or TAC 
fibroblasts reduced myocyte viability but this was blocked by SB-431542. CM+CM n=5; 
CM+CM+SB n=5; FB+CM n=6; FB+CM+SB n=6; T FB+CM n=6; T FB+CM+SB n=6 (number 
of co-culture set ups). 
 
6.3.3. SB-431542 blocked the hypertrophic response in myocytes 
Myocytes co-cultured with normal fibroblasts or TAC fibroblasts were larger than the 
controls (Figure 6.4), as was previously observed in Chapters 4 and 5. This hypertrophic 
response was blocked by the addition of the TGF-β type 1 receptor antagonist. In the 
presence of the antagonist cell volumes were not different from control. 
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Figure 6.4: Antagonism of TGF-β type 1 receptor blocked the hypertrophic response 
A) Representative images of di-8-ANEPPs stained myocytes, B) Both normal and TAC 
fibroblasts induce a hypertrophic response in myocytes. This is blocked by the 
presence of SB-431542 in the co-culture medium. CM+CM n=60; CM+CM+SB n=43; 
FB+CM n=48; FB+CM+SB n=47; T FB+CM n=44; T FB+CM+SB n=42. 
 
6.3.4. Blocking TGF-β type 1 receptors prevented the changes in myocyte Ca2+ 
transients 
The changes in the Ca2+ transient amplitude were prevented by SB 431542 (Figure 6.5). 
The transient amplitude was increased in the normal fibroblast group and decreased in 
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the TAC fibroblast group, as had previously been observed in Chapters 4 and 5. The 
amplitude was normalised to the control levels when the TGF-β type 1 receptor 
antagonist was added to the co-culture. The time to 90% decay of the Ca2+ transient 
was reduced in both fibroblast co-culture groups. This was not affected by blocking 
TGF-β type 1 receptors. 
 
There appears to be some direct effects of the antagonist on the time to peak of the 
Ca2+ transient. Although the time to peak is unchanged by the fibroblasts, it is 
shortened in the presence of the TGF-β type 1 receptor antagonist. This causes a 
significant difference in the normal fibroblast group but has a similar, although non-
significant effect in the TAC fibroblast and control groups. 
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Figure 6.5: Changes in Ca
2+
 transient parameters were blocked by SB 431542  
A) Representative Ca2+ transients recordings. B) The amplitude of the Ca2+ transient is increased by normal fibroblasts and reduces by TAC 
fibroblasts. SB 431542 blocks both of these changes. C) Time to peak is unaffected by co-culture with fibroblasts, although SB 431542 
shortens the time to peak in normal fibroblast co-cultures. D) Time to 50% decay is unchanged in any experimental group. E) Time to 90% 
decay is reduced by co-culture with either normal or TAC fibroblasts and this effect is unchanged in the presence of SB 431542. CM+CM 
n=42; CM+CM+SB n=33; FB+CM n=50; FB+CM+SB n=60; T FB+CM n=36; T FB+CM+SB n=45.  
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6.3.5. T-tubule density was unchanged in any group 
The t-tubule density was unaffected by either the fibroblasts or the addition of the 
TGF-β type 1 receptor antagonist (Figure 6.6). This is similar to the previous findings in 
Chapter 4 and 5. 
 
 
Figure 6.6: T-tubule density was unchanged by fibroblasts or TGF-β antagonism 
T-tubule density is not altered in any experimental set up. CM+CM n=53; CM+CM+SB 
n=43; FB+CM n=48; FB+CM+SB n=47; T FB+CM n=42; T FB+CM+SB n=42. 
 
 
When added to the co-culture set ups, SB 431542 blocks nearly all of the paracrine 
effects observed including the opposite effect of normal and TAC fibroblasts on the 
Ca2+ transient amplitude. This may be explained by the different levels of TGF-β. 
Alternatively, the TGF-β may be acting on the fibroblasts and inducing the release of 
different downstream paracrine mediators. To test this hypothesis we used 
conditioned medium to test the effects of blocking the TGF-β type 1 receptors on the 
myocytes only. 
 
6.3.6. SB 431542 does not block the reduction in myocyte viability with conditioned 
medium 
Normal or TAC fibroblast conditioned medium reduced the viability of myocytes 
(Figure 6.7). The addition of SB 431542 to the conditioned medium did not significantly 
block these effects as observed when it was added to the co-culture, although there is 
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a trend towards an increased viability in the presence of the antagonist (FB+CM vs. 
FB+CM+SB p=0.135; T FB+CM vs. T FB+CM+SB p=0.389). 
 
 
Figure 6.7: Myocyte viability was reduced by conditioned medium, but unaffected by SB 431542 
A) Representative recordings of myocyte viability. B) Myocyte viability is reduced by 
either normal or TAC fibroblasts conditioned medium. The addition of SB 431542 to 
the conditioned medium does not have a significant effect on the viability of myocytes. 
CM+CM n=9; FB+CM n=12; FB+CM+SB n=9; T SB +CM n=10; T FB+CM+SB n=6. 
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6.3.7. TAC fibroblast conditioned medium induced hypertrophy, and this was blocked 
by SB 431542 
TAC fibroblast conditioned medium induce myocyte hypertrophy, but normal 
fibroblasts conditioned medium did not (Figure 6.8). This is different to when co-
culture was used where both normal and TAC fibroblasts induced hypertrophy (see 
Figure 6.4). Blocking the myocyte TGF-β type 1 receptors prevented the hypertrophic 
response, which suggests fibroblast-derived TGF-β is directly driving myocyte 
hypertrophy. 
 
Figure 6.8: Myocyte volume was increased in TAC fibroblast conditioned medium, and this was 
blocked by SB 431542  
A) Representative recording of di-8-ANEPPS staining. B) TAC, but not normal, fibroblast 
conditioned medium increased the size of the myocytes. This effect was blocked by SB 
431542. CM+CM n=49; FB+CM n=48; FB+CM+SB n=49; T SB +CM n=50; T FB+CM+SB 
n=50. 
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6.3.8. Myocyte Ca2+ transient were unaffected by conditioned medium  
The Ca2+ transients were unaffected by fibroblast conditioned medium (Figure 6.9). 
Unlike in co-culture, the Ca2+ transient amplitude and time to 90% decay were the 
same for control and myocytes exposed to normal or TAC fibroblast conditioned 
medium. These parameters are also not affected by the presence of the TGF-β type 1 
receptor antagonist, although there is a direct effect of the drug on the time to peak 
which is increased in the presence of the antagonist. 
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Figure 6.9: Myocyte Ca transients were unaffected by fibroblast conditioned medium 
A) Representative recording of Ca2+ transients. Neither TAC nor normal fibroblasts conditioned medium affected the Ca2+ transient of 
myocytes normal myocytes over 24 hours. B) The amplitude, C) time to peak, D) time to 50% decay and E) time to 90% decay are all 
unaffected. SB 431542 caused a prolongation of time to peak. CM+CM n=49; FB+CM n=43; FB+CM+SB n=49; T SB +CM n=52; T FB+CM+SB 
n=47.
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6.3.9. TGF-β1 is present at different levels in fibroblast conditioned medium 
Due to the different effect of fibroblast conditioned medium to co-culture of 
fibroblasts and myocytes, the level of TGF-β1 in conditioned medium was measured. 
TGF-β1 was lower in shamfibroblast conditioned medium compared to the TAC 
fibroblast conditioned medium (Figure 6.10). These levels can be compared to the 
levels measured in co-culture (previously shown in Figure 6.2A). The level of TGF-β1 in 
sham fibroblast conditioned medium was lower than the level in sham fibroblast co-
culture with myocytes (p<0.01) and also the TAC co-culture (p<0.05). The level of TGF-
β1 was not different between TAC fibroblast conditioned medium and co-culture. The 
TGF-β1 expression in sham fibroblasts therefore appear to be modulated by the 
presence of the myocytes. 
 
 
Figure 6.10: TGF-B1 is lower in sham fibroblast conditioned medium compared to TAC fibroblast 
conditioned medium 
Sham fibroblast conditioned medium has a lower amount of TGF-β1 compared to TAC 
fibroblast conditioned medium. It is also lower than the level previously observed in 
the sham fibroblast co-culture and the TAC fibroblast co-culture. The level of TGF-β1 
was not different between TAC fibroblast conditioned medium and TAC co-culture. S 
FB n=6; T FB n=6. 
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6.4. Discussion 
This chapter has explored the role of TGF-β in the paracrine effects of fibroblasts on 
myocytes. When an antagonist to the TGF-β type 1 receptor was added to the co-
cultures it blocked the reduction in viability, the increase in volume and the changes in 
the Ca2+ transient amplitude of the myocytes. Whether this was due to a direct effect 
of TGF-β on the myocytes or an indirect effect altering downstream mediators from 
the fibroblasts was investigated by adding the TGF-β type 1 receptor antagonist to 
fibroblast conditioned medium. In this experimental set up, only the myocyte TGF-β 
type 1 receptors are blocked. The results of these experiments show that TGF-β is 
directly responsible for some of the effects, for example the hypertrophic response, 
but is acting via the release of downstream mediators from the fibroblasts in other 
effects, for example the reduction in myocyte viability. 
 
Firstly the level of TGF-β1 in the co-culture set ups was measured. It was raised in both 
the sham and TAC fibroblast co-cultures compared to control, with higher levels in the 
normal group. In a mouse model of TAC, TGF-β1 mRNA was initially raised although 
over time this returned to normal levels (Villarreal and Dillmann, 1992). It is possible 
that in established hypertrophy TGF-β1 protein levels drop below normal levels. It is 
also important to note that the ELISA used measures both latent and active forms of 
TGF-β1 and therefore the levels of active TGF-β1 in the co-culture may actually be 
different to those measured. MMPs can activate the latent form of TGF-β1 (Imai et al., 
1997, Yu and Stamenkovic, 2000) and as the level of MMPs are altered following TAC 
(Nagatomo et al., 2000) the percentage TGF-β1 that is active may be higher in the TAC 
co-culture compared to the sham group. Also, the ELISA measured the level of TGF-β1, 
and not the level of TGF-β2 or 3. The three isoforms are translated from distinct genes 
and are regulated differently. For example, after myocardial infarction, elevated levels 
of TGF-β3 persist longer than TGF-β1 and 2, and TGF-β3 was localised to the scar 
region where as TGF-β1 and 2 were found throughout the LV (Deten et al., 2001). The 
levels of each isoform after TAC have not been characterised but may be different 
compared to control. Although only TGF-β1 levels have been measured, all three 
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isoforms can act via the TGF-β type 1 receptor and therefore are affected by the use of 
SB 431542. 
 
6.4.1. Viability 
The reduction in viability of myocytes in response to fibroblast paracrine mediators has 
previously been linked to apoptosis (Shivakumar et al., 2008), although necrosis and 
hyper-contraction may also explain these effects (discussed in Section 4.4.1). TGF-β is 
pro-apoptotic in various cells (Schuster and Krieglstein, 2002). The reports on the 
effect of TGF-β on myocyte apoptosis are conflicting. TGF-β has been shown to 
mediate myocyte apoptosis in response to Ang II (Schroder et al., 2006), but others 
studies have reported that TGF-β is protective against myocyte apoptosis in a model of 
ischemia–reperfusion injury (Yang et al., 1999). During ischemia-reperfusion in ferrets, 
TGF-β has been shown to be protective against necrosis by reducing neutrophil 
recruitment (Lefer et al., 1993). As there are no immune cells within the culture set up 
this is unlikely to contribute to the reduced viability. However, TGF-β can also increase 
SR Ca2+ release in neonatal myocytes (Neylon et al., 1994), which could result in excess 
Ca2+ release into the cytoplasm. This can trigger hyper-contraction of the myocytes 
which would also reduce their viability. 
 
In the experiments reported here, the blockade of TGF-β type 1 receptors prevented 
the loss in myocyte viability in co-culture. However, when the antagonist was added to 
fibroblast conditioned medium the effect was diminished. There may be a smaller 
effect but it is not as pronounced and does not reach significance. TGF-β may 
therefore be having some direct effects, possibly by promoting apoptosis or hyper-
contraction, but mainly appears to be having an effect by stimulating the release of 
secondary mediators from the fibroblasts. An example of a downstream mediator of 
TGF-β is ET-1 (Shi-wen et al., 2007). There are reports that ET-1 is pro- and anti-
apoptotic in myocytes (Ogata et al., 2003, Mel'nikova et al., 2004, Ren et al., 2008a). 
ET-1 also raises the diastolic level of Ca2+ in myocytes and this may result in 
spontaneous hyper-contraction and reduced viability (Touyz et al., 1996). Therefore, 
the release of ET-1 from the fibroblasts in response to autocrine TGF-β signalling may 
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partially explain these results. There are many other mediators that can drive myocyte 
apoptosis that are released by fibroblasts, such as TNF-α (van Empel and De Windt, 
2004). 
 
6.4.2. Hypertrophy 
In co-culture both normal and TAC fibroblasts induce myocyte hypertrophy and this is 
blocked by the TGF-β type 1 receptor antagonist. When using fibroblast conditioned 
medium, only the TAC fibroblasts induced significant hypertrophy, but this was also 
blocked by the TGF-β type 1 receptor antagonist. 
 
TGF-β has been previously shown to induce myocyte hypertrophy (Gray et al., 1998, 
Rosenkranz et al., 2002). Our results are consistent with a direct hypertrophic effect of 
TGF-β, although it cannot be excluded that there is a further autocrine signalling 
pathway in the myocytes that is evoked by TGF-β and causing the hypertrophy, as 
described by Fredj et al (2006). The absence of a hypertrophic effect in the normal 
myocyte conditioned medium may be due to the lower levels of TGF-β in this medium 
compared to the other set ups used. This adds further support to the hypothesis that 
myocyte hypertrophy is a direct effect of TGF-β in these experiments.    
 
The difference in the level of TGF-β1 in normal fibroblast conditioned medium and 
normal fibroblast co-culture suggests that fibroblasts are responding to a paracrine 
signal from the myocytes which induces a response from the fibroblasts altering their 
paracrine signalling, which in turn affects the myocytes (Figure 6.11). Ang II is the main 
mediator that has been investigated in the paracrine effects of myocytes on fibroblasts 
(Burstein et al., 2007, Tsai et al., 2011) and has been shown to induce TGF-β expression 
in fibroblasts (Campbell and Katwa, 1997, Tsai et al., 2011). It is possible that it is 
involved in the effects observed here. This paracrine signalling from the myocytes to 
fibroblasts is also evident in the effects on the Ca2+ transients. 
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6.4.3. Ca2+ transients 
TGF-β can modulate the different elements that are involved in the Ca2+ transient 
including the ICa,L and properties of the SR. TGF-β reduces the level of ICa,L in 
neonatal myocytes (Neylon et al., 1994) but improves Ca2+ release from the SR (Avila et 
al., 2007). In adult cells TGF-β slows the time to peak and time to decay of the Ca2+ 
transient (Li et al., 2008). 
 
In the co-culture experiments the effect of fibroblasts on Ca2+ transient amplitude 
were blocked by blocking TGF-β type 1 receptors although the reduced time to decay 
was not blocked. Li et al (2008) found that the amplitude of the Ca2+ transient was 
unchanged by TGF-β. Also, the fact that both the increase in the Ca2+ transient 
amplitude with normal fibroblasts and the decrease in Ca2+ transient amplitude with 
TAC fibroblasts were blocked challenges the hypothesis that this is a direct effect of 
TGF-β. These opposing effects could be a result of different levels of TGF-β, but may 
also be due to the release of other mediators from the fibroblasts in response to TGF-
β. 
 
When using conditioned medium no effect on the Ca2+ transient was seen with either 
normal or TAC fibroblasts. The lack of change in response to the conditioned medium 
despite the presence of TGF-β shows that this is not a direct effect of TGF-β, but rather 
through downstream mediators. This also suggests that a cross talk between the 
myocytes and fibroblasts is necessary (as also observed for the hypertrophic response 
in the normal fibroblasts group) and that the fibroblasts are responding to a signal 
from the myocytes. 
 
Further work is required to gain insight into the other pathways involved. Ang II is a 
possible upstream signalling mediator from the myocytes to the fibroblasts. Due to the 
different effects of the normal and TAC fibroblasts, it appears that different mediators 
are released downstream of TGF-β. One possibility is ET-1 which is released 
downstream of TGF-β (Shi-wen et al., 2007). ET-1 increases the Ca2+ transient 
amplitude in healthy myocytes (Endoh et al., 1998) but reduces the Ca2+ transient 
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amplitude in myocytes from heart failure (Suzuki et al., 1998). The effects of ET-1 have 
been linked to changes in the ICa,L (Endoh et al., 1998) but ET-1 also affects SR Ca2+ 
handling, downregulating SERCA2a mRNA levels (Hilal-Dandan et al., 2009). ET-1 may 
therefore be responsible for some of the downstream effects of TGF-β. These putative 
pathways are highlighted in Figure 6.11. 
 
 
 
Figure 6.11: Possible pathways involved in the paracrine effects observed 
A paracrine mediator released by myocytes upregulates TGF-β release in normal 
fibroblasts. This may be Ang II. Fibroblasts then release TGF-β which has direct effects 
on the myocytes but also stimulates the fibroblasts to release other paracrine 
mediators. Downstream of TGF-β, fibroblasts release other mediators which affect the 
myocytes. ET-1 is a candidate mediator that may be involved. 
 
 
Alternatively, the absence of any effect in the conditioned medium experiments may 
be due to the degradation of a mediator within the conditioned medium. In co-culture 
there is a persistent production of mediators by fibroblasts throughout the myocyte 
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culture, whereas in the conditioned medium the mediators are produced by the 
fibroblasts which are then removed at the start of the myocyte culture. Therefore, the 
level of mediators throughout the myocyte culture may be lower due to degradation 
without continued production. It has been reported that over 24 hours in culture the 
levels of TGF-β and Ang II fall about 50% and the level of ET-1 falls about 10% (Squires 
et al., 2005). However, conditioned media have been used alongside co-culture 
previously and they have produced the same effects on myocyte hypertrophy and 
electrophysiology (Harada et al., 1997, Guo et al., 1999). Also in our experiments the 
effects of fibroblast derived mediators on myocyte viability and volume were still 
observed when using conditioned medium. Thus, the changes in the Ca2+ transient may 
be caused by a different mediator that is less stable and is degraded in the conditioned 
medium. 
 
6.4.4. Summary 
The experiments described in this chapter investigated the role of TGF-β in the 
paracrine effects of fibroblasts on myocytes using SB 431542, an antagonist of the TGF-
β type 1 receptor. The results show that TGF-β directly mediates the hypertrophic 
response of the myocytes to fibroblasts. However, the reduction in viability appears to 
be at least in part due to a downstream mediator released from fibroblasts. The effects 
on the Ca2+ transient also appear to be mediated by a downstream mediator, although 
this is only released following a paracrine signal from the myocytes. 
 
These results highlight the complexity of the paracrine interaction between fibroblasts 
and myocytes. TGF-β is an important mediator in these effects; however the effects 
are likely to be the result of a bi-directional dynamic interaction between the two cell 
types and involve a complex signalling network.  
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CHAPTER 7. 
The paracrine effects of cultured fibroblasts on the electrical 
properties of myocardial slices 
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7.1. Introduction 
Cardiac fibroblasts can affect the electrical properties of the myocardium through 
modulation of the ECM. Deposition of excess ECM produces regions of conduction 
slowing promoting conduction heterogeneity and therefore providing a substrate for 
unidirectional block and re-entry circuits leading to arrhythmias (Burstein and Nattel, 
2008, Tan and Zimetbaum, 2011). 
 
More recently interest has grown in the potential pro-arrhythmic effects of gap 
junctions between myocytes (Miragoli et al., 2006). The potential role of gap junctions 
between fibroblasts and myocytes has been discussed in detail in Section 1.5.1.1. 
Although fibroblasts are not excitable cells, they have a more positive resting 
membrane potential than myocytes (Jacquemet and Henriquez, 2007). Gap junctions 
between the two cells raise the resting membrane potential of myocytes. At low levels 
this brings the myocytes closer to the threshold of action potential initiation, 
increasing excitability and increasing conduction velocity. At higher levels, the 
depolarisation of the myocyte membrane potential reaches a level that leads to 
voltage inactivation and reduced availability of voltage gated Na+ channels. This 
reduces action potential upstroke velocity and conduction velocity which promotes 
arrhythmias (Miragoli et al., 2006). Also, fibroblasts can couple myocytes over 
distances up to 300μm but this leads to delayed conduction and would further 
promote arrhythmias (Gaudesius et al., 2003). The potential effects of heterocellular 
gap junctions are large, leading to increased risk of arrhythmias (Nguyen et al., 2012), 
but conclusive evidence of their existence in vivo is still lacking. 
 
Fibroblasts can also affect the electrophysiology of myocytes via paracrine mediators. 
In vitro fibroblast-derived paracrine mediators affect channel expression, currents and 
action potential morphology in neonatal and adult myocytes (Guo et al., 1998b, Guo et 
al., 1999, Kaur et al., 2013). However, the use of neonatal myocytes allows for the 
study of conduction velocity due to the production of a confluent monolayer (Pedrotty 
et al., 2009, Vasquez et al., 2010) whereas in isolated adult myocytes the study of 
conduction velocity is not possible. For this reason, whether fibroblast-derived 
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paracrine mediators affect the multicellular electrophysiological properties of adult 
myocardium has not been addressed. To examine the effects of fibroblasts on 
conduction velocity in the adult heart we utilised myocardial slices. These are thin 
viable sections of ventricular tissue (described in detail in Section 2.3.) that allow the 
field potential and conduction velocity of intact adult myocardium to be examined. 
Furthermore, previous studies have used rat myocytes, whereas the experiments in 
this chapter were conducted with dog tissue. The electrophysiology of the dog heart is 
more similar to human electrophysiology compared to other animals including the rat 
(Lompre et al., 1981, Su et al., 2003) making it a more relevant species to study. 
 
7.1.1. Chapter aims 
The experiments reported in this chapter aim to assess the paracrine effect of cardiac 
fibroblasts on adult dog myocardial tissue electrophysiology. Using myocardial slices, 
the effects on field potential duration and conduction velocity of adult cardiac tissue 
can be addressed. Possible mechanisms will be investigated using western blotting to 
assess protein expression.  
 
7.2. Methods 
A schematic of the experimental protocol is shown in Figure 7.1A. 
 
7.2.1. Cell, tissue and co-culture preparation 
Beagle dog hearts were provided by GlaxoSmithKline. Dogs were euthanised with 
pentobarbital and the heart was rapidly removed and couriered to the lab in ice cold 
cardioplegia.  
 
Fibroblasts were prepared as described in Section 2.3.4. Due to the unpredictable 
supply of tissue it was not possible to use freshly isolated fibroblasts at an early time 
point of culture. Freezing the cells after 24 hours in culture was attempted but was 
unsuccessful. Therefore, the fibroblasts were kept in culture for 6-8 days in FB medium 
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and then frozen for long-term storage as follows. The cells were collected from culture 
using trypsin. They were centrifuged at 620g for 5 minutes and then resuspended in 
3ml 90% foetal bovine serum, 10% DMSO at 4°C. This was frozen slowly in 1ml 
aliquots. They were kept on ice for 5 minutes, then at -20°C for 1 hour and then stored 
at -80°C overnight before being transferred to liquid nitrogen until they were needed. 
The fibroblasts were thawed two days before they were required. The frozen aliquot 
was rapidly warmed at 37°C and then added to 5ml pre-warmed FB medium. After 4 
hours incubation at 37°C in 5% CO2 the medium was replaced with fresh medium. 
 
Myocardial slices were prepared as described and put into co-culture as described in 
Section 2.5.2. Slices were cultured on Transwells at the interface of the H.ITS medium 
and air, in co-culture with 40,000 fibroblasts (Figure 7.1B). Co-culture with 40,000 HEK 
cells or culture of the slice alone was used for the control. After 24 hours in culture, 
the MEA output of the slices was recorded again. The slice was then snap frozen for 
protein analysis by SDS PAGE and western blotting. 
 
Fibroblasts were isolated from 3 dog hearts and slices were prepared from 4 dog 
hearts. Fibroblasts were used for co-culture between passages 2-4 and 9-12 days of 
culture.  
 
7.2.2. SDS PAGE and western blot analysis of connexin 43 
The level of connexin 43 protein in the slices after co-culture was analysed by SDS page 
and western blot. The SDS page was run as described in Section 2.8., using 0.125μg of 
protein for each sample. The primary antibody used for the detection of connexin 43 
was rabbit anti connexin 43 antibody (Sigma, USA; Cat. No. C6219) at a dilution of 
1:1500 in blocking solution, and the secondary antibody was donkey anti-rabbit 
alkaline phosphatase-conjugated (Pierce, USA; Cat. No. 31345) at a dilution of 1:2000. 
 
The amount of connexin 43 was normalised to the level of actin to provide accurate 
comparison between each sample. Due to the similar molecular weight of actin and 
connexin 43 it was not possible to measure both on a single blot. Therefore actin was 
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measured on a separate gel. 0.25µg of protein was loaded per sample and the primary 
antibody used was goat anti-actin (Santa Cruz Biotechnology, USA; Cat. No. sc-1616) at 
a dilution of 1:1000 and the secondary antibody was an alkaline phosphatase-
conjugated rabbit anti-goat antibody (Pierce, USA; Cat. No. 31300) at a dilution of 
1:2000. 
 
 
 
 
 
 
Figure 7.1: Schematic of the experimental protocol and co-culture set up 
A) The experimental protocol. B) The co-culture set up. 
 
 
7.3. Results 
7.3.1. Cultured fibroblasts express α-SMA 
Dog fibroblasts were used between 9 and 12 days after isolation, at passage 2 or 3. At 
this time point the cells were vimentin positive (184/184) and also DDR2 positive 
(140/140) and desmin negative (0/132) which showed that they were fibroblasts 
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without smooth muscle cell contamination. The cells were also stained for CD-31, a 
marker for endothelial cells, and were negative (0/88). The majority of the fibroblasts 
were also α-SMA positive (116/147) (Figure 7.2).  
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Figure 7.2: The dog fibroblasts used for co-culture express α-SMA 
The isolated dog cells were characterised as fibroblasts by the expression of vimentin and DDR2 and the absence of desmin and CD31. 
The majority of the cells were also positive for α-SMA the time point of use (79%). Red: nuclear marker.  
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7.3.2. A slice contains approximately 40,000 fibroblasts 
Slices were cut from a 1cm3 block of tissue with a thickness of 300µm, giving a final 
volume of 1cm by 1 cm by 300µm. There is no apparent quantification of the actual 
increase in the number of fibroblasts in cardiovascular disease in the literature, but it 
was decided the number of fibroblasts that was co-cultured with the slices was to 
match the number of resident fibroblasts within the slice. This would double the 
number of fibroblasts present within the healthy myocardium to represent the 
increase in fibroblasts in disease. It was therefore necessary to count the number of 
fibroblasts within the slice. To achieve this, the tissue was stained for vimentin and a 
nuclear marker. The number of fibroblasts (vimentin-positive cells) within a 1mm2, 
15µm thick section was counted and used to estimate the number of fibroblasts in the 
whole slice. The number of cells within the slice was 41,571±2,303 (Figure 7.3). 
Therefore 40,000 fibroblasts would be co-cultured with each slice. 
 
 
 
Figure 7.3: Each slice contained approximately 40,000 fibroblasts 
A) Representative staining of a section of a slice. Green: Vimentin. Red: Nuclear 
marker. B) The number of fibroblasts within a slice, calculated by counting the number 
of cells in a 1mm2 section and multiplying up for the whole slice. n=3 sections from 1 
slice. 
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7.3.3. The field potential duration is not affected by co-culture with fibroblasts 
The field potential is the extracellular voltage change associated with the action 
potential. Field potential duration was not different between control slices and slices 
co-cultured with fibroblasts (Figure 7.4). Increased variability of action potential 
duration is pro-arrhythmic and as a measure of this the standard deviation of the field 
potential between 16 different points in a slice was calculated. The standard deviation 
of the field potential duration was not changed by fibroblasts.  
 
 
 
Figure 7.4: The field potential duration is unaffected by co-culture with fibroblasts 
A) Representative recording of the field potential at a single electrode of the MEA 
system from a control slice and a slice co-cultured with fibroblasts. B) The field 
potential duration and C) the standard deviation of field potential duration within each 
slice were unchanged by co-culture with fibroblasts. Control n=7; FBs n=12. 
 
 
7.3.4. Longitudinal conduction velocity is lower after co-culture with fibroblasts 
The longitudinal conduction velocity (the conduction velocity in the direction of the 
muscle fibre orientation) was lower after co-culture with fibroblasts compared to 
F
ie
ld
 p
o
te
n
ti
a
l 
d
u
r
a
ti
o
n
(m
s
)
C o n tro l F B s
0
1 0 0
2 0 0
3 0 0
4 0 0
S
ta
n
d
a
r
d
 d
e
v
ia
ti
o
n
 o
f 
F
P
D
(m
s
)
C o n tro l F B s
0
5
1 0
1 5
2 0
C o n tro l
+  F B s
A B
C
1 m V
1 m V
1 0 0 m s
1 0 0 m s
 188 
control slice culture (Figure 7.5). The transverse conduction velocity (the conduction 
velocity perpendicular to the direction of the muscle fibre orientation) was not 
significantly different between the two groups. 
 
 
 
Figure 7.5: Longitudinal conduction velocity was lower after co-culture with fibroblasts 
A) The longitudinal conduction velocity of slices was lower when co-cultured with 
fibroblasts compared to control cultures. B) The transverse conduction velocity was 
not significantly different between the two groups. Control n=8; FBs n=12. 
 
 
Longitudinal conduction velocity is highly dependent on gap junctions at the 
intercalated disks allowing rapid electrical coupling between adjacent cells. In 
ventricular myocytes the predominant gap junction forming connexin is connexin 43 
(Davis et al., 1995, Vozzi et al., 1999). A reduction in connexin 43 may explain the 
lower conduction velocity after co-culture with fibroblasts. Therefore, to investigate 
the potential mechanism underlying the change in conduction velocity, the level of 
connexin 43 was measured by western blotting. 
 
7.3.5. Connexin 43 is unchanged after co-culture with fibroblasts 
Connexin 43 was not significantly different in slices co-cultured with fibroblasts 
compared to control slice (Figure 7.6) although there was a non significant reduction in 
the mean connexin level. 
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Figure 7.6: The level of connexin 43 protein is not significantly different after co-culture with 
fibroblasts 
A) Representative western blot recording of connexin 43 and actin levels from 6 
samples. B) Connexin 43 levels, normalised to actin, were not significantly different in 
myocardial slices after 24 hour co-culture with fibroblasts compared to control. 
Control n=6; FBs n=11. 
 
 
7.4. Discussion 
The results reported in this chapter show that cultured fibroblasts affect the 
electrophysiology of adult myocardial tissue through paracrine mediators. Co-culture 
of myocardial slices with fibroblasts slowed the longitudinal conduction velocity, 
although transverse conduction velocity and the field potential duration are 
unaffected. The level of connexin 43 protein was unchanged. 
 
7.4.1. Field potential duration 
The effects of fibroblasts on myocyte field potential/action potential have previously 
been investigated in neonatal myocytes and recently in isolated adult myocytes. 
Although we found that the field potential was not significantly different after co-
culture with fibroblasts, previous reports have found changes in both the action 
potential duration and the underlying currents but the nature of these reported 
changes are conflicting. Guo et al (1999) found that the action potential of neonatal 
myocytes was prolonged at time-to-25% repolarisation, although not at time-to-80% 
C o n tro l + F B
0
2
4
6
R
e
la
ti
v
e
 e
x
p
r
e
s
s
io
n
(a
r
b
a
tr
a
r
y
 u
n
it
s
)
A B
 190 
repolarisation, by fibroblasts conditioned medium. A decrease in the transient outward 
K+ current was also observed that may explain this change. Pedrotty et al (2009) 
observed a prolongation of the action potential of neonatal myocytes at time-to-90% 
repolarisation with a reduction of the transient outward K+ current and also the 
voltage gated Na+ current and the inward rectifying K+ current. In adult myocytes, 
fibroblast conditioned medium reduced the transient outward K+ current, but 
increased the voltage gated Na+ current. The overall effect on the action potential was 
not reported but these changes are consistent with a prolongation of the action 
potential (Kaur et al., 2013). However, Vasquez et al (2010) found that the action 
potential duration was reduced by medium conditioned with fibroblasts from a model 
of myocardial infarction, and found no effect with normal fibroblasts.  
 
The lack of an effect observed with normal fibroblasts by Vasquez et al (2010) as well 
as the lack of change at time-to-80% repolarisation reported by Guo et al (1999) 
matches what was observed in our experiments. However this does not fit with the 
reports by Pedrotty et al (2009) or Kaur et al (2013). The underlying cause of the 
differences in these reports is not clear. All the previous studies used cells from normal 
rats kept in culture, although Guo et al (1999) and Pedrotty et al (2009) use neonatal 
cells, Vasquez et al (2010) uses adult fibroblasts and neonatal myocytes, and Kaur et al 
(2013) uses adult fibroblasts and myocytes. We have used adult dog cells and tissue. 
There are considerable differences in the electrophysiology and in fibroblasts between 
species and it is possible that the effects may be different (Lompre et al., 1981, 
Dawson et al., 2012). The previous reports have used conditioned medium whereas we 
have used co-culture. In the previous reports there are differences in the conditioning 
protocol used for the production of the conditioned medium and also in the medium 
used. Furthermore, the length of time the myocytes/myocardial slices were kept in co-
culture or conditioned medium was different between the reports, and it has been 
previously shown that mediators can have transient effects on electrophysiology 
(Zhang et al., 2001). Whatever underlies the differences observed in these reports, 
they make it difficult to hypothesise about the effects of fibroblast in the intact heart. 
The use of the myocardial slices rather than isolated myocytes in our experiments is a 
better representation of the intact myocardium, as the myocytes are in an 
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environment closer to that of the intact heart, with the associated ECM, fibroblasts 
and other cell types. Therefore, this work examines the effect on whole myocardial 
tissue rather than just on myocytes including effects on non myocyte cells within the 
slice. Also, dog cardiovascular physiology is more similar to humans than rats are and 
therefore these results may be more applicable to the human heart. 
 
A possible criticism is that field potentials are not accurate in representing action 
potential morphology. However, using the same set up as used here, pharmacological 
intervention to block K+ currents, which are known to affect the action potential, 
prolonged the recorded field potential duration (Camelliti et al., 2011). Our work 
therefore supports some of the published data that reports no change in the field 
potential/action potential duration in response to fibroblast-derived mediators. 
However, this is an area of research that requires further investigation due to the 
conflicting nature of published data. 
 
7.4.2. Conduction velocity 
Neonatal myocytes have been essential for previous investigations of conduction 
velocity. When isolated and put into culture, neonatal myocytes form a confluent 
monolayer that is electrically continuous whereas adult myocytes remain as single 
cells. Therefore conduction velocity cannot be measured in isolated adult cells. 
However, myocardial slices keep myocardial tissue intact, and in particular maintain 
the electrical continuity between myocytes formed by gap junction. They therefore 
allow the measurement of conduction velocity with adult myocytes. The use of adult 
rather than neonatal myocytes had obvious advantages due to the maturity of the 
cells. Slices also have the advantage of maintaining anisotropy; that is the presence of 
the muscle fibres allows longitudinal and transverse conduction velocity 
measurements. In rat neonatal myocyte monolayers conduction is homogeneous and 
do not allow for longitudinal and transverse measurements. The conduction velocity of 
rat neonatal myocytes is approximately 18cm/s (Pedrotty et al., 2009, Vasquez et al., 
2010). This is markedly different from the intact rat heart which has a longitudinal 
conduction velocity of 69cm/s and a transverse conduction velocity of 33 cm/s (Rossi 
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et al., 2008). The longitudinal conduction velocity of a dog heart is 58cm/s and the 
transverse conduction velocity is 25cm/s (Roberts et al., 1979). Our results show a 
longitudinal conduction velocity of 66cm/s and a transverse conduction velocity of 
37cm/s. It is therefore clear that the results with slices are much more representative 
than neonatal myocyte monolayers. The presence of non myocytes and the intact ECM 
also makes myocardial slices a better model as these are important determinants of 
cardiac electrical activity and conduction velocity (Clayton et al., 2011). 
 
Co-culture with cultured fibroblasts slowed the longitudinal conduction velocity, but 
did not affect the transverse conduction velocity. Both Pedrotty et al (2009) and 
Vasquez et al (2010) report that fibroblast conditioned medium slowed conduction 
velocity although Vasquez et al (2010) found that conduction was only significantly 
reduced with fibroblasts from a model of myocardial infarction. The paracrine slowing 
of conduction velocity may represent a pro-arrhythmic effect of fibroblasts. 
Heterogeneous increases in the number of fibroblasts in disease could slow the 
conduction velocity in areas of the myocardium and therefore produce conduction 
heterogeneity and a substrate for arrhythmia initiation (Baum et al., 2012). 
 
The possible mechanisms of reduced conduction velocity include changes in the 
resting membrane potential of myocytes or alterations in gap junction coupling 
between cells, as well as changes in fibroblasts and ECM content interfering with 
conduction (Shaw and Rudy, 1997). Lowering the resting membrane potential of 
myocytes would reduce their excitability and therefore slow the conduction velocity. 
Alternatively, raising the resting membrane potential to the level that voltage-gated 
Na+ channels were inactivated could also reduce conduction velocity (Buchanan et al., 
1985). A reduction in gap junctions would decrease the rapid transmission of electrical 
signal between myocytes and would slow conduction velocity (Rohr, 2004). Gap 
junctions are predominantly located at the intercalated disk between myocytes within 
muscle fibres (Gourdie et al., 1991) and therefore are particularly important in the 
longitudinal conduction velocity. An increase in fibroblasts or ECM content would 
insulate between muscle fibres and be expected to affect transverse conduction. 
Therefore due to the specific reduction in longitudinal conduction velocity observed, 
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the level of connexin 43, the major connexin isoform in myocardial myocytes was 
measured. 
 
7.4.3. Connexin 43 
Previously, fibroblasts have been shown to reduce neonatal myocyte conduction 
velocity without a change in the level of connexin 43, but rather, the reduction in 
conduction velocity was linked to changes in the electrophysiology of these cells 
(Pedrotty et al., 2009). However, in vivo it has been suggested that in the infarct 
border zone following myocardial infarction fibroblasts downregulate connexin 43 
through paracrine release of interleukin 1β (Baum et al., 2012). Therefore, the effect of 
fibroblast-derived mediators on connexin 43 is still debated. We found that connexin 
43 was not significantly reduced in slices after co-culture with fibroblasts. A post hoc 
power calculation was run10 and the sample size required for an α error level of 5% and 
a β error level of 50% was found to be 16. It is therefore possible that this experiment 
is underpowered and producing a false negative result. 
 
Despite the absence of a change in the level of connexin 43 protein, it is possible that a 
reduction in connexin 43 function was responsible for the reduction in longitudinal 
conduction velocity. In cardiovascular disease it has been shown that the localisation 
of connexin 43 to the intercalated disk is lost, and that the protein is found more 
ubiquitously around the cell membrane (Smith et al., 1991). This would reduce the 
transmission of the action potential across the intercalated disk and may explain the 
reduction in longitudinal conduction velocity observed. Also, connexin 43 function is 
altered by phosphorylation and this is another pathway by which connexin 43 function 
could be reduced despite the unchanged level of total protein (Lampe et al., 2000). 
 
Canine ventricular myocytes also express connexin 40 and connexin 45 which are 
active in the formation of gap junctions (Kanter et al., 1992, Kanter et al., 1993). Down 
regulation of either connexin 40 or 45 is another alternative explanation for the 
reduced conduction velocity (Kirchhoff et al., 1998). Changes in the electrophysiology 
                                                 
10
 http://www.dssresearch.com/KnowledgeCenter/toolkitcalculators/samplesizecalculators.aspx 
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of the individual myocytes within the slice, such as changes in resting membrane 
potential, could also underpin these observations and could not be excluded in this set 
of experiments. 
 
7.4.4. Summary 
In this chapter we have shown that co-culture with cultured fibroblasts reduces the 
longitudinal conduction velocity in adult myocardial tissue. This adds to data previously 
showing slowing of conduction in neonatal myocytes and represents a possible pro-
arrhythmic effect of fibroblasts. The level of connexin 43 was measured to investigate 
a possible mechanism underlying these effects but was not significantly altered. 
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CHAPTER 8. 
General Discussion 
  
 196 
This project investigated the hypothesis that fibroblasts can modulate myocyte size 
and excitation contraction coupling via the release of paracrine mediators, and that 
these effects are altered in disease. We set out to investigate potential paracrine 
effects using adult rather than neonatal myocardium, to allow analysis in the setting of 
mature excitation contraction coupling, and adult fibroblasts used before they are 
activated to express α-SMA in culture, to improve the applicability of data to the in 
vivo environment (although this was not possible with the dog fibroblast work). 
 
Initially the effects of normal rat fibroblasts were investigated, and these were found 
to reduce myocyte viability and increase the myocyte volume and Ca2+ transient 
amplitude. Next we showed that these effects are altered when using rat fibroblasts 
from pressure overloaded hearts. Although the loss of cell viability and increase in cell 
size was similar between pressure overload and control fibroblasts, the effect on the 
Ca2+ transient was different with fibroblasts from pressure overloaded hearts causing a 
reduction in the amplitude of the Ca2+ transient.  
 
To examine the effects of fibroblasts on myocardial electrical activity in the 
multicellular setting, dog fibroblasts were co-cultured with myocardial slices. Co-
culture with fibroblasts slowed the longitudinal conduction velocity without altering 
transverse conduction velocity or the action potential duration and variability. 
 
The potential mechanisms of these observations were also investigated. In the cellular 
work, TGF-β type 1 receptors were blocked both in co-culture and in myocytes 
exposed to fibroblasts conditioned medium. TGF-β type 1 receptors appear to directly 
mediate the hypertrophic response of myocytes. They are also involved in the reduced 
viability and changes in the Ca2+ transient, however, these effects are mediated by 
downstream mediators released by fibroblasts in response to TGF-β. Signalling from 
the myocytes to the fibroblasts also modulate the effects of fibroblasts on the 
myocytes, as normal fibroblasts conditioned medium does not induce hypertrophy in 
normal myocytes and the effects on the Ca2+ transient observed in co-culture were 
absent when using conditioned medium. 
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The level of connexin 43 was measured in the myocardial slices as a reduction in 
connexin 43 could explain the changes in longitudinal conduction velocity. However, 
the level of connexin 43 was not significantly affected after co-culture with fibroblasts. 
 
8.1. Strengths and limitations 
One of the major aims at the outset of this thesis was to work with fibroblasts before 
their activation in culture. This was assessed by measuring α-SMA development and 
the fibroblasts were used before they had been activated to express α-SMA in culture. 
This is a strength of this work when compared to previous investigations into fibroblast 
paracrine activity that have used longer time periods and less tightly controlled 
fibroblast culture. Furthermore, adult myocytes and myocardial tissue was used 
throughout. Again, this is a major strength of this work as the majority of previous 
work has worked with neonatal cells. The use of adult myocytes and tissue allows a 
better insight into the effects on myocyte function due to the maturity of the systems 
involved in excitation contraction coupling. Finally, this thesis has directly compared 
fibroblasts from normal and pathological hearts, an essential element of 
understanding the potential roles of fibroblasts in cardiovascular health and disease. 
Vasquez et al (2010) is the only previous report to compare normal and diseased 
fibroblasts, and all other previous reports have only examined the effects of cultured 
fibroblasts from normal hearts.  
 
It is important to note that these major attributes of this work come with inherent 
weaknesses. The use of fibroblasts within 48 hours of isolation also limits the depth at 
which it was possible to investigate the changes observed. By using the fibroblasts at 
this early time point the number of co-culture set ups was lower than if fibroblasts had 
been allowed to proliferate in culture. Therefore, the mechanisms behind the changes 
in Ca2+ handling such as SR Ca2+ content could not be fully investigated. Also, all co-
culture set ups were used for functional experiments and therefore could not be used 
to investigate molecular changes using western blots, to look at protein changes, or 
polymerase chain reaction, to look at mRNA changes. This is a limitation that may be 
overcome by increasing the number of animals used, but was not feasible in this set of 
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experiments. Furthermore adult myocytes and myocardial slices are altered by culture, 
so although they are more mature than neonatal preparations they are limited by 
evident changes in the function of the myocytes and the slices over the 24 hours of 
culture used. It also cannot be excluded that there are changes in the fibroblasts 
despite the absence of α-SMA development.  
 
Another limitation of this work was that only 1 ratio of fibroblasts to 
myocytes/myocardial slice was used. Furthermore, only 1 time point was measured 
after 24 hours. The effects with different ratios of fibroblasts to myocytes, which is 
something that changes in disease states (Zeisberg et al., 2007), requires further future 
studies. It would also have been interesting to look at a longer time course to see if the 
effects were different.  
 
8.2. Implications and further work 
This works add to the growing understanding of how fibroblasts can modulate 
myocyte structure and function. The exciting concept in this field of work is that 
fibroblasts may respond to pathological stimuli and then induce the myocardial 
response to these stimuli through paracrine communication. Fibroblasts are known to 
be sensitive to traditional pathological stimuli such as mechanical stress, biochemical 
mediators (such as Ang II) and hypoxia (Yokoyama et al., 1999, Roy et al., 2003, Porter 
and Turner, 2009). Increasing our understanding of what effects fibroblasts have on 
myocytes, and the potential pathways involved, may therefore eventually open up 
novel therapeutic targets to interfere with the development of cardiovascular disease.  
 
We have shown that fibroblasts from pressure overloaded hearts induce hypertrophy 
in myocytes in co-culture or through conditioned medium, whereas fibroblasts from 
normal hearts only induce hypertrophy in response to signals from the myocytes. This 
backs up previous observations that fibroblasts can induce hypertrophy (e.g. (Harada 
et al., 1997)), and the in vivo models that show fibroblasts paracrine communication is 
important in myocyte hypertrophy in response to pressure overload or isoproterenol 
infusion (Jaffre et al., 2009, Takeda et al., 2010). 
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 A novel finding of this thesis is the change in the paracrine effects of fibroblasts on 
myocyte Ca2+ transients after aortic constriction and pressure overload. Normal 
fibroblasts were found to increase the Ca2+ transient amplitude whereas fibroblast 
from TAC decreased the Ca2+ transient amplitude. Depression of Ca2+ transient 
amplitude is a characteristic of myocytes in failing hearts and it is therefore interesting 
to speculate that fibroblasts may be responding to pressure overload and contributing 
to myocyte dysfunction, which would have clear therapeutic implications. 
 
Another relevant finding was the loss of myocyte viability in response to fibroblast-
derived mediators. Myocyte loss is a characteristic of multiple cardiovascular diseases 
such as hypertrophic cardiomyopathy, atrial fibrillation and ischaemic heart disease 
(Olivetti et al., 1996, Aime-Sempe et al., 1999, Harvey and Leinwand, 2011). A possible 
role in ischaemic heart disease is particularly interesting when the observations of 
myocyte loss is coupled with the previous reports that fibroblasts are sensitive to 
changes in O2 levels (Roy et al., 2003, Kang et al., 2004, Shivakumar et al., 2008). Again, 
it is interesting to hypothesise that fibroblasts may be responding to external stimuli 
and driving the changes in myocytes through paracrine communication. 
 
We have also shown that fibroblasts can affect the electrophysiology of adult 
myocardial tissue. The reduction of longitudinal conduction velocity is potentially pro-
arrhythmic, and it is important to ascertain whether these results are relevant to 
fibroblasts in normal and disease settings. 
 
This work adds to the understanding of the communication between fibroblasts and 
myocytes, but raises many questions that will require further work to answer. Further 
work should be focused on two areas: 
 
Firstly, future work should aim at providing a more detailed mechanistic insight into 
the effects that have been observed here. We have shown that there is a signal arising 
from the myocytes that affects the fibroblasts. Identification of what mediators are 
involved in this signal and the effects on the fibroblast phenotype is equally important 
as understanding the signalling from the fibroblasts to the myocytes. In this respect we 
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have shown that TGF-β is involved, but that there also appears to be downstream 
mediators released from the fibroblasts in response to TGF-β. Identification of these 
downstream mediators is essential in understanding this relationship. Finally, the 
mechanisms behind the changes observed require elucidating. Putative mechanisms 
have been discussed within each chapter but clarification of the mechanisms is 
important. Of particular interest are the level of SR Ca2+ and SERCA that may underlie 
the changes in Ca2+ transients. Finally, the effects of freshly isolated fibroblasts from 
normal and diseased hearts on myocardial slices would improve the applicability of the 
data. 
 
Secondly, future work should look to translate these results into in vivo settings. The 
difficulties working with cultured fibroblasts, myocytes and myocardial slices have 
been discussed at length. This thesis has used fibroblasts at as early a time point of 
culture as possible when examining paracrine communication in vitro. This was 
important to provide the most applicable data to cardiac physiology possible. 
Therefore, to take this further in vivo work is required. The production of fibroblast-
selective transgenic and knock out animals is a young field but has already shown that 
fibroblast-derived paracrine mediators are important in the hypertrophic response of 
the myocardium. It is through examination of myocyte excitation contraction coupling 
in these animals that the results here can be applied to in vivo physiology, ultimately 
improving our understanding of cardiovascular disease. 
 
The use of transgenic animals will allow the investigation of the effects observed in this 
work to be investigated in an in vivo setting. Initially in vivo intervention could be used 
to alter fibroblast function before using the co-culture set up described in this thesis. 
Due to the time frame of the experiments involved in vitro modification of fibroblasts 
using shRNA is not feasible. However, through isolation of fibroblasts from genetically 
modified animals that either lack or overexpress TGF-β, its role in the relationship 
could be explored further by looking at the effect of these cells on isolated myocytes.  
This would still require an in vitro preparation but developing the use of myocardial 
slices to study fibroblasts may allow further transition towards in vivo understanding. 
As myocardial slices contain fibroblasts and myocytes they could be used as a model to 
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understand the paracrine interaction without the addition of external fibroblasts, and 
this would be a further step towards an understanding of in vivo paracrine interaction. 
Myocardial slices from genetically modified animals or the addition of pharmaceutical 
intervention would allow study of interaction between the in situ fibroblasts and 
myocytes. Again, genetic modification targeted specifically at fibroblasts, using a 
promoter such as the pro-2 α -collagen promoter would allow more targeted 
intervention at the level of the fibroblasts. 
 
It is increasingly apparent that a greater understanding of the role of fibroblasts in 
terms of ECM regulation and inter cellular communication is important, and 
particularly with regards to the diversity of fibroblasts. Differences in fibroblasts from 
atria and ventricles have been found (Burstein et al., 2008), and therefore whether the 
paracrine effects of fibroblasts from different parts of the heart have different 
paracrine effects would be interesting to study. Fibroblasts from the atria appear more 
reactive, and therefore may have a role in the initiation of disease. Furthermore, it is 
possible that paracrine factors released from atrial fibroblasts in disease, such as atrial 
fibrillation, could signal to the rest of the heart and be involved in the progression of 
disease through the heart. Other differences may be present in fibroblasts from the 
left free wall, septum and right ventricles that may underlie some changes associated 
with these areas. For example, in hypertrophic obstructive cardiomyopathy, 
hypertrophy and fibrosis are both apparent in the left ventricle outflow tract and it is 
interesting to speculate that fibroblasts activation associated with the fibrosis may 
contribute to exacerbate the hypertrophy through soluble mediators (Noureldin et al., 
2012). 
 
Another areas where an understanding of fibroblasts is important is the development 
of direct reprogramming of fibroblasts to myocytes as a potential intervention to 
increase heart ‘regeneration’ after myocardial infarction (Ieda et al., 2010). The clear 
focus here is the increase in the number of myocytes to improve cardiac pumping 
function. However, the other side of the equation is the potential reduction of the 
number of fibroblasts.  This could have implications on the function of fibroblasts, in 
terms of ECM modulation but also in terms of the interaction with myocytes. Although 
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our α-SMA positive fibroblasts are from a different setting to myocardial infarction 
they had a negative effect on myocyte function. Therefore this could possible present 
another beneficial effect of transformation of fibroblasts to myocytes, although this 
requires further investigation.  
 
8.3. Concluding remark 
We have shown that fibroblasts modulate myocyte size, viability and excitation 
contraction coupling through the release of paracrine mediators, and that TGF-β is 
important in driving these effects. Furthermore, these effects are altered in fibroblasts 
after pressure overload and this may represent a novel pathway in which fibroblasts 
drive the changes in myocardial function in cardiovascular disease. Further work is 
necessary to better identify the mechanism involved and the applicability of this data 
to cardiovascular physiology and disease.  
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